Grand Duchy of Luxembourg
|
|
3711
|
|
98-1569771
|
(Jurisdiction of Incorporation or Organization)
|
|
(Primary Standard Industrial Classification Code Number)
|
|
(I.R.S. Employer Identification Number)
|
Frank R. Adams, Esq.
Faiza Rahman, Esq.
Weil, Gotshal & Manges LLP
767 Fifth Avenue
New York, New York 10153
Tel:
(212) 310-8000
Fax:
(212) 310-8007
|
|
Byron B. Rooney, Esq.
Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, New York 10017
Tel: (212)
450-4000
|
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☐
|
Non-accelerated filer
|
|
☒
|
|
Smaller reporting company
|
|
☐
|
|
|
Emerging growth company
|
|
☒
|
|
|
|||||||||||||||
Title of each class of
securities to be registered |
|
Amount
to be registered |
|
|
Proposed
maximum offering price per share |
|
|
Proposed
maximum aggregate offering price |
|
|
Amount of
registration fee |
|
||||
Primary Offering Ordinary Shares, with a nominal value of €0.10 per share
|
|
|
28,750,000
|
(1)
|
|
$
|
14.01
|
|
|
$
|
402,787,500
|
(1)(2)
|
|
$
|
37,388.40
|
|
|
|
(1)
|
Consists of (i) 25,000,000 Ordinary Shares, with a nominal value of €0.10 per share (“Ordinary Shares”) of Arrival, a joint stock company (
société anonyme
|
(2)
|
Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(a) and Rule 457(c) under the Securities Act of 1933, as amended. The maximum price per share and the maximum aggregate offering price are based on the average of the $14.52 (high) and $13.51 (low) sale price of the Registrant’s Ordinary Shares as reported on the The Nasdaq Stock Market LLC on November 11, 2021, which date is within five business days prior to filing this Registration Statement. Includes the offering price of 3,750,000 additional Ordinary Shares that the underwriters have the option to purchase. See “Underwriting.”
|
|
|
Per
Share
|
|
|
Total
|
|
||
Public offering price
|
|
$
|
|
|
|
$
|
|
|
Underwriting discount(1)
|
|
$
|
|
|
|
$
|
|
|
Proceeds, before expenses, to us
|
|
$
|
|
|
|
$
|
|
|
(1)
|
We refer you to “Underwriting,” beginning on page 127 of this prospectus, for additional information regarding total underwriter compensation.
|
Goldman Sachs International
|
|
J.P. Morgan
|
|
Barclays
|
|
Cowen
|
i |
• |
the ability to maintain the listing of the Ordinary Shares on Nasdaq;
|
• |
changes in applicable laws or regulations;
|
• |
the effects of the
COVID-19
pandemic, including the potential impact of the emergence of variants of
COVID-19,
on Arrival’s business;
|
• |
the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities;
|
• |
the ability to raise additional capital necessary to execute its business plan, which may not be available on acceptable terms or at all;
|
• |
the ability to control expenses and capital expenditures in order to execute on our business plan on time;
|
• |
the risk of downturns and the possibility of rapid change in the highly competitive industry in which Arrival operates;
|
• |
the risk that Arrival and its current and future collaborators are unable to successfully develop and commercialize Arrival’s products or services, or experience significant delays in doing so;
|
• |
the risk that we may never achieve or sustain profitability;
|
• |
the risk that we experience difficulties in managing our growth and expanding operations;
|
• |
the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations;
|
• |
the risk that the utilization of microfactories will not provide the expected benefits due to, among other things, the inability to locate appropriate buildings to use as microfactories, microfactories needing a larger than anticipated factory footprint, and the inability of Arrival to deploy microfactories in the anticipated time frame;
|
• |
that Arrival has identified material weaknesses in its internal control over financial reporting which, if not corrected, could affect the reliability of Arrival’s financial statements;
|
• |
the risk that Arrival is unable to secure or protect its intellectual property; and
|
• |
the possibility that Arrival may be adversely affected by other economic, business, and/or competitive factors.
|
• |
the existing ordinary and preferred shareholders of Arrival Luxembourg SARL contributed their respective equity interests in Arrival Luxembourg SARL to the Company in exchange for Ordinary Shares (the “Exchanges”);
|
• |
following the Exchanges, CIIG merged with and into Merger Sub and all shares of CIIG Common Stock were exchanged for Ordinary Shares, and, in connection therewith, CIIG’s corporate name changed to Arrival Vault US, Inc. (the “Merger”);
|
• |
each outstanding warrant to purchase shares of CIIG’s Common Stock was converted into a Warrant to purchase Ordinary Shares;
|
• |
each Arrival Luxembourg SARL option, whether vested or unvested, was assumed by the Company and now represents an option award exercisable for Ordinary Shares;
|
• |
the Arrival Luxembourg SARL restricted shares were exchanged for restricted Ordinary Shares; and
|
• |
Arrival Luxembourg SARL and CIIG became direct, wholly-owned subsidiaries of the Company.
|
• |
2,391,666 Ordinary Shares issuable upon exercise of Warrants that remaining outstanding as of October 31, 2021 after the giving effect to the redemption described above at an exercise price of $11.50 per share;
|
• |
7,487,670 Ordinary Shares issuable on a time basis and 6,752,938 Ordinary Shares issuable on a milestone basis upon exercise of stock options outstanding as of October 31, 2021 with a weighted-average exercise price of $7.1955 per share;
|
• |
83,635,542 Ordinary Shares reserved under the Arrival Share Option Plan 2020, Arrival Restricted Share Plan and Arrival Incentive Compensation Plan;
|
• |
Ordinary Shares that will be reserved for issuance under Convertible Notes that are expected to be issued concurrently with this Offering.
|
• |
Rock Hill, South Carolina, USA installation has commenced and is expected to be substantially complete by the end of 2021 with Bicester, UK expected to be substantially complete by the end of the first quarter of 2022.
|
• |
Bicester, UK technology cells are being installed to build Arrival Vans for product validation in 2021.
|
• |
Over 1,400 composite panels manufactured using production equipment in Bicester, UK.
|
• |
Over 1,850 high voltage battery modules assembled.
|
• |
In-house
developed autonomous mobile robots (“AMRs”) are now capable of coordinating their movement over a wireless link. This allows multiple AMRs to operate as a single unit to move large or heavy loads.
|
• |
Total capital expenditure at Rock Hill, South Carolina is expected to be approximately $50 million.
|
• |
Bicester, UK is our lab microfactory where we have prioritized being on time for the start of production of the Arrival Van. As a result, we expect total capital expenditure at Bicester, UK to be approximately $75 million.
|
• |
From the learnings gained at Bicester, UK, we expect total capital expenditure at Charlotte, North Carolina to be lower than at Bicester, UK, with continued reductions in capital expenditure per microfactory as we scale beyond the initial microfactories.
|
• |
In order to reduce risks relating to the start of production and enable us to scale, we are incurring additional costs, including: 1) a decision to assemble battery modules and bring logistics
in-house,
which is adding capital expenditure and operating expenditure; 2)
pre-payments
to LG Energy Systems (as assignee of LG Chem Ltd., “LG Chem”) to secure battery cell line capacity for the next several years; and 3) higher selling, general and administrative expenses as we scale sales, finance and legal.
|
• |
In addition, we are experiencing industry-wide increases in the expected cost of raw materials including aluminum and petrochemicals.
|
• |
We also expect higher working capital in our first factories to ensure we have the necessary components and parts to start production of our vehicles.
|
• |
not being required to comply with the auditor attestation requirements for the assessment of our internal control over financial reporting provided by Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”);
|
• |
reduced disclosure obligations regarding executive compensation; and
|
• |
not being required to hold a nonbinding advisory vote on executive compensation or seek shareholder approval of any golden parachute payments not previously approved.
|
• |
the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act;
|
• |
the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and
|
• |
the rules under the Exchange Act requiring the filing with the Securities and Exchange Commission (the “SEC”) of quarterly reports on Form
10-Q
containing unaudited financial and other specified information, or current reports on Form
8-K,
upon the occurrence of specified significant events.
|
• |
Arrival is an early stage company with a history of losses, and expects to incur significant expenses and continuing losses for the foreseeable future.
|
• |
Arrival has a limited operating history and has not yet manufactured or sold any production vehicles to customers and may never develop or manufacture any vehicles.
|
• |
While Arrival has received orders for vehicles, the period of time from the receipt of orders to implementation and delivery is long, potentially spanning over several months, and the orders are subject to the risks of cancellation or postponement of the orders.
|
• |
Arrival’s growth is dependent upon the willingness of operators of commercial vehicle fleets and small to medium sized businesses to adopt EVs and on Arrival’s ability to produce, sell and service vehicles that meet their needs. If the market for commercial EVs does not develop as Arrival expects or develops slower than Arrival expects, Arrival’s business, prospects, financial condition and operating results will be adversely affected.
|
• |
The orders from UPS, LeasePlan and Anaheim Transportation Network constitute all of the current orders for Arrival vehicles. If these orders are cancelled, modified or delayed, Arrival’s prospects, results of operations, liquidity and cash flow will be materially adversely affected.
|
• |
Certain of Arrival’s strategic, development and deployment arrangements could be terminated or may not materialize into long-term contract partnership arrangements and may restrict or limit Arrival from developing EVs with other strategic partners.
|
• |
Arrival’s ability to execute its microfactory production model on a large scale is unproven, still evolving and dependent on Arrival’s ability to raise sufficient capital to support production. This
|
production model may lead to increased costs and/or reduced production of its vehicles and adversely affect Arrival’s ability to operate its business.
|
• |
Arrival may encounter obstacles outside of its control that slow market adoption of EVs, such as regulatory requirements or infrastructure limitations.
|
• |
As Arrival expands into new territories, many of which will be international territories, it may encounter stronger market resistance than it currently expects, including from incumbent competitors in those territories.
|
• |
Arrival is dependent on its suppliers, some of which are single or limited source suppliers, and the inability of these suppliers to deliver the raw materials and components of Arrival’s vehicles in a timely manner and at prices and volumes acceptable to it could have a material adverse effect on its business, prospects and operating results.
|
• |
There are complex software and technology systems that need to be developed in coordination with vendors and suppliers in order to reach production for Arrival’s EVs, and there can be no assurance such systems will be successfully developed.
|
• |
Arrival may incur significant costs and expenses in connection with obtaining, maintaining, protecting, defending and enforcing its intellectual property rights (covering patents, trademarks, trade names, and trade secrets), including through litigation. If such intellectual property is not adequately protected, Arrival may not be able to build name recognition in its markets of interest, and its business and competitive position may be harmed. Additionally, even if Arrival is able to take measures to protect its intellectual property, third-parties may independently develop technologies that are the same or similar to Arrival, and Arrival may not be able to obtain and protect its intellectual property rights throughout the world.
|
• |
Patent applications which have been submitted to the authorities may not result in granted patents or may require the applications to be modified in order for patent coverage to be obtained.
|
• |
The discovery of defects in Arrival vehicles may result in delays in new model launches, recall campaigns or increased warranty costs. Additionally, discovery of such defects may result in a decrease in the residual value of its vehicles, which may materially harm its business.
|
• |
Arrival may become subject to product liability claims, which could harm its financial condition and liquidity if it is not able to successfully defend or insure against such claims.
|
• |
Arrival will rely on complex robotic assembly and component manufacturing for its production, which involves a significant degree of risk and uncertainty in terms of operational performance and costs.
|
• |
If Arrival fails to comply with its obligations under license or technology agreements with third parties, it may be required to pay damages, and Arrival could lose license rights that are critical to its business.
|
• |
Some of Arrival’s products contain open source software, which may pose particular risks to its proprietary software, products and services in a manner that could harm its business.
|
• |
Arrival is subject to stringent and changing laws, rules, regulations and standards, information security policies and contractual obligations related to data privacy and security. Arrival’s actual or perceived failure to comply with such obligations could result in proceedings, actions or penalties and harm its business.
|
• |
Arrival is subject to cybersecurity risks to its various systems and software and any material failure, weakness, interruption, cyber event, incident, undetected defects, errors or bugs, or breach of security could prevent Arrival from effectively operating its business.
|
• |
Arrival is likely to face competition from a number of sources, which may impair its revenues, increase its costs to acquire new customers, and hinder its ability to acquire new customers.
|
• |
Arrival is highly dependent on the services of its senior management team (including Denis Sverdlov, its Founder and Chief Executive Officer), and if Arrival is unable to retain some or all of this team, its ability to compete could be harmed.
|
• |
A market for the Arrival’s securities may not continue, which would adversely affect the liquidity and price of its securities.
|
• |
We do not anticipate paying any cash dividends in the foreseeable future.
|
• |
New investors in our Ordinary Shares will experience immediate and substantial book value dilution after this offering.
|
• |
The Concurrent Convertible Notes Offering could cause the market price for our Ordinary Shares to decline.
|
• |
We may not have the ability to raise the funds necessary to settle conversions of the Convertible Notes in cash or to repurchase the Convertible Notes upon a fundamental change, and our future debt may contain limitations on our ability to pay cash upon conversion or repurchase of the Convertible Notes.
|
• |
The conditional conversion feature of the Convertible Notes, if triggered, may adversely affect our financial condition and operating results.
|
• |
The accounting method for the Convertible Notes could adversely affect Arrival’s reported financial condition and results.
|
Ordinary Shares to be issued and offered by us
|
25,000,000 | |
Underwriters’ option to purchase additional Ordinary Shares
|
We have granted the underwriters the right for 30 days from the date of this prospectus to purchase up to an additional 3,750,000 Ordinary Shares, at the public offering price, less underwriting discounts and commissions. | |
Use of Proceeds
|
We will receive all of the net proceeds from the offering of shares, which we estimate will be approximately $ , after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, assuming an offering price of $ per share. We expect to use the net proceeds from the offering for general corporate purposes. | |
Dividend policy
|
Other than as disclosed elsewhere in this prospectus, we currently expect to retain all future earnings for use in the operation and expansion of our business and do not plan to pay any dividends on our ordinary shares in the near future. The declaration and payment of any dividends in the future will be determined by the Board of Directors in its discretion, and will depend on a number of factors, including our earnings, capital requirements, overall financial condition, applicable law and contractual restrictions. See “
Dividend Policy
|
|
Registration Rights and
Lock-Up
Agreement
|
Our directors, officers and certain of our shareholders are subject to certain restrictions on transfer until the termination of
applicable lock-up periods
and have rights to require that we register the resale of their shares. See “
Shares Eligible for Future Sale
|
|
Market for our securities
|
Our Ordinary Shares are listed on The Nasdaq Global Select Market under the symbol “ARVL”. | |
Risk factors
|
Investing in our securities involves substantial risks. See “
Risk Factors
|
• |
2,391,666 Ordinary Shares issuable upon exercise of Warrants that remain outstanding as of October 31, 2021 after the giving effect to the redemption described above at an exercise price of $11.50 per share;
|
• |
7,487,670 Ordinary Shares issuable on a time basis and 6,752,938 Ordinary Shares issuable on a milestone basis upon exercise of stock options outstanding as of October 31, 2021 with a weighted-average exercise price of $7.1955 per share;
|
• |
83,635,542 Ordinary Shares reserved under the Arrival Share Option Plan 2020, Arrival Restricted Share Plan and Arrival Incentive Compensation Plan;
|
• |
Ordinary Shares that will be reserved for issuance under Convertible Notes that are expected to be issued concurrently with this Offering.
|
• |
no exercise by the underwriters of their option to purchase additional Ordinary Shares; and
|
• |
no exercise of the outstanding warrants or options described above.
|
Nine months ended
|
Year Ended
|
|||||||||||||||
September 30,
2021 |
September 30,
2020* |
December 31,
2020
|
December 31,
2019
|
|||||||||||||
(
In thousands of euro)
|
||||||||||||||||
Administrative expenses
|
(111,627 | ) | (43,248 | ) | (75,133 | ) | (31,392 | ) | ||||||||
Research and development expenses
|
(21,737 | ) | (8,277 | ) | (17,947 | ) | (11,149 | ) | ||||||||
Impairment expense
|
(1,918 | ) | (650 | ) | (391 | ) | (4,972 | ) | ||||||||
Other operating income
|
1,887 | 1,366 | 2,362 | 2,583 | ||||||||||||
Listing expense**
|
(1,018,024 | ) | — | — | — | |||||||||||
Other expenses
|
(5 | ) | (208 | ) | (6,853 | ) | (6,911 | ) | ||||||||
Operating (loss)
|
|
(1,151,424
|
)
|
|
(51,017
|
)
|
|
(97,962
|
)
|
|
(51,841
|
)
|
||||
Finance income
|
119,573 | 1,797 | 2,703 | 51 | ||||||||||||
Finance cost
|
(11,527 | ) | (3,567 | ) | (5,758 | ) | (3,235 | ) | ||||||||
Net Finance income/(cost)
|
|
108,046
|
|
|
(1,770
|
)
|
|
(3,055
|
)
|
|
(3,184
|
)
|
||||
(Loss) before tax
|
|
(1,043,378
|
)
|
|
(52,787
|
)
|
|
(101,017
|
)
|
|
(55,025
|
)
|
||||
Tax income/(expense)
|
(7,118 | ) | 3,337 | 17,802 | 6,929 | |||||||||||
(Loss) for the period
|
|
(1,050,496
|
)
|
|
(49,450
|
)
|
|
(83,215
|
)
|
|
(48,096
|
)
|
||||
Attributable to:
|
||||||||||||||||
Owners of the Company
|
|
(1,050,496
|
)
|
|
(49,450
|
)
|
|
(83,215
|
)
|
|
(48,096
|
)
|
* |
Comparative figures are of Arrival Luxembourg S.à r.l. in accordance with IFRS 2 for reverse merger.
|
** |
As a result of the conclusion of the merger with CIIG, Arrival issued shares and warrants to CIIG shareholders, comprised of the fair value of the Company’s shares that were issued to CIIG shareholders of €1,347 million as well as the fair value of the Company’s warrants of €189 million. In exchange, the Company received the identifiable net assets held by CIIG, which had a fair value upon closing of €534 million. The excess of the fair value of the equity instruments issued over the fair value of the identified net assets received, represents a
non-cash
expense in accordance with IFRS 2. This
one-time
expense as a result of the transaction, in the amount of €1,002 million, is recognized as a share listing expense presented as part of the operating results within the Consolidated Statement of Profit or Loss. Listing expense also includes €16 million of other related transaction expenses.
|
• |
design and produce safe, reliable and quality vehicles on an ongoing basis;
|
• |
obtain the necessary regulatory approvals in a timely manner;
|
• |
build a well-recognized and respected brand;
|
• |
establish and expand its customer base;
|
• |
successfully market not just Arrival’s vehicles but also the other services it intends to provide;
|
• |
properly price its services, including its charging solutions, financing and lease options, and successfully anticipate the take-rate and usage of such services by users;
|
• |
successfully service its vehicles after sales and maintain a good flow of spare parts and customer goodwill;
|
• |
improve and maintain its operational efficiency;
|
• |
successfully execute its microfactory production model and maintain a reliable, secure,
high-performance
and scalable technology infrastructure at costs that enable it to remain competitive;
|
• |
predict its future revenues and appropriately budget for its expenses;
|
• |
obtain sufficient capital to support production needs;
|
• |
attract, retain and motivate talented employees;
|
• |
anticipate trends that may emerge and affect its business;
|
• |
anticipate and adapt to changing market conditions, including technological developments and changes in competitive landscape; and
|
• |
navigate an evolving and complex regulatory environment.
|
• |
whether Arrival can obtain sufficient capital to begin and support its production needs, execute its business plan and grow its business;
|
• |
whether Arrival can control its costs and capital expenditures needed to execute its business plan;
|
• |
Arrival’s ability to manage its growth;
|
• |
whether Arrival can manage relationships with key suppliers;
|
• |
whether Arrival can rapidly deploy its microfactories and successfully execute its production methodologies in such microfactories (including its robotic assembly process and composite manufacturing);
|
• |
the ability to obtain necessary regulatory approvals;
|
• |
demand for Arrival products and services;
|
• |
whether Arrival can achieve its expected pricing for its products and services;
|
• |
the timing and costs of new and existing marketing and promotional efforts;
|
• |
competition, including from established and future competitors;
|
• |
Arrival’s ability to retain existing key management, to integrate recent hires and to attract, retain and motivate qualified personnel;
|
• |
the overall strength and stability of the economies in the markets in which it operates or intends to operate in the future; and
|
• |
regulatory, legislative and political changes;
|
• |
the difference in the initial purchase prices of commercial EVs with comparable vehicles powered by ICE, both including and excluding the effect of government and other subsidies and incentives designed to promote the purchase of EVs;
|
• |
the total cost of ownership of the vehicle over its expected life, which includes the initial purchase price and ongoing operating and maintenance costs;
|
• |
the availability and terms of financing options for purchases of vehicles and, for commercial EVs, financing options for battery systems;
|
• |
the availability of tax and other governmental incentives to purchase and operate EVs and future regulations requiring increased use of nonpolluting vehicles;
|
• |
government regulations and economic incentives promoting fuel efficiency and alternate forms of energy;
|
• |
fuel prices, including volatility in the cost of diesel or a prolonged period of low gasoline and natural gas costs that could decrease incentives to transition to EVs;
|
• |
the cost and availability of other alternatives to diesel fueled vehicles, such as vehicles powered by natural gas;
|
• |
corporate sustainability initiatives;
|
• |
commercial EV quality, performance and safety (particularly with respect to
lithium-ion
battery packs);
|
• |
the quality and availability of service for the vehicle, including the availability of replacement parts;
|
• |
the limited range over which commercial EVs may be driven on a single battery charge;
|
• |
access to charging stations and related infrastructure costs, and standardization of EV charging systems;
|
• |
electric grid capacity and reliability; and
|
• |
macroeconomic factors.
|
• |
may require a larger than anticipated factory footprint, which would increase Arrival’s costs of setting up the microfactories and would significantly delay production of its vehicles;
|
• |
may not be able to reach its rate of production targets within its microfactories for its primary products, which would reduce its ability to be profitable;
|
• |
may not be able to locate existing buildings meeting the requirements for its microfactories with respect to size, shape, power supply, and strength of construction, which would increase its costs of setting up the microfactories and would significantly delay production of its vehicles;
|
• |
may not be able to build the expected number of microfactories, which would reduce its production targets and have a material adverse impact on its results of operations and financial condition; and
|
• |
may experience higher local wages and supplier, manufacturing and construction costs than expected in local regions, resulting in higher operating costs and reducing its ability to be profitable.
|
• |
conforming Arrival’s EVs to various international regulatory requirements where its EVs are sold which requirements may change over time;
|
• |
difficulties in obtaining or complying with various licenses, approvals, certifications and other governmental authorizations necessary to manufacture, sell or service its EVs in any of these jurisdictions;
|
• |
difficulty in staffing and managing foreign operations;
|
• |
difficulties attracting customers in new jurisdictions;
|
• |
foreign government taxes, regulations and permit requirements, including foreign taxes that Arrival may not be able to offset against taxes imposed upon Arrival in the U.S.;
|
• |
a heightened risk of failure to comply with corporation and employment tax laws;
|
• |
fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities Arrival undertakes;
|
• |
U.S. and foreign government trade restrictions, tariffs and price or exchange controls;
|
• |
foreign labor laws, regulations and restrictions;
|
• |
changes in diplomatic and trade relationships;
|
• |
political instability, natural disasters, global health concerns, including health pandemics such as the
COVID-19
pandemic, war or events of terrorism; and
|
• |
the strength of international economies.
|
• |
perceptions about EV quality, safety, design, performance, reliability and cost, especially if adverse events or accidents occur that are linked to the quality or safety of EVs;
|
• |
perceptions about vehicle safety in general, including the use of advanced technology, such as vehicle electronics, batteries and regenerative braking systems;
|
• |
the decline of vehicle efficiency and/or range resulting from deterioration over time in the ability of the battery to hold a charge;
|
• |
changes or improvements in the fuel economy of ICE, the vehicle and the vehicle controls or competitors’ electrified systems;
|
• |
the availability of service, charging and fueling and other associated costs for EVs;
|
• |
access to sufficient charging infrastructure;
|
• |
the risk that government support for EVs and infrastructure may not continue;
|
• |
volatility in the cost of energy, electricity, oil and gasoline could affect buying decisions;
|
• |
government regulations and economic incentives promoting fuel efficiency and alternate forms of energy, including new regulations mandating zero tailpipe emissions compared to overall carbon reduction;
|
• |
the availability of tax and other governmental incentives to purchase and operate EVs or future regulation requiring increased use of nonpolluting vehicles; and
|
• |
macroeconomic factors.
|
• |
expanding the management team;
|
• |
hiring and training new personnel;
|
• |
leveraging consultants to assist with company growth and development;
|
• |
forecasting production and revenue;
|
• |
controlling expenses and investments in anticipation of expanded operations;
|
• |
establishing or expanding design, production, sales and service facilities;
|
• |
implementing and enhancing administrative infrastructure, systems and processes; and
|
• |
expanding into international markets.
|
• |
cease selling, incorporating certain components into, or using vehicles or offering goods or services that incorporate or use the challenged intellectual property;
|
• |
pay substantial damages;
|
• |
seek a license from the holder of the infringed intellectual property right, which license may not be available on reasonable terms, or at all;
|
• |
redesign its vehicles or other goods or services; or
|
• |
establish and maintain alternative branding for its products and services.
|
• |
result in substantial costs and diversion of its resources;
|
• |
put Arrival’s patents or other intellectual property at risk of being invalidated or interpreted narrowly;
|
• |
put Arrival’s patent applications or applications for other intellectual property registrations at risk of not issuing;
|
• |
require Arrival to enter into unfavorable royalty or license agreements, which may not be available on commercially reasonable terms or at all;
|
• |
require Arrival to
re-design
its solutions, which could be costly, time-consuming or impossible; or
|
• |
require that Arrival comply with other unfavorable terms.
|
• |
the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of
lithium-ion
cells required to support the growth of the EV industry as demand for such cells increases;
|
• |
an increase in the cost, or decrease in the available supply, of materials used in the cells;
|
• |
disruption in the supply of cells due to quality issues or recalls by battery cell manufacturers; and
|
• |
fluctuations in the value of any foreign currencies in which battery cell and related raw material purchases are or may be denominated against the purchasing entity’s operating currency.
|
• |
increased subsidies for corn and ethanol production, which could reduce the operating cost of vehicles that use ethanol or a combination of ethanol and gasoline;
|
• |
increased support for other alternative fuel systems, which could have an impact on the acceptance of Arrival’s electric powertrain system; and
|
• |
increased sensitivity by regulators to the needs of established automobile manufacturers with large employment bases, high fixed costs and business models based on the ICE, which could lead them to pass regulations that could reduce the compliance costs of such established manufacturers or mitigate the effects of government efforts to promote alternative fuel vehicles.
|
• |
the requirement that a majority of the Board of Directors consist of independent directors;
|
• |
the requirement that compensation of its executive officers be determined by a majority of the independent directors of the Board of Directors or a compensation committee comprised solely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and
|
• |
the requirement that director nominees be selected, or recommended for the Board of Directors’ selection, either by a majority of the independent directors of the Board of Directors or a nominating committee comprised solely of independent directors with a written charter addressing the committee’s purpose and responsibilities.
|
• |
the judgment of the U.S. court is final and enforceable (
exécutoire
|
• |
the U.S. court had jurisdiction over the subject matter leading to the judgment (that is, its jurisdiction was in compliance both with Luxembourg private international law rules and with the applicable domestic U.S. federal or state jurisdictional rules);
|
• |
the U.S. court applied to the dispute the substantive law that would have been applied by Luxembourg courts (based on recent case law and legal doctrine, it is not certain that this condition would still be required for an exequatur to be granted by a Luxembourg court);
|
• |
the judgment was granted following proceedings where the counterparty had the opportunity to appear and, if it appeared, to present a defense, and the decision of the foreign court must not have been obtained by fraud, but in compliance with the rights of the defendant;
|
• |
the U.S. court acted in accordance with its own procedural laws; and
|
• |
the decisions and the considerations of the U.S. court must not be contrary to Luxembourg international public policy rules or have been given in proceedings of a tax or criminal nature or rendered subsequent to an evasion of Luxembourg law (
fraude à la loi
|
Assumed public offering price per share
|
$ | 13.52 | ||
Pro forma net tangible book value per share as of September 30, 2021
|
€ | 1.37 | ||
Increase in pro forma net tangible book value per share attributable to new investors
|
€ | 0.39 | ||
|
|
|||
Pro forma as adjusted net tangible book value per share after this offering
|
€ | 1.76 | ||
|
|
|||
Dilution in net tangible book value per share to new investors in this offering
|
€ | 9.88 | ||
|
|
Shares Purchased
|
Total Consideration
|
Average
Price Per Share |
||||||||||||||||||
Number
(€ million) |
Percent
|
Amount
(€ million) |
Percent
|
|||||||||||||||||
Existing stockholders
|
599.5 | 96.0 | % | 4,958.9 | 94.7 | % | € | 8.27 | ||||||||||||
New investors
|
25.0 | 4.0 | % | 278.0 | 5.3 | % | € | 11.12 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total
|
624.5 | 100.0 | % | 5,236.9 | $ | 100.0 | % | € | 8.39 | |||||||||||
|
|
|
|
|
|
|
|
|
|
As of September 30, 2021
((€) in millions)
|
||||||||
Actual
|
As Adjusted
|
|||||||
Non-current
assets
|
567.7 | 567.7 | ||||||
Cash and cash equivalents(1)
|
380.7 | 658.7 | ||||||
Other current assets
|
90.3 | 90.3 | ||||||
|
|
|
|
|||||
Total assets
|
|
1,038.7
|
|
|
1,316.7
|
|
||
|
|
|
|
|||||
Current liabilities(2)
|
51.5 | 51.5 | ||||||
Loans and borrowings(3)
|
143.0 | 143.0 | ||||||
Deferred tax liability
|
7.0 | 7.0 | ||||||
Warrant liability
|
13.0 | 13.0 | ||||||
|
|
|
|
|||||
Total liabilities
|
|
214.5
|
|
|
214.5
|
|
||
|
|
|
|
|||||
Share capital(4)
|
62.0 | 64.5 | ||||||
Share premium(5)
|
4,896.9 | 5,172.4 | ||||||
Other reserves
|
(2,825.4 | ) | (2,825.4 | ) | ||||
Accumulated deficit
|
(1,309.3 | ) | (1,309.3 | ) | ||||
|
|
|
|
|||||
Total shareholders’ equity
|
|
824.2
|
|
|
1,102.2
|
|
||
|
|
|
|
|||||
Total liabilities and shareholders’ equity
|
|
1,038.7
|
|
|
1,316.7
|
|
(1) |
The adjusted cash and cash equivalents give pro forma effect as if the assumed proceeds from the equity offering less underwriter fees and discounts of €277,966,945 were received as of September 30, 2021.
|
(2) |
Includes short-term loans and borrowings of €6.0 million, which relate to the short-term part of lease liabilities.
|
(3) |
Consists of lease liabilities, primarily on Arrival facilities.
|
(4) |
The adjusted Share capital gives pro forma effect as if 25,000,000 Ordinary Shares with a par value of €0.10 was issued as of September 30, 2021.
|
(5) |
The adjusted Share premium gives pro forma effect as if the assumed proceeds less underwriter fees and discounts of €277,966,645 less the amount allocated to Share capital of €2,500,000 was received at September 30, 2021.
|
• |
Prototype Arrival Vans have been built and are being tested.
|
• |
Buses for public road trials are currently being built.
|
• |
Arrival has installed and is running production equipment to manufacture the battery modules used on both the Arrival Bus and Arrival Van
..
|
• |
Arrival has installed and is running production equipment to manufacture composite panels at its Bicester, UK microfactory.
|
• |
Equipment delivery to Arrival’s Rock Hill, South Carolina microfactory is underway. Installation of equipment is expected to be substantially complete in the fourth quarter of 2021.
|
• |
Vehicle assembly in Arrival’s highly flexible, local microfactories that can be set up quickly with lower capital expenditures;
|
• |
Development of Arrival’s high and low voltage
“plug
& play” components
|
• |
Use a
modular skateboard platform
|
• |
Use of
proprietary composite material
|
• |
Use of our
in-house
developed software
|
• |
Battery related innovations
|
• |
Composite material innovations
|
• |
Microfactory and vehicle design flow innovations
|
• |
Modular hardware and modular software innovations
|
• |
Robotics related innovations
|
• |
Van innovations
|
• |
Bus innovations
|
• |
Car innovations
|
• |
Miscellaneous inventions related to vehicle parts/and systems
|
• |
Rapid Engineering Design Tools
|
• |
Mobility as a service offerings
|
• |
New vehicle concepts, platforms and segments
|
• |
Components development
|
• |
Materials research
|
• |
Charging infrastructure
|
• |
Fintech and insurance
|
• |
New servicing and maintenance technologies and solutions
|
• |
Robotics
|
• |
Digital sales platform
|
• |
Arrival’s modular skateboard platform allows for multiple vehicle platforms and variants. Arrival believes this configurable design enables customization for local markets and accelerated entry into new vehicle segments.
|
• |
Arrival is building multiple customer-facing software packages such as vehicle health monitoring, fleet optimization tools, and driver applications that work with its vehicles.
|
• |
Arrival’s vehicles have been designed with the sensing, computing and chassis system capabilities required for the implementation of autonomous driving that can be used as vehicle platforms by third-party companies developing autonomous software.
|
• |
Finally, various regulatory agencies are adopting credit mechanisms to encourage the adoption of electric commercial vehicles. As Arrival only manufactures EVs, it expects to generate a surplus of these credits. These credits can then be sold to OEMs that are at risk of not meeting their regulatory credit requirements.
|
• |
Gulf States—based on U.S. requirements
|
• |
China—based on EU requirements
|
• |
South Korea—based on EU, U.S. requirements
|
• |
India—based on EU requirements
|
• |
Brazil—based on U.S. requirements
|
• |
the existing ordinary and preferred shareholders of Arrival Luxembourg SARL contributed their respective equity interests in Arrival Luxembourg SARL to the Company in exchange for Ordinary Shares (the “Exchanges”);
|
• |
following the Exchanges, CIIG merged with and into Merger Sub and all shares of CIIG Common Stock were exchanged for Ordinary Shares, and, in connection therewith, CIIG’s corporate name changed to Arrival Vault US, Inc. (the “Merger”);
|
• |
each outstanding warrant to purchase shares of CIIG’s common stock was converted into a Warrant to purchase Ordinary Shares;
|
• |
each Arrival Luxembourg SARL option, whether vested or unvested, was assumed by the Company and now represents an option award exercisable for Ordinary Shares;
|
• |
the Arrival Luxembourg SARL restricted shares were exchanged for restricted Ordinary Shares; and
|
• |
Arrival Luxembourg SARL and CIIG became direct, wholly-owned subsidiaries of the Company.
|
• |
2,391,666 Ordinary Shares issuable upon exercise of Warrants that remaining outstanding as of October 31, 2021 after the giving effect to the redemption described above at an exercise price of $11.50 per share;
|
• |
7,487,670 Ordinary Shares issuable on a time basis and 6,752,938 Ordinary Shares issuable on a milestone basis upon exercise of stock options outstanding as of October 31, 2021 with a weighted-average exercise price of $7.1955 per share;
|
• |
83,635,542 Ordinary Shares reserved under the Arrival Share Option Plan 2020, Arrival Restricted Share Plan and Arrival Incentive Compensation Plan;
|
• |
Ordinary Shares that will be reserved for issuance under Convertible Notes that are expected to be issued concurrently with this Offering.
|
• |
Rock Hill, South Carolina, USA installation has commenced and is expected to be substantially complete by the end of 2021 with Bicester, UK expected to be substantially complete by the end of the first quarter of 2022.
|
• |
Bicester, UK technology cells are being installed to build Arrival Vans for product validation in 2021.
|
• |
Over 1,400 composite panels manufactured using production equipment in Bicester, UK.
|
• |
Over 1,850 high voltage battery modules assembled.
|
• |
In-house
developed autonomous mobile robots (“AMRs”) are now capable of coordinating their movement over a wireless link. This allows multiple AMRs to operate as a single unit to move large or heavy loads.
|
• |
Total capital expenditure at Rock Hill, South Carolina is expected to be approximately $50 million.
|
• |
Bicester, UK is our lab microfactory where we have prioritized being on time for the start of production of the Arrival Van. As a result, we expect total capital expenditure at Bicester, UK to be approximately $75 million.
|
• |
From the learnings gained at Bicester, UK, we expect total capital expenditure at Charlotte, North Carolina to be lower than at Bicester, UK, with continued reductions in capital expenditure per microfactory as we scale beyond the initial microfactories.
|
• |
In order to reduce risks relating to the start of production and enable us to scale, we are incurring additional costs, including: 1) a decision to assemble battery modules and bring logistics
in-house,
which is adding capital expenditure and operating expenditure; 2)
pre-payments
to LG Energy Systems (as assignee LG Chem) to secure battery cell line capacity for the next several years; and 3) higher selling, general and administrative expenses as we scale sales, finance and legal.
|
• |
In addition, we are experiencing industry-wide increases in the expected cost of raw materials including aluminum and petrochemicals.
|
• |
We also expect higher working capital in our first factories to ensure we have the necessary components and parts to start production of our vehicles.
|
• |
Prototype Arrival Vans have been built and are being tested.
|
• |
Buses for public road trials are currently being built.
|
• |
Arrival has installed and is running production equipment to manufacture the battery modules used on both the Arrival Bus and Arrival Van.
|
• |
Arrival has installed and is running production equipment to manufacture composite panels at its Bicester, UK microfactory.
|
• |
Equipment delivery to Arrival’s Rock Hill, South Carolina microfactory is underway. Installation of equipment is expected to be substantially complete in the fourth quarter of 2021.
|
Nine months ended
September 30,
|
Changes
|
%
Changes |
||||||||||||||
2021
|
2020*
|
|||||||||||||||
In thousands of euro | ||||||||||||||||
Revenue
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cost of Revenue
|
— | — | — | — | ||||||||||||
Gross Profit
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Administrative expenses
|
(111,627 | ) | (43,248 | ) | (68,379 | ) | (158 | %) | ||||||||
Research and development expenses
|
(21,737 | ) | (8,277 | ) | (13,460 | ) | (163 | %) | ||||||||
Impairment expense
|
(1,918 | ) | (650 | ) | (1,268 | ) | (195 | %) | ||||||||
Other operating income
|
1,887 | 1,366 | 521 | 38 | % | |||||||||||
Listing expense**
|
(1,018,024 | ) | — | (1,018,024 | ) | — | ||||||||||
Other expenses
|
(5 | ) | (208 | ) | 203 | 98 | % | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating (loss)
|
|
(1,151,424
|
)
|
|
(51,017
|
)
|
|
(1,100,407
|
)
|
|
(2,157
|
%)
|
||||
|
|
|
|
|
|
|
|
|||||||||
Finance income
|
119,573 | 1,797 | 117,776 | 6,554 | % | |||||||||||
Finance cost
|
(11,527 | ) | (3,567 | ) | (7,960 | ) | (223 | %) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net Finance income/(cost)
|
|
108,046
|
|
|
(1,770
|
)
|
|
109,816
|
|
|
6,204
|
%
|
||||
|
|
|
|
|
|
|
|
|||||||||
(Loss) before tax
|
(1,043,378 | ) | (52,787 | ) | (990,591 | ) | (1,877 | %) | ||||||||
Tax income/(expense)
|
(7,118 | ) | 3,337 | (10,455 | ) | (313 | %) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
(Loss) for the period
|
|
(1,050,496
|
)
|
|
(49,450
|
)
|
|
(1,001,046
|
)
|
|
(2,024
|
%)
|
||||
|
|
|
|
|
|
|
|
|||||||||
Attributable to:
|
||||||||||||||||
Owners of the Company
|
(1,050,496 | ) | (49,450 | ) | (1,001,046 | ) | (2,024 | %) |
* |
Comparative figures are of Arrival Luxembourg S.à r.l. in accordance with IFRS 2 for reverse merger.
|
** |
As a result of the conclusion of the merger with CIIG, Arrival issued shares and warrants to CIIG shareholders, comprised of the fair value of the Company’s shares that were issued to CIIG shareholders of €1,347 million as well as the fair value of the Company’s warrants of €189 million. In exchange, the Company received the identifiable net assets held by CIIG, which had a fair value upon closing of €534 million. The excess of the fair value of the equity instruments issued over the fair value of the identified net assets received, represents a
non-cash
expense in accordance with IFRS 2. This
one-time
expense as a result of the transaction, in the amount of €1,002 million, is recognized as a share listing expense presented as part of the operating results within the Consolidated Statement of Profit or Loss. Listing expense also includes €16 million of other related transaction expenses.
|
For the Year Ended
December 31, |
Changes
|
%
Changes |
||||||||||||||
2020
|
2019
|
|||||||||||||||
In thousands of euro | ||||||||||||||||
Revenue
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cost of Revenue
|
— | — | — | — | ||||||||||||
Gross Profit
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Administrative Expenses
|
(75,133 | ) | (31,392 | ) | (43,741 | ) | (139 | %) | ||||||||
Research and Development Expenses
|
(17,947 | ) | (11,149 | ) | (6,798 | ) | (61 | %) | ||||||||
Impairment Expense
|
(391 | ) | (4,972 | ) | 4,581 | 92 | % | |||||||||
Other Income
|
2,362 | 2,583 | (221 | ) | (9 | %) | ||||||||||
Other Expenses
|
(6,853 | ) | (6,911 | ) | 58 | (1 | %) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating Loss
|
|
(97,962
|
)
|
|
(51,841
|
)
|
|
(46,121
|
)
|
|
89
|
%
|
||||
|
|
|
|
|
|
|
|
|||||||||
Finance Income
|
2,703 | 51 | 2,652 | 5,200 | % | |||||||||||
Finance Expense
|
(5,758 | ) | (3,235 | ) | (2,523 | ) | (78 | %) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net Finance (Expense)/Income
|
|
(3,055
|
)
|
|
(3,184
|
)
|
|
129
|
|
|
4
|
%
|
||||
|
|
|
|
|
|
|
|
|||||||||
Loss Before Tax
|
(101,017 | ) | (55,025 | ) | (45,992 | ) | (84 | %) | ||||||||
Tax Income
|
17,802 | 6,929 | 10,873 | 157 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss for the Year
|
|
(83,215
|
)
|
|
(48,096
|
)
|
|
(35,119
|
)
|
|
(73
|
%)
|
||||
|
|
|
|
|
|
|
|
For the Year Ended
December 31, |
Changes
|
%
Changes |
||||||||||||||
2019
|
2018
|
|||||||||||||||
In thousands of euro | ||||||||||||||||
Revenue
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cost of Revenue
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross Profit
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Administrative Expenses
|
(31,392 | ) | (16,769 | ) | (14,623 | ) | (87 | %) | ||||||||
Research and Development Expenses
|
(11,149 | ) | (6,219 | ) | (4,930 | ) | (79 | %) | ||||||||
Impairment Expense
|
(4,972 | ) | (9,347 | ) | 4,375 | 47 | % | |||||||||
Other Income
|
2,583 | 1,167 | 1,416 | 121 | % | |||||||||||
Other Expenses
|
(6,911 | ) | (13 | ) | (6,898 | ) | (53,062 | %) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating Loss
|
|
(51,841
|
)
|
|
(31,181
|
)
|
|
(20,660
|
)
|
|
(66
|
%)
|
||||
|
|
|
|
|
|
|
|
|||||||||
Finance Income
|
51 | 140 | (89 | ) | (64 | %) | ||||||||||
Finance Expense
|
(3,235 | ) | (99 | ) | (3,136 | ) | (3,168 | %) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net Finance (Expense)/Income
|
|
(3,184
|
)
|
|
41
|
|
|
(3,225
|
)
|
|
(7,866
|
%)
|
||||
|
|
|
|
|
|
|
|
|||||||||
Loss Before Tax
|
(55,025 | ) | (31,140 | ) | (23,885 | ) | (77 | %) | ||||||||
Tax Income
|
6,929 | 951 | 5,978 | 629 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss for the Year
|
|
(48,096
|
)
|
|
(30,189
|
)
|
|
(17,907
|
)
|
|
(59
|
%)
|
||||
|
|
|
|
|
|
|
|
For the Year
Ended December 31, |
||||||||||||
2020
|
2019
|
2018
|
||||||||||
In thousands of euro |
Restated*
|
Restated*
|
||||||||||
Net cash provided by (used in)
|
||||||||||||
Operating activities
|
(77,326 | ) | (35,135 | ) | (19,523 | ) | ||||||
Investing activities
|
(106,688 | ) | (48,342 | ) | (25,914 | ) | ||||||
Financing activities
|
153,754 | 178,624 | 41,052 | |||||||||
|
|
|
|
|
|
|||||||
Net change in cash and cash equivalents
|
(30,260 | ) | 95,147 | (4,385 | ) | |||||||
|
|
|
|
|
|
* |
Restated to reflect reclassification of cash flows described in Note 2 in the accompanying consolidated financial statements of Arrival included elsewhere in this prospectus.
|
Payments Due by Period
|
||||||||||||||||
Total
|
Less than
1 Year |
1-5 Years
|
More than
5 Years |
|||||||||||||
In thousands of euro
|
||||||||||||||||
Contractual Obligations:
|
||||||||||||||||
Operating Lease Obligations
|
135,595 | 9,891 | 42,905 | 82,799 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total
|
135,595 | 9,891 | 42,905 | 82,799 | ||||||||||||
|
|
|
|
|
|
|
|
Name
|
Age
|
Title
|
||||
Denis Sverdlov
|
43 | Chief Executive Officer | ||||
John Wozniak
|
50 | Chief Financial Officer | ||||
Avinash Rugoobur
|
40 | President and Director | ||||
Michael Ableson
|
60 | Chief Executive Officer, Automotive | ||||
Daniel Chin
|
38 | General Counsel | ||||
Tawni Nazario-Cranz
|
47 | Director | ||||
F. Peter Cuneo (Chairman)
|
77 | Director | ||||
Alain Kinsch
|
50 | Director | ||||
Kristen O’Hara
|
51 | Director | ||||
Yunseong Hwang
|
53 | Director | ||||
Rexford J. Tibbens
|
53 | Director |
• |
appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm;
|
• |
discussing with our independent registered public accounting firm their independence from management;
|
• |
reviewing, with our independent registered public accounting firm, the scope and results of their audit;
|
• |
approving all audit and permissible
non-audit
services to be performed by our independent registered public accounting firm;
|
• |
overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the annual financial statements that we file with the SEC;
|
• |
overseeing our financial and accounting controls and compliance with legal and regulatory requirements;
|
• |
reviewing our policies on risk assessment and risk management;
|
• |
reviewing related person transactions; and
|
• |
establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters.
|
• |
reviewing and approving the corporate goals and objectives, evaluating the performance of and reviewing and approving, (either alone or, if directed by the Board of Directors, in conjunction with a majority of the independent members of the Board of Directors) the compensation of our Chief Executive Officer;
|
• |
overseeing an evaluation of the performance of and reviewing and setting or making recommendations to our Board of Directors regarding the compensation of our other executive officers;
|
• |
reviewing and approving or making recommendations to our Board of Directors regarding our incentive compensation and equity-based plans, policies and programs;
|
• |
reviewing and approving all employment agreement and severance arrangements for our executive officers;
|
• |
making recommendations to our Board of Directors regarding the compensation of our directors; and
|
• |
retaining and overseeing any compensation consultants.
|
• |
overseeing succession planning for our Chief Executive Officer and other executive officers;
|
• |
periodically reviewing our Board of Directors’ leadership structure and recommending any proposed changes to our Board of Directors;
|
• |
overseeing an annual evaluation of the effectiveness of our board of directors and its committees; and
|
• |
developing and recommending to our Board of Directors a set of corporate governance guidelines.
|
• |
2,391,666 Ordinary Shares issuable upon exercise of Warrants that remaining outstanding as of October 31, 2021 after the giving effect to the redemption described above at an exercise price of $11.50 per share;
|
• |
7,487,670 Ordinary Shares issuable on a time basis and 6,752,938 Ordinary Shares issuable on a milestone basis upon exercise of stock options outstanding as of October 31, 2021 with a weighted-average exercise price of $7.1955 per share;
|
• |
83,635,542 Ordinary Shares reserved under the Arrival Share Option Plan 2020, Arrival Restricted Share Plan and Arrival Incentive Compensation Plan;
|
• |
Ordinary Shares that will be reserved for issuance under Convertible Notes that are expected to be issued concurrently with this Offering.
|
• |
no exercise by the underwriters of their option to purchase additional Ordinary Shares; and
|
• |
no exercise of the outstanding warrants or options described above.
|
• |
prior authorization by a simple majority vote at an ordinary general meeting of shareholders, which authorization sets forth:
|
• |
the terms and conditions of the proposed repurchase and in particular the maximum number of Ordinary Shares to be repurchased;
|
• |
the duration of the period for which the authorization is given, which may not exceed five years; and
|
• |
the shares repurchases, taking into account the treasury shares held pursuant to previous redemptions, may not have the effect of reducing the net assets below the thresholds set forth in article 430-15 of the 1915 Law;
|
• |
only fully
paid-up
Ordinary Shares may be repurchased;
|
• |
the voting and dividend rights attached to the repurchased shares will be suspended as long as the repurchased Ordinary Shares are held by the Company; and the acquisition offer must be made on the same terms and conditions to all the shareholders who are in the same position, except for acquisitions which were unanimously decided by a general meeting at which all the shareholders were present or represented. In addition, listed companies may repurchase their own shares on the stock exchange without an acquisition offer having to be made to our shareholders.
|
• |
On September 12, 2017, Arrival acquired TRA Robotics Ltd (later renamed Arrival Robotics Ltd) from K Remy Robotics S.à r.l. (an affiliate of Kinetik S.à r.l.) for $1.8 million.
|
• |
On October 30, 2018, Arrival Ltd, a subsidiary of Arrival, acquired
Sim-ply
Designed Ltd from Studio 26 S.à r.l. (an affiliate of Kinetik S.à r.l.) for €1.7 million.
|
• |
On April 11, 2019, Arrival acquired Arrival Management Systems Limited (later renamed Arrival M Ltd) from K Cybernation S.à r.l. (an affiliate of Kinetik S.à r.l.) for €3.3 million.
|
• |
On September 2, 2019, Arrival Ltd, a subsidiary of Arrival, acquired Roborace Limited (later renamed Arrival R Ltd) from K Robolife S.à r.l. (an affiliate of Kinetik S.à r.l.) for €61.1 million.
|
• |
On September 2, 2019, Arrival acquired Roborace Inc. (later renamed Arrival USA Inc.) from K Robolife S.à r.l. (an affiliate of Kinetik S.à r.l.) for €4.5 million.
|
Tim Holbrow:
|
176,001 | |
Avinash Rugoobur:
|
880,001 | |
Mike Ableson:
|
440,001 | |
Daniel Chin:
|
293,334 |
• |
each person known by us to own beneficially more than five percent of our common stock;
|
• |
each of our directors;
|
• |
each of our named executive officers; and
|
• |
all of our current executive officers and directors as a group.
|
Name of Beneficial Owner
|
Number of
Common Shares Beneficially Owned |
Percentage of
Outstanding Common Shares
(1)
|
||||||
Executive Officers and Directors:
|
||||||||
Denis Sverdlov
(2)
|
818,639 | * | ||||||
John Wozniak
|
— | — | ||||||
Tim Holbrow
|
98,237 | * | ||||||
Avinash Rugoobur
|
491,184 | * | ||||||
Michael Ableson
|
245,593 | * | ||||||
Daniel Chin
|
163,728 | * | ||||||
Tawni Nazario-Cranz
|
2,500 | * | ||||||
F. Peter Cuneo
(3)
|
681,346 | * | ||||||
Alain Kinsch
|
2,500 | * | ||||||
Kristen O’Hara
|
27,500 | * | ||||||
Rexford J. Tibbens
Yunseong Hwang
|
|
2,500
—
|
|
|
*
—
|
|
||
All directors and executive officers as a group (12 individuals)
|
2,533,727 | * | ||||||
Five Percent or More Holders:
|
||||||||
Kinetik S.à r.l.
(4)
|
463,275,682 | 74.67 | % |
* |
Less than one percent of outstanding Ordinary Shares.
|
(1) |
Percentages are based on 620,431,341 Ordinary Shares outstanding as of October 31, 2021.
|
(2) |
Does not include the 818,639 milestone-based options for which the vesting event has not occurred. Does not include Ordinary Shares held by Kinetik S.à r.l. Mr. Sverdlov is the founder of Kinetik S.à r.l. Kinetik S.à r.l. is owned by The Kinetik Trust, of which Mr. Sverdlov is a beneficiary. Mr. Sverdlov disclaims beneficial interest of such shares.
|
(3) |
Includes Ordinary Shares held in joint ownership with Maris S. Cuneo.
|
(4) |
Includes 75,770,000 Ordinary Shares held by Kinetik Finance SARL, a wholly-owned subsidiary of Kinetik S.à r.l. The trustee of The Kinetik Trust, The Kinetik Foundation, may be deemed to have voting and dispositive power of the Ordinary Shares held by Kinetik S.à r.l. and Kinetik Finance SARL. Voting and investment decisions are made on behalf of The Kinetik Foundation by a council of three members, none of whom have individual or investment power with respect to such shares.
|
• |
2,391,666 Ordinary Shares issuable upon exercise of Warrants that remaining outstanding as of October 31, 2021 after the giving effect to the redemption described above at an exercise price of $11.50 per share;
|
• |
7,487,670 Ordinary Shares issuable on a time basis and 6,752,938
|
• |
14,240,608 Ordinary Shares reserved under the Arrival Share Option Plan 2020;
|
• |
Ordinary Shares that will be reserved for issuance under Convertible Notes that are expected to be issued concurrently with this Offering.
|
• |
1.0% of the number of Ordinary Shares then outstanding, which will equal approximately Ordinary Shares immediately after the completion of this offering based on the number of Ordinary Shares outstanding as of October 31, 2021; and
|
• |
the average weekly trading volume of our Ordinary Shares on Nasdaq during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale, provided, in each case, that we have been subject to the Exchange Act periodic reporting requirements for at least 90 days before the sale. Such sales by affiliates must also comply with the manner of sale, current public information and notice provisions of Rule 144.
|
• |
the issuer of the securities that was formerly a shell company has ceased to be a shell company;
|
• |
the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;
|
• |
the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials); and
|
• |
at least one year has elapsed from the time that the issuer filed Form
20-F
type information with the SEC, which we filed on March 26, 2021, reflecting our status as an entity that is not a shell company.
|
• |
financial institutions or financial services entities;
|
• |
insurance companies;
|
• |
government agencies or instrumentalities thereof;
|
• |
regulated investment companies and real estate investment trusts;
|
• |
expatriates or former residents of the United States;
|
• |
persons that acquired the Ordinary Shares pursuant to an exercise of employee share options, in connection with employee share incentive plans or otherwise as compensation;
|
• |
dealers or certain electing traders subject to a
mark-to-market
|
• |
persons holding the Ordinary Shares as part of a “straddle,” constructive sale, integrated transactions or similar transactions;
|
• |
persons whose functional currency is not the U.S. dollar;
|
• |
partnerships or other pass-through entities for U.S. federal income tax purposes or investors in such entities;
|
• |
persons required to accelerate the recognition of any item of gross income with respect to the Ordinary Shares as a result of such income being recognized on an applicable financial statement;
|
• |
persons actually or constructively owning 10% or more of the Ordinary Shares; or
|
• |
tax-exempt
entities.
|
• |
an individual who is a citizen or resident of the United States;
|
• |
a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;
|
• |
an estate whose income is subject to U.S. federal income tax regardless of its source; or
|
• |
a trust if (1) a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust; or (2) the trust has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person.
|
• |
the gain or excess distribution will be allocated ratably over the period during which the U.S. holder held its Ordinary Shares;
|
• |
the amount allocated to the current taxable year, will be treated as ordinary income; and
|
• |
the amount allocated to prior taxable years will be subject to the highest tax rate in effect for that taxable year and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.
|
Underwriter
|
Number
of shares |
|||
Goldman Sachs International
|
||||
J.P. Morgan Securities LLC
|
||||
Barclays Capital Inc.
|
||||
Cowen and Company, LLC
|
||||
Total
|
||||
Per
Share |
Without
Option |
With
Option
|
||||||||||
Public offering price
|
$ | $ | $ | |||||||||
Underwriting discount
|
$ | $ | $ | |||||||||
Proceeds, before expenses, to us
|
$ | $ | $ |
• |
offer, pledge, sell or contract to sell any common stock,
|
• |
sell any option or contract to purchase any common stock,
|
• |
purchase any option or contract to sell any common stock,
|
• |
grant any option, right or warrant for the sale of any common stock,
|
• |
lend or otherwise dispose of or transfer any common stock,
|
• |
request or demand that we file or make a confidential submission of a registration statement related to the common stock, or
|
• |
enter into any swap or other agreement that transfers, in whole or in part, the economic consequence of ownership of any common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise.
|
a. |
to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
|
b. |
to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer; or
|
c. |
in any other circumstances falling within Article 1(4) of the Prospectus Regulation,
|
(a) |
a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or
|
(b) |
a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,
|
(a) |
to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA;
|
(b) |
where no consideration is or will be given for the transfer;
|
(c) |
where the transfer is by operation of law; or
|
(d) |
as specified in Section 276(7) of the SFA.
|
U.S. Dollar
|
||||
SEC Registration Fee
|
$ | 37,388.40 | ||
FINRA Filing Fee
|
$ | 60,918,13 | ||
Legal Fees and Expenses
|
||||
Accounting Fees and Expenses
|
||||
Printing Expenses
|
||||
Transfer Agent Expenses
|
||||
Miscellaneous Expenses
|
||||
|
|
|||
Total
|
$ | |||
|
|
Page
|
||||
ARRIVAL LUXEMBOURG SARL
|
||||
Audited Financial Statements
|
||||
F-4
|
||||
F-5
|
||||
F-6
|
||||
F-7
|
||||
F-8
|
||||
F-9
|
||||
ARRIVAL
|
||||
For the period from October 27, 2020 (inception) through December 31, 2020
|
||||
Audited Financial Statements
|
||||
F-59
|
||||
F-60
|
||||
F-61
|
||||
F-62
|
||||
F-63
|
||||
F-64
|
||||
For the nine and three months periods ended September 30, 2021 and September 30, 2020
|
||||
Unaudited Financial Statements
|
||||
F-73 | ||||
F-74 | ||||
F-75 | ||||
F-76 | ||||
F-77 | ||||
F-79 |
Page | ||
F-4 | ||
F-5 | ||
F-6 | ||
F-7 | ||
F-8 | ||
F-9 - F-56
|
In thousands of euro
|
2020
|
2019
|
2018
|
|||||||||||||
Note | ||||||||||||||||
Continuing Operations
|
||||||||||||||||
Administrative expenses
|
19C | (75,133 | ) | (31,392 | ) | (16,769 | ) | |||||||||
Research and development expenses
|
19C | (17,947 | ) | (11,149 | ) | (6,219 | ) | |||||||||
Impairment expense
|
19C | (391 | ) | (4,972 | ) | (9,347 | ) | |||||||||
Other income
|
19A | 2,362 | 2,583 | 1,167 | ||||||||||||
Other expenses
|
19B | (6,853 | ) | (6,911 | ) | (13 | ) | |||||||||
|
|
|
|
|
|
|||||||||||
Operating loss
|
|
(97,962
|
)
|
|
(51,841
|
)
|
|
(31,181
|
)
|
|||||||
|
|
|
|
|
|
|||||||||||
Finance income
|
20 | 2,703 | 51 | 140 | ||||||||||||
Finance expense
|
20 | (5,758 | ) | (3,235 | ) | (99 | ) | |||||||||
|
|
|
|
|
|
|||||||||||
Net finance expense
|
|
(3,055
|
)
|
|
(3,184
|
)
|
|
41
|
|
|||||||
|
|
|
|
|
|
|||||||||||
Loss before tax
|
|
(101,017
|
)
|
|
(55,025
|
)
|
|
(31,140
|
)
|
|||||||
Tax income
|
16A | 17,802 | 6,929 | 951 | ||||||||||||
|
|
|
|
|
|
|||||||||||
Loss for the year
|
|
(83,215
|
)
|
|
(48,096
|
)
|
|
(30,189
|
)
|
|||||||
|
|
|
|
|
|
|||||||||||
Attributable to:
|
||||||||||||||||
Owners of the Company
|
(83,215 | ) | (48,096 | ) | (30,189 | ) | ||||||||||
Earnings per share
(presented in euro)
|
14 | |||||||||||||||
Basic earnings per share
|
(0.09 | ) | (0.05 | ) | (0.03 | ) | ||||||||||
Diluted earnings per share
|
(0.09 | ) | (0.05 | ) | (0.03 | ) |
Loss for the year
|
|
(83,215
|
)
|
|
(48,096
|
)
|
|
(30,189
|
)
|
|||||||
|
|
|
|
|
|
|||||||||||
Items that may be reclassified subsequently to the consolidated statement profit or (loss)
|
|
|
|
|||||||||||||
Exchange differences on translating foreign operations
|
13C | (7,757 | ) | 4,894 | (554 | ) | ||||||||||
|
|
|
|
|
|
|||||||||||
Total other comprehensive (loss)/income
|
|
(7,757
|
)
|
|
4,894
|
|
|
(554
|
)
|
|||||||
|
|
|
|
|
|
|||||||||||
Total comprehensive loss for the year
|
|
(90,972
|
)
|
|
(43,202
|
)
|
|
(30,743
|
)
|
|||||||
|
|
|
|
|
|
|||||||||||
Attributable to:
|
||||||||||||||||
Owners of the Company
|
(90,972 | ) | (43,202 | ) | (30,743 | ) |
In thousands of euro
|
2020
|
2019
|
||||||||||
ASSETS
|
||||||||||||
Non-Current
Assets
|
Note | |||||||||||
Property, plant and equipment
|
7 | 112,719 | 34,947 | |||||||||
Intangible assets and goodwill
|
8 | 171,726 | 84,250 | |||||||||
Deferred tax asset
|
16B | 1,134 | 159 | |||||||||
Trade and other receivables
|
10A | 10,786 | 8,209 | |||||||||
|
|
|
|
|||||||||
Total
Non-Current
Assets
|
|
296,365
|
|
|
127,565
|
|
||||||
|
|
|
|
|||||||||
Current Assets
|
||||||||||||
Inventory
|
11 | 11,820 | 5,716 | |||||||||
Loans to executives
|
22,25 | 4,244 | — | |||||||||
Trade and other receivables
|
10B | 51,424 | 8,509 | |||||||||
Prepayments
|
18,956 | 4,733 | ||||||||||
Cash and cash equivalents
|
12 | 67,080 | 96,644 | |||||||||
|
|
|
|
|||||||||
Total Current Assets
|
|
153,524
|
|
|
115,602
|
|
||||||
|
|
|
|
|||||||||
TOTAL ASSETS
|
|
449,889
|
|
|
243,167
|
|
||||||
|
|
|
|
|||||||||
EQUITY AND LIABILITIES
|
||||||||||||
Capital and reserves
|
||||||||||||
Share capital
|
13A | 239,103 | 227,333 | |||||||||
Share premium
|
13B | 288,539 | 139,752 | |||||||||
Other reserves
|
13C | 51,425 | 7,035 | |||||||||
Accumulated deficit
|
(258,756 | ) | (174,875 | ) | ||||||||
|
|
|
|
|||||||||
Total Equity
|
|
320,311
|
|
|
199,245
|
|
||||||
|
|
|
|
|||||||||
Non-Current
Liabilities
|
||||||||||||
Deferred tax liability
|
16B | 2,750 | — | |||||||||
Loans and borrowings
|
15 | 87,907 | 19,943 | |||||||||
|
|
|
|
|||||||||
Total
Non-Current
Liabilities
|
|
90,657
|
|
|
19,943
|
|
||||||
|
|
|
|
|||||||||
Current Liabilities
|
||||||||||||
Current tax liabilities
|
501 | 124 | ||||||||||
Loans and borrowings
|
15 | 4,255 | 3,045 | |||||||||
Trade and other payables
|
17 | 34,165 | 20,810 | |||||||||
|
|
|
|
|||||||||
Total Current Liabilities
|
|
38,921
|
|
|
23,979
|
|
||||||
|
|
|
|
|||||||||
TOTAL EQUITY AND LIABILITIES
|
|
449,889
|
|
|
243,167
|
|
||||||
|
|
|
|
In thousands of euro
|
Note
|
Share
capital |
Share
premium |
Accumulated
deficit |
Other
reserves* |
Total
equity |
||||||||||||||||||
Balance at January 1, 2020
|
|
227,333
|
|
|
139,752
|
|
|
(174,875
|
)
|
|
7,035
|
|
|
199,245
|
|
|||||||||
Loss for the year
|
— | — | (83,215 | ) | — | (83,215 | ) | |||||||||||||||||
Other comprehensive income
|
— | — | — | (7,757 | ) | (7,757 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Transactions with shareholders
|
|
227,333
|
|
|
139,752
|
|
|
(258,090
|
)
|
|
(722
|
)
|
|
108,273
|
|
|||||||||
Capital increase
|
13 | 11,770 | 148,787 | — | — | 160,557 | ||||||||||||||||||
Restrictive Share Plan to employees
|
13,10 A | — | — | — | 27,400 | 27,400 | ||||||||||||||||||
Equity-settled share-based payments
|
21 | — | — | — | 24,747 | 24,747 | ||||||||||||||||||
Business combination under common control
|
— | — | (666 | ) | — | (666 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2020
|
|
239,103
|
|
|
288,539
|
|
|
(258,756
|
)
|
|
51,425
|
|
|
320,311
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Unadjusted balance at January 1, 2019
|
|
16
|
|
|
116,160
|
|
|
(68,361
|
)
|
|
2,141
|
|
|
49,956
|
|
|||||||||
Changes in accounting policy to reflect IFRS 16
|
— | — | (475 | ) | — | (475 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at January 1, 2019
|
|
16
|
|
|
116,160
|
|
|
(68,836
|
)
|
|
2,141
|
|
|
49,481
|
|
|||||||||
Loss for the year
|
— | — | (48,096 | ) | (48,096 | ) | ||||||||||||||||||
Other comprehensive income
|
— | — | — | 4,894 | 4,894 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Transactions with shareholders
|
|
16
|
|
|
116,160
|
|
|
(116,932
|
)
|
|
7,035
|
|
|
6,279
|
|
|||||||||
Capital increase
|
13 | 7,333 | 243,576 | — | — | 250,909 | ||||||||||||||||||
Conversion of share premium to share capital
|
13 | 219,984 | (219,984 | ) | — | — | — | |||||||||||||||||
Business combination under common control
|
— | — | (57,943 | ) | — | (57,943 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2019
|
|
227,333
|
|
|
139,752
|
|
|
(174,875
|
)
|
|
7,035
|
|
|
199,245
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at January 1, 2018
|
|
16
|
|
|
71,607
|
|
|
(38,172
|
)
|
|
2,695
|
|
|
36,146
|
|
|||||||||
Loss for the year
|
— | — | (30,189 | ) | — | (30,189 | ) | |||||||||||||||||
Other comprehensive loss
|
— | — | — | (554 | ) | (554 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Transactions with shareholders
|
|
16
|
|
|
71,607
|
|
|
(68,361
|
)
|
|
2,141
|
|
|
5,403
|
|
|||||||||
Capital increase
|
12 | — | 44,553 | — | — | 44,553 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2018
|
|
16
|
|
|
116,160
|
|
|
(68,361
|
)
|
|
2,141
|
|
|
49,956
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
* |
Other reserves comprise of translation reserves and equity reserves which are not distributable (see note 13).
|
In thousands of euro
|
2020
|
2019
|
2018
|
|||||||||||||
Note | Restated* | Restated* | ||||||||||||||
Cash flows used in operating activities
|
||||||||||||||||
Loss for the year
|
|
(83,215
|
)
|
|
(48,096
|
)
|
|
(30,189
|
)
|
|||||||
Adjustments for:
|
||||||||||||||||
•
|
7,8,19 | 9,652 | 4,770 | 2,120 | ||||||||||||
•
|
8,10,19 | 397 | 4,972 | 9,347 | ||||||||||||
•
|
40 | 105 | (141 | ) | ||||||||||||
•
|
20 | 2,180 | 2,524 | (94 | ) | |||||||||||
•
|
19C,21 | 9,326 | — | — | ||||||||||||
•
|
19A,19B | — | (542 | ) | — | |||||||||||
•
|
19A | (1,036 | ) | (64 | ) | — | ||||||||||
•
|
16 | 1,621 | (65 | ) | (1,108 | ) | ||||||||||
•
|
16 | (19,423 | ) | (6,864 | ) | 157 | ||||||||||
|
|
|
|
|
|
|||||||||||
Cash flows
used in
operations
before
working capital changes
|
|
(80,458
|
)
|
|
(43,260
|
)
|
|
(19,908
|
)
|
|||||||
(Increase)/decrease in trade and other receivables
|
(4,545 | ) | (4,803 | ) | 3,128 | |||||||||||
Increase/(decrease) in trade and other payables
|
9,736 | 9,317 | (1,652 | ) | ||||||||||||
(Increase) of inventory
|
(6,191 | ) | (3,413 | ) | (1,067 | ) | ||||||||||
|
|
|
|
|
|
|||||||||||
Cash flows used in operations
|
|
(81,458
|
)
|
|
(42,159
|
)
|
|
(19,499
|
)
|
|||||||
Income tax and other taxes received/(paid)
|
4,108 | 6,973 | (118 | ) | ||||||||||||
Interest received
|
24 | 51 | 94 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Net cash used in operating activities
|
|
(77,326
|
)
|
|
(35,135
|
)
|
|
(19,523
|
)
|
|||||||
|
|
|
|
|
|
|||||||||||
Cash flows from investing activities
|
||||||||||||||||
Acquisition of intangible assets and goodwill
|
8 | (80,684 | ) | (38,484 | ) | (19,334 | ) | |||||||||
Acquisition of property, plant and equipment
|
7 | (9,844 | ) | (6,054 | ) | (3,182 | ) | |||||||||
Grants received
|
1,067 | 844 | — | |||||||||||||
Prepayments for tangible and intangible assets
|
(17,350 | ) | (4,644 | ) | (889 | ) | ||||||||||
Cash received on acquisition of entities, net of consideration paid
|
9 | 117 | 486 | — | ||||||||||||
Proceeds from the sale of fixed assets
|
6 | — | — | |||||||||||||
Loans granted
|
— | (490 | ) | (2,509 | ) | |||||||||||
|
|
|
|
|
|
|||||||||||
Net cash used in investing activities
|
|
(106,688
|
)
|
|
(48,342
|
)
|
|
(25,914
|
)
|
|||||||
|
|
|
|
|
|
|||||||||||
Cash flows from financing activities
|
||||||||||||||||
Issuance of Preferred A shares
|
13 | 160,500 | 100,000 | — | ||||||||||||
Contribution of Kinetik to the share premium of the Company without the issuance of any shares
|
13 | — | 81,911 | 41,052 | ||||||||||||
Proceeds from borrowings
|
12,396 | — | — | |||||||||||||
Repayment of borrowings
|
(12,396 | ) | — | — | ||||||||||||
Repayment of interest
|
(51 | ) | — | — | ||||||||||||
Repayment of lease liabilities
|
15 | (6,695 | ) | (3,287 | ) | — | ||||||||||
|
|
|
|
|
|
|||||||||||
Net cash from financing activities
|
|
153,754
|
|
|
178,624
|
|
|
41,052
|
|
|||||||
|
|
|
|
|
|
|||||||||||
Net increase/(decrease) in cash and cash equivalents
|
|
(30,260
|
)
|
|
95,147
|
|
|
(4,385
|
)
|
|||||||
Cash and cash equivalents at January 1
|
12 | 96,644 | 1,053 | 5,476 | ||||||||||||
Effects of movements in exchange rates on cash held
|
696 | 444 | (38 | ) | ||||||||||||
|
|
|
|
|
|
|||||||||||
Cash and cash equivalents at December 31
|
|
67,080
|
|
|
96,644
|
|
|
1,053
|
|
|||||||
|
|
|
|
|
|
* |
Restated to reflect reclassification of cash flows described in note 2
|
Effective date
|
New standards or amendments
|
|
January 1, 2020
|
Amendments to References to Conceptual Framework in IFRS Standards | |
IFRS 3 – Definition of a Business | ||
IAS 1 and IAS 8 – Definition of Material | ||
IFRS 9, IAS 39 and IFRS 7 – Interest rate benchmark Reform | ||
June 1, 2020
|
Amendments to IFRS 16 Leases
COVID-19
– Related Rent Concessions
|
|
January 1, 2019
|
IFRIC 23 – Uncertainty over Tax Treatments | |
IFRS 16 – Leases | ||
IFRS 9 – Prepayments Features with Negative Compensation | ||
Annual improvements to IFRSs 2015-2017 Cycle (Amendments to IFRS3, IFRS 11, IAS 12 and IAS 23) |
• |
IFRS 16 “Leases”
|
|
•
|
|
IFRS 16 “Leases”
|
In thousands of euro
|
|
January 1,
2019 |
|
|
The impact at transition
|
|
|||
Right of use assets – property plant and equipment
|
|
|
5,720
|
|
Lease liability
|
|
|
(6,195
|
)
|
Retained earnings
|
|
|
475
|
|
In thousands of euro
|
|
|
|
|
Lease liabilities at transition
|
|
|||
Operating lease commitments at December 31, 2018 as disclosed under IAS 17
|
|
|
14,847
|
|
Discounted using the incremental borrowing rate at January 1, 2019*
|
|
|
6,195
|
|
Lease liabilities recognised at January 1, 2019
|
|
|
6,195
|
|
*
|
When measuring lease liabilities for leases that were classified as operating leases, the Group discounted the lease payments using its incremental borrowing rate at January 1, 2019. The weighted average of the incremental borrowing rate applied to the lease liabilities was 18.3%.
|
|
•
|
|
IFRS 16 “Leases”
|
January 1, 2021
|
IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 – Interest Rate Benchmark Reform – Phase 2 | |
January 1, 2022
|
IFRS 3 – Amendments to References to Conceptual Framework | |
January 1, 2022
|
IAS 16 – Proceeds before intended use | |
January 1, 2022
|
IAS 37 – Cost of fulfilling a contract | |
January 1, 2023
|
IAS 1 – Classification of Liabilities as Current or
Non-Current
|
|
January 1, 2023
|
IFRS 17 – Insurance Contracts | |
Available for optional adoption/effective date deferred indefinitely
|
IFRS 10 and IAS 28 – Sale or Contribution of Assets between Investor and its Associate or Joint Venture |
a) |
Subsidiary companies
|
b)
|
Business combinations
|
b)
|
Business combinations (continued)
|
The Group
|
|
Country of
registration |
|
Participation in share
capital |
|
|
Principal activity and status
|
|||||
|
|
|
|
2020
|
|
|
2019
|
|
|
|
||
|
|
|
|
%
|
|
|
%
|
|
|
|
||
Arrival Ltd
|
|
UK |
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D |
Arrival Nominees Ltd
|
|
UK |
|
|
—
|
|
|
|
—
|
|
|
Dissolved – February 5, 2019 |
Arrival Software Ltd
|
|
UK |
|
|
—
|
|
|
|
80
|
%
|
|
Dissolved – January 14, 2020 |
Sim-ply
Designed Ltd
|
|
UK |
|
|
—
|
|
|
|
—
|
|
|
Dissolved – May 7, 2019 |
Arrival One Ltd
|
|
UK |
|
|
—
|
|
|
|
—
|
|
|
Dissolved – March 26, 2019 |
Arrival Robotics Ltd (previously named TRA
Robotics Ltd) |
|
UK |
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D |
Arrival R Ltd (previously named Roborace Ltd)
|
|
UK |
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D |
Arrival M Ltd (previously named
Cybernation Ltd) |
|
UK |
|
|
—
|
|
|
|
100
|
%
|
|
Dissolved – September 22, 2020 |
Arrival Jet Ltd
|
|
UK |
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D |
Arrival Elements Ltd
|
|
UK |
|
|
—
|
|
|
|
100
|
%
|
|
Dissolved – March 3, 2020 |
Roborace Ltd
|
|
UK |
|
|
100
|
%
|
|
|
—
|
|
|
R&D |
Arrival Management Systems Ltd
|
|
UK |
|
|
—
|
|
|
|
100
|
%
|
|
Dissolved – January 14, 2020 |
Arrival Automotive UK Ltd
|
UK | 100 | % | 100 | % | Manufacturing | ||||||
Arrival Solutions UK Ltd
|
UK | 100 | % | — | Services | |||||||
Arrival Mobility Ltd
|
UK | 100 | % | 100 | % | Services |
b)
|
Business combinations (continued)
|
The Group
|
|
Country of
registration |
|
Participation in share
capital |
|
|
Principal activity and status
|
|||||
|
|
|
|
2020
|
|
|
2019
|
|
|
|
||
|
|
|
|
%
|
|
|
%
|
|
|
|
||
Arrival Vault UK Ltd
|
|
UK
|
|
|
100
|
%
|
|
|
—
|
|
|
Services
|
Arrival Elements B.V.
|
|
NL
|
|
|
100
|
%
|
|
|
100
|
%
|
|
Distributor
|
Arrival USA Inc (previously named Roborace Inc)
|
|
US
|
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D
|
Arrival Automotive USA Inc
|
|
US
|
|
|
100
|
%
|
|
|
100
|
%
|
|
Manufacturing
|
ARSNL Merger Sub Inc
|
|
US
|
|
|
100
|
%
|
|
|
—
|
|
|
Holding
|
Roborace Inc
|
|
US
|
|
|
100
|
%
|
|
|
—
|
|
|
R&D
|
Arrival Solutions USA Inc
|
|
US
|
|
|
100
|
%
|
|
|
—
|
|
|
Services
|
Arrival Automotive PTE Ltd
|
|
SGP
|
|
|
100
|
%
|
|
|
100
|
%
|
|
Acquisition and holding of participating interests
|
Arrival RUS LLC (previously named Arrival
Software LLC) |
|
Russia
|
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D
|
Arrival Robotics LLC (previously named TRA Robotics LLC)
|
|
Russia
|
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D
|
Arrival Germany GmbH
|
|
GER
|
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D
|
Arrival Automotive Germany GmbH
|
|
GER
|
|
|
100
|
%
|
|
|
100
|
%
|
|
Manufacturing
|
Arrival Solutions Germany GmbH (previously named Cybernation Germany GmbH)
|
|
GER
|
|
|
100
|
%
|
|
|
—
|
|
|
Services
|
Arrival Israel Ltd
|
|
IL
|
|
|
100
|
%
|
|
|
100
|
%
|
|
R&D
|
Arrival LT UAB
|
|
LT
|
|
|
100
|
%
|
|
|
—
|
|
|
R&D
|
Arrival (previously named Arrival Group S.A.)
|
|
Lux
|
|
|
100
|
%
|
|
|
—
|
|
|
Holding
|
c)
|
Transactions eliminated at consolidation
|
1. |
Foreign currency transactions
|
2.
|
Foreign operations
|
Consolidated Balance Sheet
Closing rates |
Consolidated Statement of profit or (loss) and
other comprehensive (loss)/income Average rates |
|||||||||||||||||||||
2020 | 2019 | 2020 | 2019 | 2018 | ||||||||||||||||||
British Pounds
|
GBP | 1.11234705 | 1.17536436 | 1.12440301 | 1.14171543 | 1.12873080 | ||||||||||||||||
Russian Rubles
|
RUB | 0.01093289 | 0.01429464 | 0.01187300 | 0.01384692 | 0.01348233 | ||||||||||||||||
US Dollar
|
USD | 0.81492950 | 0.89015489 | 0.87183958 | 0.89329581 | 0.84794867 | ||||||||||||||||
Singapore Dollar
|
SGD | 0.61659884 | 0.66176957 | 0.63344594 | 0.6556159 | 0.64139567 | ||||||||||||||||
Israeli Shekel
|
ILS | 0.25350470 | 0.25743339 | 0.25488151 | 0.25138208 | — |
Depreciation method | Depreciation Rate | |||||||
Plant and machinery
|
Straight line | 20 | % | |||||
Furniture & Fittings
|
Straight line | 20 | % | |||||
Computer equipment
|
Straight line | 33 | % | |||||
Motor vehicles
|
Straight line | 20 | % |
|
|
Amortisation method
|
|
Amortisation Rate
|
Trademarks and Patents
|
|
Straight line
|
|
10 years
|
Software
|
|
Straight line
|
|
33.33% or over the
period which any licenses cover |
—
|
Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.
|
—
|
Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).
|
—
|
Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).
|
1.
|
Definition of a lease
|
2.
|
Leased assets
|
2.
|
Leased assets (Continued)
|
• |
fixed payments, including
in-substance
fixed payments, less any lease incentives receivable; and
|
• |
amounts expected to be payable under a residual value guarantee.
|
3.
|
Short-t
e
rm leases and leases of
low-value
assets
|
Change required for
carrying amount to equal recoverable amount |
||||
Weighted average cost of capital
|
78 | % | ||
Product growth rate
|
0.319 | % |
December 31, 2020 | ||||||||
Increase | Decrease | |||||||
Resign before one year (1% movement)
|
0 | 0 | ||||||
Resign before the milestone dates (1% movement)
|
(62 | ) | 62 | |||||
Milestones be achieved (6 months earlier or 6 months later)
|
(872 | ) | 1,508 |
December 31, 2020 | ||||||||
Increase | Decrease | |||||||
Repayment of loans (6 months movement)
|
134 | (16 | ) | |||||
Discount rate (2.5% movement)
|
43 | (44 | ) | |||||
Annual increase in savings (0.2% decrease, 1% increase)
|
(268 | ) | 54 | |||||
Initial savings (2.5% movement)
|
(636 | ) | 646 | |||||
Volatility (10% movement)
|
1,239 | (1,263 | ) |
• |
Liquidity risk
|
• |
Credit risk
|
• |
Market risk
|
2020
|
2019
|
2018
|
||||||||||
EUR/USD
|
(2.40 | %) | 5.34 | % | (3.72 | %) | ||||||
EUR/GBP
|
(1.52 | %) | 1.15 | % | (1.17 | %) | ||||||
EUR/RUB
|
(14.26 | %) | 2.70 | % | (12.08 | %) | ||||||
EUR/ILS
|
1.39 | % | 6.92 | % | — |
1. |
Operational risk
|
2. |
Compliance risk
|
3. |
Legal risk
|
4. |
Risk due to the
COVID-19
pandemic
|
5. |
Risk due to Brexit
|
• |
Capitalised development costs – These assets are in relation to projects that will deliver value via electric vehicle production and services for these vehicles starting in 2022. We do not consider that there is any impairment as 1) this extends into the period during which the pandemic is likely to have ended, 2) we anticipate that demand for Arrival’s electric vehicles to be largely unimpacted by the pandemic.
|
• |
The Group’s
right-of-use
COVID-19
as we continue to plan to build micro-factories in these locations. As the activities of the Group has continued to grow over 2020 this required us to lease additional premises in UK, USA, Russia, Lithuania, Israel and Germany. As the real estate market has been impacted by
COVID-19,
this presented us with the opportunity to enter into favourable lease agreements.
|
In thousands of euro
|
Land and
Buildings* |
Plant and
Equipment |
Furniture and
fittings |
Motor
Vehicles |
Assets under
Construction** |
TOTAL
|
||||||||||||||||||
Cost
|
||||||||||||||||||||||||
At January 1, 2020
|
23,945 | 16,268 | 3,536 | 116 | 1,533 |
|
45,398
|
|
||||||||||||||||
Additions
|
50,491 | 10,541 | 2,460 | 83 | 3,731 |
|
67,306
|
|
||||||||||||||||
Disposals
|
— | (157 | ) | (231 | ) | — | — |
|
(388
|
)
|
||||||||||||||
Modification of lease***
|
24,506 | — | — | — | — |
|
24,506
|
|
||||||||||||||||
Additions through business combinations under common control
|
— | 139 | 131 | 392 | — |
|
662
|
|
||||||||||||||||
Transfers
|
(1,812 | ) |
|
(1,812
|
)
|
|||||||||||||||||||
Additions through business combinations
|
165 | 735 | 4 | 10 | — |
|
914
|
|
||||||||||||||||
Foreign exchange differences
|
(3,579 | ) | (1,573 | ) | (209 | ) | 1 | (122 | ) |
|
(5,482
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
At December 31, 2020
|
93,716 | 25,953 | 5,691 | 602 | 5,142 |
|
131,104
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Depreciation/impairment
|
||||||||||||||||||||||||
At January 1, 2020
|
(3,549 | ) | (5,984 | ) | (864 | ) | (54 | ) | — |
|
(10,451
|
)
|
||||||||||||
Additions through business combinations under common control
|
— | (59 | ) | (25 | ) | (95 |
)
|
— |
|
(179
|
)
|
|||||||||||||
Depreciation
|
(6,157 | ) | (4,984 | ) | (788 | ) | (72 | ) | — |
|
(12,001
|
)
|
||||||||||||
Modification of lease***
|
1,114 |
|
1,114
|
|
||||||||||||||||||||
Transfers
|
1,812 |
|
1,812
|
|
||||||||||||||||||||
Impairment
|
— | (25 | ) | — | — | — |
|
(25
|
)
|
|||||||||||||||
Disposal
|
— | 157 | 225 | — | — |
|
382
|
|
||||||||||||||||
Foreign exchange differences
|
333 | 574 | 54 | 2 | — |
|
963
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2020
|
|
|
(6,447
|
)
|
|
|
(10,321
|
)
|
|
|
(1,398
|
)
|
|
|
(219
|
)
|
|
|
—
|
|
|
|
(18,385
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net book Value
|
|
|
|
|
|
|
||||||||||||||||||
At January 1, 2020
|
|
|
20,396
|
|
|
|
10,284
|
|
|
|
2,672
|
|
|
|
62
|
|
|
|
1,533
|
|
|
|
34,947
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2020
|
|
|
87,269
|
|
|
|
15,632
|
|
|
|
4,293
|
|
|
|
383
|
|
|
|
5,142
|
|
|
|
112,719
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
|
|
|
|
|
|
|
||||||||||||||||||
At January 1, 2019
|
|
|
—
|
|
|
|
8,270
|
|
|
|
1,029
|
|
|
|
78
|
|
|
|
1,475
|
|
|
|
10,852
|
|
Recognition of
right-of-use
|
|
|
6,027
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
6,027
|
|
Additions
|
|
|
14,732
|
|
|
|
4,335
|
|
|
|
2,135
|
|
|
|
19
|
|
|
|
—
|
|
|
|
21,221
|
|
Disposals
|
|
|
—
|
|
|
|
(3,199
|
)
|
|
|
(33
|
)
|
|
|
(188
|
)
|
|
|
(17
|
)
|
|
|
(3,437
|
)
|
Modification of lease
|
|
|
22
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
22
|
|
In thousands of euro
|
|
Land and
Buildings* |
|
|
Plant and
Equipment |
|
|
Furniture and
fittings |
|
|
Motor
Vehicles |
|
|
Assets under
Construction** |
|
|
TOTAL
|
|
||||||
Additions through business combinations under common control
|
2,584 | 5,989 | 276 | 189 | — |
|
9,038
|
|
||||||||||||||||
Foreign exchange differences
|
580 | 873 | 129 | 18 | 75 |
|
1,675
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
At December 31, 2019
|
23,945 | 16,268 | 3,536 | 116 | 1,533 |
|
45,398
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Depreciation/impairment
|
||||||||||||||||||||||||
At January 1, 2019
|
— | (2,513 | ) | (339 | ) | (28 | ) | — |
|
(2,880
|
)
|
|||||||||||||
Recognition of
right-of-use
t
ial application of IFRS 16
|
(981 | ) | — | — | — | — |
|
(981
|
)
|
|||||||||||||||
Additions through business combinations under common control
|
(251 | ) | (1,547 | ) | (53 | ) | (169 | ) | — |
|
(2,020
|
)
|
||||||||||||
Depreciation
|
(2,267 | ) | (2,606 | ) | (465 | ) | (39 | ) | — |
|
(5,377
|
)
|
||||||||||||
Modification of lease
|
42 | — | — | — | — |
|
42
|
|
||||||||||||||||
Disposal
|
— | 981 | 26 | 188 | — |
|
1,195
|
|
||||||||||||||||
Foreign exchange differences
|
(92 | ) | (299 | ) | (33 | ) | (6 | ) | — |
|
(430
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
At December 31, 2019
|
(3,549 | ) | (5,984 | ) | (864 | ) | (54 | ) | — |
|
(10,451
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net book Value
|
||||||||||||||||||||||||
At January 1, 2019
|
— | 5,757 | 690 | 50 | 1,475 |
|
7,972
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
At December 31, 2019
|
20,396 | 10,284 | 2,672 | 62 | 1,533 |
|
34,947
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
In thousands of euro
|
|
Plant and
Equipment |
|
|
Furniture
and fittings |
|
|
Motor
Vehicles |
|
|
Assets under
Construction |
|
|
TOTAL
|
|
|||||
Cost
|
|
|
|
|
|
|||||||||||||||
At January 1, 2018
|
|
|
5,249
|
|
|
|
774
|
|
|
|
41
|
|
|
|
1,841
|
|
|
|
7,905
|
|
Additions
|
|
|
1,769
|
|
|
|
264
|
|
|
|
37
|
|
|
|
1,112
|
|
|
|
3,182
|
|
Reclassification
|
|
|
1,466
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,466
|
)
|
|
|
—
|
|
Foreign exchange differences
|
|
|
(214
|
)
|
|
|
(9
|
)
|
|
|
—
|
|
|
|
(12
|
)
|
|
|
(235
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2018
|
|
|
8,270
|
|
|
|
1,029
|
|
|
|
78
|
|
|
|
1,475
|
|
|
|
10,852
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In thousands of euro
|
|
Plant and
Equipment |
|
|
Furniture
and fittings |
|
|
Motor
Vehicles |
|
|
Assets under
Construction |
|
|
TOTAL
|
|
|||||
Depreciation/impairment
|
||||||||||||||||||||
At January 1, 2018
|
(660 | ) | (110 | ) | (15 | ) | — |
|
(785
|
)
|
||||||||||
Depreciation
|
(1,927 | ) | (232 | ) | (13 | ) | — |
|
(2,172
|
)
|
||||||||||
Reclassification
|
— | — | — | — |
|
—
|
|
|||||||||||||
Impairment
|
— | — | — | — |
|
—
|
|
|||||||||||||
Foreign exchange differences
|
74 | 3 | — | — |
|
77
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2018
|
(2,513 | ) | (339 | ) | (28 | ) | — |
|
(2,880
|
)
|
||||||||||
|
|
|
|
|
|
|
|
|
|
* |
Land and Building comprise of leased buildings and leasehold improvements. The cost of leased buildings amounts to EUR 93,575 (2019: EUR 23,945) and the accumulated depreciation is EUR 6,559 (2019: 3,549).
|
** |
Assets under construction classified under property, plant and equipment are assets bought and/or lease hold improvements that are not ready for use.
|
*** |
During 2020, the Group has entered a number of new leases and amended several existing agreements. The Group has entered into 4 material lease agreements in the USA which have a right of use of asset of EUR 23,770. In addition, the Group has leased office and factory buildings in the UK of total right of use value of EUR 24,683. Due to the growth the Group, we have renegotiated several of the existing lease agreements, which resulted in obtaining better terms and at the same time extent the period of the lease terms. The total modification of the lease amounted to EUR 24,506.
|
In thousands of euro
|
|
Goodwill
|
|
|
Assets under
construction**** |
|
|
Patent, trademarks
and other rights |
|
|
Software
|
|
|
TOTAL
|
|
|||||
Cost
|
||||||||||||||||||||
At January 1, 2020
|
6 | 124,938 | 104 | 2,394 |
|
127,442
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Additions
|
26 | 91,996 | — | 2,304 |
|
94,326
|
|
|||||||||||||
Additions through business combinations under common control
|
— | — | 361 | — |
|
361
|
|
|||||||||||||
Additions through business combinations
|
— | — | — | 4 |
|
4
|
|
|||||||||||||
Transfer
|
(4 | ) | — | — | — |
|
(4
|
)
|
||||||||||||
Disposal
|
— | — | — | (10 | ) |
|
(10
|
)
|
||||||||||||
Foreign exchange differences
|
— | (8,147 | ) | 2 | (150 | ) |
|
(8,295
|
)
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2020
|
28 | 208,787 | 467 | 4,542 |
|
213,824
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
In thousands of euro
|
|
Goodwill
|
|
|
Assets under
construction**** |
|
|
Patent, trademarks
and other rights |
|
|
Software
|
|
|
TOTAL
|
|
|||||
Amortisation/impairment
|
|
|
|
|
|
|||||||||||||||
At January 1, 2020
|
(6 | ) | (41,949 | ) | (17 | ) | (1,220 | ) |
|
(43,192
|
)
|
|||||||||
Amortisation
|
— | — | (27 | ) | (893 | ) |
|
(920
|
)
|
|||||||||||
Additions through business combinations under common control
|
— | — | (39 | ) | — |
|
(39
|
)
|
||||||||||||
Transfer
|
4 | — | — | — |
|
4
|
|
|||||||||||||
Disposal
|
— | — | — | 5 |
|
5
|
|
|||||||||||||
Impairment
|
— | (366 | ) | — | — |
|
(366
|
)
|
||||||||||||
Foreign exchange differences
|
— | 2,337 | — | 73 |
|
2,410
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2020
|
(2 | ) | (39,978 | ) | (83 | ) | (2,035 | ) |
(
42,098
|
)
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net book Value
|
||||||||||||||||||||
At January 1, 2020
|
— | 82,989 | 87 | 1,174 |
|
84,250
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2020
|
26 | 168,809 | 384 | 2,507 |
|
171,726
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
In thousands of euro
|
Goodwill
|
Assets under
construction**** |
Patent, trademarks
and other rights |
Software
|
TOTAL
|
|||||||||||||||
Cost
|
||||||||||||||||||||
At January 1, 2019
|
2 | 49,325 | 102 | 917 |
|
50,346
|
|
|||||||||||||
Additions
|
4 | 46,145 | — | 836 |
|
46,985
|
|
|||||||||||||
Additions through business combinations under common control
|
— | 24,020 | 121 | 543 |
|
24,684
|
|
|||||||||||||
Disposal
|
— | (2 |
)
|
(133 | ) | — |
|
(135
|
)
|
|||||||||||
Foreign exchange differences
|
— | 5,450 | 14 | 98 |
|
5,562
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2019
|
6 | 124,938 | 104 | 2,394 |
|
127,442
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortisation/impairment
|
||||||||||||||||||||
At January 1, 2019
|
(2 | ) | (15,298 | ) | (9 | ) | (476 | ) |
|
(15,785
|
)
|
|||||||||
Amortisation
|
— | — | (17 | ) | (419 | ) |
|
(436
|
)
|
|||||||||||
Additions through business combinations under common control
|
— | (19,661 | ) | (121 | ) | (275 | ) |
|
(20,057
|
)
|
||||||||||
Disposal
|
— | — | 133 | — |
|
133
|
|
|||||||||||||
Impairment
|
(4 | ) | (4,968 | ) | — | — |
|
(4,972
|
)
|
|||||||||||
Foreign exchange differences
|
— | (2,022 | ) | (3 | ) | (50 | ) |
|
(2,075
|
)
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2019
|
(6 | ) | (41,949 | ) | (17 | ) | (1,220 | ) |
|
(43,192
|
)
|
|||||||||
|
|
|
|
|
|
|
|
|
|
In thousands of euro
|
|
Goodwill
|
|
|
Assets under
construction**** |
|
|
Patent, trademarks
and other rights |
|
|
Software
|
|
|
TOTAL
|
|
|||||
Net book Value
|
||||||||||||||||||||
At January 1, 2019
|
— | 34,027 | 93 | 441 |
|
34,561
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2019
|
— | 82,989 | 87 | 1,174 |
|
84,250
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cost
|
||||||||||||||||||||
At January 1, 2018
|
2 | 28,934 | — | 570 |
|
29,506
|
|
|||||||||||||
Additions
|
— | 19,155 | 103 | 355 |
|
19,613
|
|
|||||||||||||
Foreign exchange differences
|
— | 1,236 | (1 | ) | (8 | ) |
|
1,227
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2018
|
2 | 49,325 | 102 | 917 |
|
50,346
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Amortisation/impairment
|
||||||||||||||||||||
At January 1, 2018
|
(2 | ) | (6,090 | ) | — | (262 | ) |
|
(6,354
|
)
|
||||||||||
Amortisation
|
— | — | (9 | ) | (218 | ) |
|
(227
|
)
|
|||||||||||
Impairment
|
— | (9,347 | ) | — | — |
|
(9,347
|
)
|
||||||||||||
Foreign exchange differences
|
— | 139 | — | 4 |
|
143
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
At December 31, 2018
|
(2 | ) | (15,298 | ) | (9 | ) | (476 | ) |
|
(15,785
|
)
|
|||||||||
|
|
|
|
|
|
|
|
|
|
a.
|
The identifiable net assets acquired and liabilities recognised on acquisition were:
|
In thousands of euro
|
Note
|
|||||||
Property, plant and equipment
|
7 | 914 | ||||||
Intangible assets
|
8 | 4 | ||||||
Trade and other receivables
|
89 | |||||||
Cash and cash equivalent
|
59 | |||||||
Lease liabilities
|
(153 | ) | ||||||
Deferred tax
|
(56 | ) | ||||||
Trade and other payables
|
(880 | ) | ||||||
|
|
|||||||
Total
|
|
(23
|
)
|
|||||
|
|
b. |
Measurement of fair values
|
Assets acquired
|
Valuation technique
|
|
-Property, plant and equipment
|
Market comparison technique and cost technique was applied to all assets acquired. The valuation
model considers market prices for similar items. |
c. |
Goodwill:
|
In thousands of euro
|
Note
|
|||||||
Consideration transferred
|
3 | |||||||
Fair value of identifiable net assets
|
23 | |||||||
|
|
|||||||
Goodwill
|
|
26
|
|
|||||
|
|
B.
|
Business combinations under common control
|
B.
|
Business combinations under common control (continued)
|
2020
|
2019
|
|||||||
In thousands of euro
|
||||||||
Loans receivable
|
1,841 | — | ||||||
Other
|
— | 1,246 | ||||||
Call deposit
|
1,617 | 2,351 | ||||||
Cash Guarantees and deposits
|
7,328 | 4,612 | ||||||
|
|
|
|
|||||
Total
|
|
10,786
|
|
|
8,209
|
|
||
|
|
|
|
• |
The assets are held within a business model whose objective is to collect the contractual cash flows and
|
• |
The contractual terms give rise to cash flows that are solely payments of principal and interest.
|
2020
|
2019
|
|||||||
In thousands of euro
|
||||||||
VAT receivable
|
5,260 | 1,943 | ||||||
Tax receivable
|
21,298 | — | ||||||
Call deposit
|
427 | — | ||||||
Deferred charges
|
43 | 82 | ||||||
Loans receivable
|
23,913 | 1,279 | ||||||
Impairment of other receivables
|
(6 | ) | — | |||||
Other receivables
|
489 | 5,205 | ||||||
|
|
|
|
|||||
Total
|
|
51,424
|
|
|
8,509
|
|
||
|
|
|
|
In thousands of euro
|
2020
|
2019
|
||||||
Raw materials and consumables
|
11,820 | 5,716 | ||||||
|
|
|
|
|||||
Inventory
|
|
11,820
|
|
|
5,716
|
|
||
|
|
|
|
In thousands of euro
|
2020
|
2019
|
||||||
Bank balances
|
67,080 | 96,644 | ||||||
|
|
|
|
|||||
Total
|
|
67,080
|
|
|
96,644
|
|
||
|
|
|
|
A.
|
Share capital
|
In thousands of shares
|
2020
|
2019
|
||||||
Authorised
|
||||||||
Ordinary shares (nominal value 2019: EUR 0.25)
|
|
880,000
|
|
|
880,000
|
|
||
Preferred A shares (nominal value EUR 0.25)
|
|
88,000
|
|
|
88,000
|
|
In thousands of euro
|
||||||||
Ordinary shares issued and fully paid
|
||||||||
Ordinary shares as of January 1
|
220,000 | 16 | ||||||
Contribution of ordinary shares by Kinetik S.à r.l.
|
(12,500 | ) | — | |||||
Treasury shares
|
9,377 | — | ||||||
Shares sold to RSP Scheme Members
|
3,123 | — | ||||||
Contribution from share premium
|
— | 219,984 | ||||||
|
|
|
|
|||||
Ordinary shares issued and fully paid as of December 31
|
|
220,000
|
|
|
220,000
|
|
||
|
|
|
|
|||||
Preferred A shares issued and fully paid
|
||||||||
Preferred A shares as of January 1
|
7,333 | — | ||||||
Issue of Preferred A shares
|
11,770 | 7,333 | ||||||
|
|
|
|
|||||
Preferred A shares issued and fully paid as of December 31
|
|
19,103
|
|
|
7,333
|
|
||
|
|
|
|
|||||
Total share capital December 31
|
|
239,103
|
|
|
227,333
|
|
||
|
|
|
|
A.
|
Share capital
|
A.
|
Share capital
|
In thousands of euro
|
||||
January 1, 2019
|
116,160 | |||
Additions
|
243,576 | |||
Contribution to share capital
|
(219,984 | ) | ||
|
|
|||
December 31, 2019
|
|
139,752
|
|
|
|
|
|||
January 1, 2020
|
139,752 | |||
Additions
|
148,787 | |||
|
|
|||
December 31, 2020
|
|
288,539
|
|
|
|
|
1.
|
Other Comprehensive Income accumulated in reserves, net of tax
|
In thousands of euro
|
||||
January 1, 2018
|
|
2,695
|
|
|
Foreign operations – foreign currency translation differences
|
(554 | ) | ||
|
|
|||
December 31, 2018
|
|
2,141
|
|
|
|
|
|||
January 1, 2019
|
2,141 | |||
Foreign operations – foreign currency translation differences
|
4,894 | |||
|
|
|||
December 31, 2019
|
|
7,035
|
|
|
|
|
|||
January 1, 2020
|
7,035 | |||
Foreign operations – foreign currency translation differences
|
(7,757 | ) | ||
|
|
|||
December 31 2020
|
|
(722
|
)
|
|
|
|
|
2.
|
Equity Reserves
|
In thousands of euro
|
||||
January 1, 2020
|
|
—
|
|
|
Treasury shares acquired by the employees of the Group
|
27,400 | |||
Equity-settled Share Plan to employees
|
24,747 | |||
|
|
|||
December 31 2020
|
|
52,147
|
|
|
|
|
A. |
Basic earnings per share
|
i. |
(Loss) attributable to Ordinary shareholders:
|
In thousands of euro
|
2020
|
2019
|
2018
|
|||||||||||||||||||||
Continuing
operations |
Total
|
Continuing
operations |
Total
|
Continuing
operations |
Total
|
|||||||||||||||||||
(Loss) for the year, attributable to the owners of the Company (basic)
|
(74,894 | ) | (74,874 | ) | (46,542 | ) | (46,542 | ) | (30,189 | ) | (30,189 | ) |
In thousands of shares
|
2020
|
2019
|
2018
|
|||||||||
Ordinary shares as at January 1
|
880,000 | 16 | 16 | |||||||||
Share split
|
— | 48 | 48 | |||||||||
Conversion of distributable reserves into shares
|
— | 879,936 | 879,936 | |||||||||
Treasury shares and RSP 2020 shares
|
(11,612 | ) | — | — | ||||||||
RSP shares vested
|
1,451 | — | — | |||||||||
|
|
|
|
|
|
|||||||
Weighted-average number of Ordinary and Preferred A shares as at December 31
|
|
869,839
|
|
|
880,000
|
|
|
880,000
|
|
|||
|
|
|
|
|
|
A.
|
Diluted earnings per share
|
i. |
(Loss) attributable to Ordinary and Preferred A shares (diluted)
|
In thousands of euro
|
2020
|
2019
|
2018
|
|||||||||||||||||||||
Continuing
operations |
Total
|
Continuing
operations |
Total
|
Continuing
operations |
Total
|
|||||||||||||||||||
(Loss) for the year, attributable to the owners of the Company (basic)
|
(83,215 | ) | (83,215 | ) | (48,096 | ) | (48,096 | ) | (30,189 | ) | (30,189 | ) |
A.
|
Diluted earnings per share (continued)
|
ii.
|
Weighted-average number of Ordinary and Preferred A shares
|
In thousands of shares
|
2020
|
2019
|
2018
|
|||||||||
Ordinary and Preferred A shares as at January 1
|
880,161 | 16 | 16 | |||||||||
Share split
|
— | 48 | 48 | |||||||||
Conversion of distributable reserves into shares
|
— | 879,936 | 879,936 | |||||||||
Treasury shares and RSP 2020 shares
|
(11,612 | ) | — | — | ||||||||
RSP shared vested
|
1,451 | — | — | |||||||||
|
|
|
|
|||||||||
Issue of Preference A shares
|
41,652 | 161 | — | |||||||||
|
|
|
|
|
|
|||||||
Weighted-average number of Ordinary and Preferred A shares as at December 31
|
|
911,652
|
|
|
880,161
|
|
|
880,000
|
|
|||
|
|
|
|
|
|
In thousands of euro
|
Liabilities
Lease liabilities
|
Total
|
||||||
January 1, 2020
|
|
22,988
|
|
|
22,988
|
|
||
|
|
|
|
|||||
Changes from financing cash flows
|
||||||||
Payment of lease liabilities
|
(2,371 | ) | (2,371 | ) | ||||
Payment of interest
|
(4,324 | ) | (4,324 | ) | ||||
|
|
|
|
|||||
Total
hanges from financing cash flows
|
|
(6,695
|
)
|
|
(6,695
|
)
|
||
|
|
|
|
|||||
The effects of changes in foreign exchange rates
|
|
(3,438
|
)
|
|
(3,438
|
)
|
||
|
|
|
|
|||||
Other changes
|
||||||||
Interest on leases
|
4,733 | 4,733 | ||||||
New and modification of leases
|
74,574 | 74,574 | ||||||
|
|
|
|
|||||
Total of other changes
|
|
79,307
|
|
|
79,307
|
|
||
|
|
|
|
|||||
December 31, 2020
|
|
92,162
|
|
|
92,162
|
|
||
|
|
|
|
|||||
January 1, 2019
|
|
6,195
|
|
|
6,195
|
|
||
|
|
|
|
|||||
Changes from financing cash flows
|
||||||||
Payment of lease liabilities
|
(713 | ) | (713 | ) | ||||
Payment of interest
|
(2,574 | ) | (2,574 | ) | ||||
|
|
|
|
|||||
Total
hanges from financing cash flows
|
|
(3,287
|
)
|
|
(3,287
|
)
|
||
|
|
|
|
|||||
The effects of changes in foreign exchange rates
|
|
556
|
|
|
556
|
|
||
|
|
|
|
|||||
Other changes
|
||||||||
New and modification of leases
|
19,524 | 19,524 | ||||||
|
|
|
|
|||||
Total of other changes
|
|
19,524
|
|
|
19,524
|
|
||
|
|
|
|
|||||
December 31, 2019
|
|
22,988
|
|
|
22,988
|
|
||
|
|
|
|
In thousands of euro
|
2020
|
2019
|
||||||
Non-current
lease liabilities
|
||||||||
Lease liability
|
87,907 | 19,943 | ||||||
|
|
|
|
|||||
Total
non-current
lease liabilities
|
|
87,907
|
|
|
19,943
|
|
||
|
|
|
|
|||||
Current lease liabilities
|
||||||||
Current portion of lease liabilities
|
4,255 | 3,045 | ||||||
|
|
|
|
|||||
Total current loans and borrowings
|
|
4,255
|
|
|
3,045
|
|
||
|
|
|
|
In thousands of euro
|
Carrying
amount |
Total |
Within one
year |
Between 1 and
5 years |
More than
5 years |
|||||||||||||||
December 31, 2020
|
||||||||||||||||||||
Leases
|
92,162 | 135,595 | 9,891 | 42,905 | 82,799 | |||||||||||||||
December 31, 2019
|
||||||||||||||||||||
Leases
|
22,988 | 68,773 | 6,610 | 34,593 | 27,570 |
In thousands of euro
|
|
2020
|
|
|
2019
|
|
||
Amounts recognised in consolidated statement of profit or loss and other comprehensive (loss)/income
|
||||||||
Interest on lease liability
|
4,733 | 2,574 | ||||||
Expenses relating to short-term leases and low value leases
|
311 | 336 | ||||||
|
|
|
|
|||||
5,044 | 2,910 | |||||||
|
|
|
|
|||||
Amount recognised in the statement of cash flows
|
||||||||
Total cash outflow for leases
|
6,695 | 3,287 | ||||||
|
|
|
|
In thousands of euro
|
2020
|
2019
|
2018
|
|||||||||
Current tax
|
||||||||||||
Current year
|
(2,186 | ) | (294 | ) | (152 | ) | ||||||
Other taxes
|
(431 | ) | (5 | ) | (5 | ) | ||||||
True up adjustments for taxes for prior years
|
22,040 | 7,163 | — | |||||||||
|
|
|
|
|
|
|||||||
Total current tax income
|
|
19,423
|
|
|
6,864
|
|
|
(157
|
)
|
|||
|
|
|
|
|
|
|||||||
Deferred tax
|
||||||||||||
True up adjustments for taxes for prior years
|
954 | — | ||||||||||
Relating to origination and reversal of temporary differences
|
(2,575 | ) | 65 | 1,108 | ||||||||
|
|
|
|
|
|
|||||||
Total deferred tax
|
|
(1,621
|
)
|
|
65
|
|
|
1,108
|
|
|||
|
|
|
|
|
|
|||||||
Total tax income recognised in consolidated statement of profit or loss and other comprehensive (loss)/income
|
|
17,802
|
|
|
6,929
|
|
|
951
|
|
|||
|
|
|
|
|
|
In thousands of euro
|
|
2020
|
|
|
2019
|
|
||
Asset
|
||||||||
Accruals
|
—
|
96 | ||||||
Tax losses
|
14,213 | 2,223 | ||||||
Other
|
202 | 360 | ||||||
|
|
|
|
|||||
14,415
|
2,679
|
|||||||
|
|
|
|
In thousands of euro
|
2020
|
2019
|
||||||
Liabilities
|
||||||||
Tangible and Intangible fixed assets
|
(16,031 | ) | (2,520 | ) | ||||
|
|
|
|
|||||
|
(16,031
|
)
|
|
(2,520
|
)
|
|||
|
|
|
|
|||||
Net deferred tax
|
|
(1,616
|
)
|
|
159
|
|
||
|
|
|
|
In thousands of euro
|
2020
|
2019
|
||||||
Tax losses
|
32,327 | 24,638 | ||||||
Share options
|
149 | — | ||||||
Tangible and Intangible fixed assets
|
1,063 | — | ||||||
Other temporary differences
|
2,096 | — | ||||||
|
|
|
|
|||||
Total
|
|
35,635
|
|
|
24,638
|
|
||
|
|
|
|
2020
|
2019
|
2018
|
||||||||||||||||||||||
In thousands of euro
|
Gross
amount |
Tax
effect |
Gross
amount |
Tax
effect |
Gross
amount |
Tax
effect |
||||||||||||||||||
Tax losses
|
162,574 | 32,327 | 60,009 | 10,224 | 60,009 | 10,224 |
In thousands of euro
|
2020
|
2019
|
2018
|
|||||||||
Expiry 2021 - 2037
|
22,770 | 7,457 | 249 | |||||||||
No expiry
|
139,804 | 133,988 | 59,760 |
In thousands of euro
|
2020
|
2020
|
2019
|
2019
|
2018
|
2018
|
||||||||||||||||||
Loss before tax from continuing operations
|
(101,017 | ) | (55,025 | ) | (31,140 | ) | ||||||||||||||||||
Tax rate using the Company’s domestic tax rate
|
24.94 | % | (25,194 | ) | 24.94 | % | (13,723 | ) | 26,01 | % | (8,100 | ) | ||||||||||||
Effect of tax rates in foreign jurisdictions
|
(4.17 | %) | 4,212 | (5.96 | %) | 3,283 | (7.36 | %) | 2,375 | |||||||||||||||
Non-deductible
expenses
|
(2.70 | %) | 2,727 | (0.31 | %) | 172 | (0.90 | %) | 280 | |||||||||||||||
Tax exempt income/tax incentives
|
0.85 | % | (855 | ) | 0.03 | % | (16 | ) | 0.17 | % | (52 | ) | ||||||||||||
Current year losses for which no deferred tax asset is recognised
|
(23.46 | %) | 23,696 | (19.11 | %) | 10,511 | (17.97 | %) | 5,597 | |||||||||||||||
True up adjustments for taxes for prior years*
|
22.76 | % | (22,994 | ) | 13.02 | % | (7,162 | ) | 3.39 | % | (1,056 | ) | ||||||||||||
Other domestic taxes
|
(0.60 | %) | 606 | (0.01 | %) | 6 | (0.02 | %) | 5 | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Income tax income
|
17.62 | % |
|
(17,802
|
)
|
12.59 | % |
|
(6,929
|
)
|
|
(951
|
)
|
|||||||||||
|
|
|
|
|
|
* |
True up adjustment for taxes for prior years relate to changes in estimates to UK R&D claims for prior periods, which were calculated and submitted in 2020.
|
2020
|
2019
|
|||||||
Current liabilities
|
||||||||
Trade payables
|
9,144 | 9,131 | ||||||
Accrued expenses
|
8,815 | 7,165 | ||||||
Other payables
|
16,206 | 4,514 | ||||||
|
|
|
|
|||||
|
34,165
|
|
|
20,810
|
|
|||
|
|
|
|
In thousands of euro
|
Note |
Financial
Assets at amortised cost |
Total |
Fair
Value |
Level in
the fair value hierarchy |
|||||||||||||||
December 31, 2020
|
||||||||||||||||||||
Loan receivables
|
10 | 29,998 |
|
29,998
|
|
30,231 | 3 | |||||||||||||
Cash guarantees and deposits
|
10 | 9,364 |
|
9,364
|
|
— | 1 | |||||||||||||
December 31, 2019
|
||||||||||||||||||||
Cash guarantees and deposits
|
10 | 6,963 |
|
6,963
|
|
— | 1 |
In thousands of euro
|
|
2020
|
|
|
2019
|
|
|
2018
|
|
|||
A. Other income
|
|
|
|
|||||||||
Government grants
|
1,023 | 1,865 | 1,138 | |||||||||
Gain on disposal of fixed assets
|
6 | 546 | — | |||||||||
Gain from modification of lease
|
1,036 | 64 | — | |||||||||
Other income
|
297 | 108 | 29 | |||||||||
|
|
|
|
|
|
|||||||
Total other income
|
|
2,362
|
|
|
2,583
|
|
|
1,167
|
|
|||
|
|
|
|
|
|
|||||||
B. Other expenses
|
||||||||||||
Impairment of receivable
|
|
(6
|
)
|
|
—
|
|
||||||
Loss on disposal of fixed assets
|
(5 | ) | (5 | ) | — | |||||||
Other charges
|
(6,842 | ) | (6,906 | ) | (13 | ) | ||||||
|
|
|
|
|
|
|||||||
Total other expenses
|
|
(6,853
|
)
|
|
(6,911
|
)
|
|
(13
|
)
|
|||
|
|
|
|
|
|
In thousands of euro
|
2020
|
2019
|
2018
|
|||||||||
C. Expenses by nature
|
||||||||||||
Depreciation
|
(9,652 | ) | (4,770 | ) | (2,120 | ) | ||||||
Impairment of intangible assets and receivable
|
(391 | ) | (4,972 | ) | (9,347 | ) | ||||||
Wages and salaries
|
(31,754 | ) | (14,260 | ) | (8,466 | ) | ||||||
Consultancy fees
|
(11,667 | ) | (4,547 | ) | (1,718 | ) | ||||||
Contractors
|
(1,535 | ) | (2,241 | ) | (1,316 | ) | ||||||
Rent and property utilities
|
(4,691 | ) | (2,820 | ) | (2,666 | ) | ||||||
Legal fees
|
(5,362 | ) | (633 | ) | (311 | ) | ||||||
Employee share scheme
|
(9,326 | ) | — | — | ||||||||
Raw material and consumables
|
(9,683 | ) | (5,107 | ) | (1,640 | ) | ||||||
Marketing
|
(1,676 | ) | (535 | ) | (938 | ) | ||||||
Recruitment fees
|
(1,183 | ) | (1,447 | ) | (597 | ) | ||||||
Travel expenses and accommodation
|
(1,003 | ) | (2,365 | ) | (1,137 | ) | ||||||
Fees payable to the Company’s auditors for the 2020 audit of the Company’s annual accounts
|
(1,224 | ) | — | — | ||||||||
Fees payable to the Company’s auditors for the prior year audits of the Company’s annual accounts
|
(1,809 | ) | (393 | ) | (111 | ) | ||||||
Fees payable to the Company’s auditors for other services
|
(272 | ) | (154 | ) | (90 | ) | ||||||
Other
|
(2,243 | ) | (3,269 | ) | (1,878 | ) | ||||||
|
|
|
|
|
|
|||||||
Total cost of administrative, research and development and impairment expenses
|
|
(93,471
|
)
|
|
(47,513
|
)
|
|
(32,335
|
)
|
|||
|
|
|
|
|
|
In thousands of euro
|
2020
|
2019
|
2018
|
|||||||||
Finance income
|
||||||||||||
Foreign exchange differences
|
— | — | 18 | |||||||||
Interest receivable
|
2,703 | 51 | 122 | |||||||||
|
|
|
|
|
|
|||||||
Total finance income
|
|
2,703
|
|
|
51
|
|
|
140
|
|
|||
|
|
|
|
|
|
|||||||
Finance cost
|
||||||||||||
Bank charges
|
(298 | ) | (160 | ) | (72 | ) | ||||||
Interest payable
|
(149 | ) | — | (27 | ) | |||||||
Interest on leases
|
(4,733 | ) | (2,574 | ) | — | |||||||
Foreign exchange differences
|
(578 | ) | (501 | ) | — | |||||||
|
|
|
|
|
|
|||||||
Total finance cost
|
|
(5,758
|
)
|
|
(3,235
|
)
|
|
(99
|
)
|
|||
|
|
|
|
|
|
2020
|
RSP
|
SOP
|
||||||
Weighted average fair value at grant date
|
2.62 | 1.93 | ||||||
Share price of Preferred A shares based on transactions occurred at the same time of the issues of the scheme
|
|
3.41
|
|
3.41 | ||||
Exercise price
|
— | 3.41 | ||||||
Contractual life of the options
|
— | 10 years |
In thousands
|
SOP
|
|||
2020
|
||||
Outstanding at the beginning of the year
|
— | |||
Granted during the year
|
26,890 | |||
Exercised during the year
|
— | |||
Expired during the year
|
— | |||
Forfeited during the year
|
— | |||
|
|
|||
Outstanding at the end of the year
|
|
26,890
|
|
|
|
|
|||
Exercisable at the end of the year
|
— |
Input
|
IPO
|
Delayed exit
|
Justification
|
|||
Valuation date
|
October 2, 2020 | October 2, 2020 | This is the date that the option scheme was communicated to the employees and the date that management has made an estimation of the valuation of the scheme. Given the short time elapsed between the valuation date and the date that the actual agreements were signed management does not consider there to be any material change in value across the valuation date and the date the agreements have been signed (grant date). | |||
Risk free rate
|
0% | 0% | Risk free rates are taken from yields on UK government bonds for corresponding periods to the exit dates for each valuation event. Rates are linearly interpolated from yields for bonds with the closest available maturities. Where negative, rates have been capped at 0%. | |||
Dividend yield
|
Nil | Nil | No dividend is anticipated to be paid prior to an exit event. SOPs are not entitled to dividends but RSPs are. | |||
Expected volatility
|
146% | 102% | Based on the average observed volatility in the equity value of listed comparable companies over a historic period commensurate with the expected exit date | |||
Expected exit event
|
January 31, 2021 | January 1, 2022 | Estimation as to when the exit event will occur | |||
Scenario weighting
|
75% | 25% |
This is the expected likelihood of the different exit routes as at the grant dates. We have assumed a
one-year
delay if the exit does not occur in early 2021.
|
In thousands of euro
|
Transactions for the year
|
Balance outstanding
|
||||||||||||||||||
Related party |
2020
|
2019
|
2018
|
December 31,
2020 |
December 31,
2019 |
|||||||||||||||
Arrival Management Systems LLC
|
(10 | ) | (256 | ) | — | (53 | ) | |||||||||||||
Arrival Solutions LLC
|
4 | (30 | ) | 5 | (26 | ) | ||||||||||||||
Shishkov Rodion
|
— | 62 | 123 | — | 64 | |||||||||||||||
Studio S.à r.l.
|
— | — | (1,690 | ) | ||||||||||||||||
K Cybernation S.à r.l.
|
— | (3,297 | ) | — | — | |||||||||||||||
K Robolife S.à r.l.
|
(66 | ) | (65,649 | ) | — | — | ||||||||||||||
Kinetik S.à r.l.
|
(23,959 | ) | (150,909 | ) | (44,553 | ) | — | — | ||||||||||||
Charge Cars Ltd
|
294 | (39 | ) | 165 | — | — | ||||||||||||||
Smart Space LLC
|
(386 | ) | (152 | ) | ||||||||||||||||
Smekalka LLC
|
(299 | ) | — | — | — | |||||||||||||||
Experiment X Ltd
|
(66 | ) | ||||||||||||||||||
Happy Electron Ltd
|
(127 | ) | ||||||||||||||||||
Cybernation Ltd
|
(60 | ) | ||||||||||||||||||
Remy Robotics LLC
|
31 | 36 | — | — | ||||||||||||||||
Denis Sverdlov
|
195 |
In thousands of euro
|
Transactions for the year
|
|||||||||||
Key Management personnel
|
2020
|
2019
|
2018
|
|||||||||
Wages and salaries
|
2,937 | 2,903 | 2,924 | |||||||||
Social contributions
|
334 | 561 | 372 | |||||||||
Other benefits
|
48 | 1 | — | |||||||||
Other earnings
|
— | 34 | — | |||||||||
RSP loans
|
13,700 | — | — | |||||||||
SOP expense
|
3,141 | — | — |
Name | Nominal Amount |
Fair Value of
December 31, (see note 10A.iii) |
||||||
In thousands of euro
|
||||||||
Tim Holbrow
|
600 | 426 | ||||||
Avinash Rugoobur
|
3,000 | 2,130 | ||||||
Mike Ableson
|
1,500 | 978 | ||||||
Daniel Chin
|
1,000 | 710 | ||||||
|
|
|
|
|||||
Total
|
|
6,100
|
|
|
4,244
|
|
||
|
|
|
|
In thousands of euro
|
Personnel cost
|
|||||||||||
2020
|
2019
|
2018
|
||||||||||
UK
|
65,178 | 27,601 | 12,562 | |||||||||
Russia
|
31,255 | 11,265 | 6,586 | |||||||||
US
|
4,987 | 2,597 | — | |||||||||
Germany
|
4,589 | 2,165 | 62 | |||||||||
Israel
|
1,793 | 57 | — | |||||||||
Other
|
2,167 | — | — | |||||||||
|
|
|
|
|
|
|||||||
|
109,969
|
|
|
43,685
|
|
|
19,210
|
|
||||
|
|
|
|
|
|
Page | ||
F-59 | ||
F-60 | ||
F-61 | ||
F-62 | ||
F-63 | ||
F-64 - F-70
|
In thousands of euro
|
October 27, 2020 to
December 31, 2020 |
|||||
Note | ||||||
Continuing Operations
|
||||||
Administrative expenses
|
8 | (102 | ) | |||
Legal Expenses
|
8 | (3,285 | ) | |||
|
|
|||||
Operating loss
|
|
(3,387
|
)
|
|||
|
|
|||||
Loss for the period
|
|
(3,387
|
)
|
|||
|
|
|||||
Attributable to:
|
||||||
Owners of the Company
|
(3,387 | ) | ||||
Earnings per share
(presented in euro)
|
||||||
Basic earnings per share
|
(11.29 | ) | ||||
Diluted earnings per share
|
(11.29 | ) |
Loss for the period
|
|
(3,387
|
)
|
|||||
|
|
|||||||
Total comprehensive loss for the period
|
|
(3,387
|
)
|
|||||
|
|
In thousands of euro
|
Note |
2020
|
||||
ASSETS
|
||||||
Current Assets
|
||||||
Cash and cash equivalents
|
4 | 28 | ||||
|
|
|||||
Total Current Assets
|
|
28
|
|
|||
|
|
|||||
TOTAL ASSETS
|
|
28
|
|
|||
|
|
|||||
EQUITY AND LIABILITIES
|
||||||
Capital and reserves
|
||||||
Share capital
|
5 | 30 | ||||
Accumulated deficit
|
(3,387 | ) | ||||
|
|
|||||
Total Equity
|
|
(3,357
|
)
|
|||
|
|
|||||
Current Liabilities
|
||||||
Trade and other payables
|
7 | 3,385 | ||||
|
|
|||||
Total Current Liabilities
|
|
3,385
|
|
|||
|
|
|||||
TOTAL EQUITY AND LIABILITIES
|
|
28
|
|
|||
|
|
In thousands of euro
|
Note
|
Share
capital |
Accumulated
deficit |
Total
equity |
||||||||||||
Balance at October 27, 2020
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Loss for the period
|
— | (3,387 | ) | (3,387 | ) | |||||||||||
|
|
|
|
|
|
|||||||||||
Transactions with shareholders
|
|
—
|
|
|
(3,387
|
)
|
|
(3,387
|
)
|
|||||||
Capital increase
|
5 | 30 | — | 30 | ||||||||||||
|
|
|
|
|
|
|||||||||||
Balance at December 31, 2020
|
|
30
|
|
|
(3,387
|
)
|
|
(3,357
|
)
|
|||||||
|
|
|
|
|
|
In thousands of euro
|
Note |
October 27
to
December 31, 2020 |
||||||
Cash flows used in operating activities
|
||||||||
Loss for the period
|
|
(3,387
|
)
|
|||||
Increase in trade and other payables
|
7 | 3,385 | ||||||
|
|
|||||||
Net cash used in operating activities
|
|
(2
|
)
|
|||||
|
|
|||||||
Cash flows from financing activities
|
||||||||
Capital increase
|
5 | 30 | ||||||
|
|
|||||||
Net cash from financing activities
|
|
30
|
|
|||||
|
|
|||||||
Net increase in cash and cash equivalents
|
|
28
|
|
|||||
Cash and cash equivalents as at October 27, 2020
|
— | |||||||
|
|
|||||||
Cash and cash equivalents at December 3
1
|
|
28
|
|
|||||
|
|
January 1, 2021 | IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 – Interest Rate Benchmark Reform – Phase 2 | |
January 1, 2022 | IFRS 3 – Amendments to References to Conceptual Framework | |
January 1, 2022 | IAS 16 – Proceeds before intended use | |
January 1, 2022 | IAS 37 – Cost of fulfilling a contract | |
January 1, 2023 |
IAS 1 – Classification of Liabilities as Current or
Non-Current
|
|
January 1, 2023 | IFRS 17 – Insurance Contracts | |
Available for optional adoption/effective date deferred
indefinitely |
IFRS 10 and IAS 28 – Sale or Contribution of Assets between Investor and its Associate or Joint Venture |
In thousands of euro
|
2020
|
|||
Bank balances
|
28 | |||
|
|
|||
Total
|
|
28
|
|
|
|
|
In thousands of shares
|
2020
|
|||
Authorised
|
||||
Ordinary shares
|
|
300
|
|
|
In thousands of euro
|
||||
Ordinary shares issued and fully paid
|
||||
Ordinary shares issued on October 27
|
30 | |||
|
|
|||
Ordinary shares issued and fully paid as of December 31
|
|
30
|
|
|
|
|
In thousands of euro
|
2020
|
|||
Tax losses
|
(3,387 | ) | ||
|
|
|||
Total
|
|
(3,387
|
)
|
|
|
|
2020
|
||||
In thousands of euro
|
Gross
amount |
Tax
effect |
||
Tax losses | 3,387 | 845 |
In thousands of euro
|
2020
|
|||
Expiry in 2037
|
3,387 |
In thousands of euro
|
2020
|
|||||||
Loss before tax from continuing operations
|
(3,387 | ) | ||||||
Tax rate using the Company’s domestic tax rate
|
24.94 | % | (845 | ) | ||||
Current year losses for which no deferred tax asset is recognised
|
(24.94 | %) | 845 | |||||
|
|
|||||||
Income tax expense
|
|
—
|
|
|||||
|
|
2020
|
||||
Current liabilitie
s
|
||||
Other payables and accrued expenses
|
(3,385 | ) | ||
|
|
|||
|
(3,385
|
)
|
||
|
|
In thousands of euro
|
|
2020
|
|
|
Other
|
|
|
(53
|
)
|
Audit fees
|
|
|
(49
|
)
|
Legal fees
|
|
|
(3,285
|
)
|
|
|
|
|
|
Total other expenses
|
|
|
(3,387
|
)
|
|
|
|
|
Page | ||
F-73 | ||
F-74 | ||
F-75 | ||
F-76 | ||
F-77-F-78
|
||
F-79-F-96
|
In thousands of euro
|
Note |
Nine months ended
|
Three months ended
|
|||||||||||||||||
September 30,
2021 |
September 30,
2020 |
September 30,
2021 |
September 30,
2020 |
|||||||||||||||||
Continuing Operations
|
||||||||||||||||||||
Administrative expenses
|
(111,627 | ) | (43,248 | ) | (37,826 | ) | (19,843 | ) | ||||||||||||
Research and development expenses
|
(21,737 | ) | (8,277 | ) | (8,591 | ) | (1,368 | ) | ||||||||||||
Impairment expense
|
4 | (1,918 | ) | (650 | ) | — | — | |||||||||||||
Other operating income
|
1,887 | 1,366 | 277 | 607 | ||||||||||||||||
Listing expense
|
15 | (1,018,024 | ) | — | — | — | ||||||||||||||
Other expenses
|
(5 | ) | (208 | ) | 180 | (2 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Operating (loss)
|
|
(1,151,424
|
)
|
|
(51,017
|
)
|
|
(45,960
|
)
|
|
(20,606
|
)
|
||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Finance income
|
16 | 119,573 | 1,797 | 27,953 | 2 | |||||||||||||||
Finance cost
|
16 | (11,527 | ) | (3,567 | ) | (7,561 | ) | (1,224 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net Finance Income/(cost)
|
|
108,046
|
|
|
(1,770
|
)
|
|
20,392
|
|
|
(1,222
|
)
|
||||||||
|
|
|
|
|
|
|
|
|||||||||||||
(Loss) before tax
|
|
(1,043,378
|
)
|
|
(52,787
|
)
|
|
(25,568
|
)
|
|
(21,828
|
)
|
||||||||
Tax income/(expense)
|
12 | (7,118 | ) | 3,337 | (823 | ) | (497 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
(Loss) for the period
|
|
(1,050,496
|
)
|
|
(49,450
|
)
|
|
(26,391
|
)
|
|
(22,325
|
)
|
||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Attributable to:
|
||||||||||||||||||||
Owners of the Company
|
|
(1,050,496
|
)
|
|
(49,450
|
)
|
|
(26,391
|
)
|
|
(22,325
|
)
|
||||||||
Earnings per share
(presented in euro)
|
||||||||||||||||||||
Basic and diluted earnings per share
|
(1.86 | ) | (0.10 | ) | (0.04 | ) | (0.04 | ) |
In thousands of euro
|
Nine months ended
|
Three months ended
|
||||||||||||||
September 30,
2021 |
September 30,
2020 |
September 30,
2021 |
September 30,
2020 |
|||||||||||||
(Loss) for the period
|
|
(1,050,496
|
)
|
|
(49,450
|
)
|
|
(26,391
|
)
|
|
(22,325
|
)
|
||||
Items that may be reclassified subsequently to profit or (loss)
|
||||||||||||||||
Exchange differences on translating foreign operations
|
12,061 | (11,617 | ) | (2,356 | ) | (790 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive gain/(loss)
|
|
12,061
|
|
|
(11,617
|
)
|
|
(2,356
|
)
|
|
(790
|
)
|
||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive (loss) for the period
|
|
(1,038,435
|
)
|
|
(61,067
|
)
|
|
(28,747
|
)
|
|
(23,115
|
)
|
||||
|
|
|
|
|
|
|
|
|||||||||
Attributable to:
|
||||||||||||||||
Owners of the Company
|
(1,038,435 | ) | (61,067 | ) | (28,747 | ) | (23,115 | ) |
In thousands of euro
|
Note |
Share
capital |
Share
premium |
Accumulated
deficit |
Other
reserves* |
Total equity
|
||||||||||||||||
Balance at January 1, 2021**
|
|
239,103
|
|
|
288,539
|
|
|
(258,756
|
)
|
|
51,425
|
|
|
320,311
|
|
|||||||
(Loss) for the period
|
— | — | (1,050,496 | ) | — | (1,050,496 | ) | |||||||||||||||
Other comprehensive income
|
— | — | — | 12,061 | 12,061 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Transactions with shareholders
|
|
239,103
|
|
|
288,539
|
|
|
(1,309,252
|
)
|
|
63,486
|
|
|
(718,124
|
)
|
|||||||
Issuance of share capital as consideration for the merger with CIIG
|
8 | 7,232 | 602,413 | — | 737,264 | 1,346,909 | ||||||||||||||||
Adjustment of shareholding transfer from Arrival Luxembourg S.à r.l. to Arrival
|
8 | (185,719 | ) | 3,888,593 | — | (3,702,874 | ) | — | ||||||||||||||
Initial share capital of Arrival
|
30 | — | — | — | 30 | |||||||||||||||||
Reduction of capital of Arrival
|
(30 | ) | — | — | 30 | — | ||||||||||||||||
Conversion of warrants into shares
|
8, 10 | 1,427 | 117,347 | — | 69,239 | 188,013 | ||||||||||||||||
Acquisition of own shares
|
8 | — | — | — | (150 | ) | (150 | ) | ||||||||||||||
Equity-settled share-based payments
|
— | — | — | 7,562 | 7,562 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance at September 30, 2021
|
|
62,043
|
|
|
4,896,892
|
|
|
(1,309,252
|
)
|
|
(2,825,443
|
)
|
|
824,240
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
** |
Comparatives in Statement of changes in equity represent Arrival Luxembourg S.à r.l.’s capital structure up to the point of the
share-for-share
|
In thousands of euro
|
Note |
Share
capital |
Share
premium |
Accumulated
deficit |
Other
reserves* |
Total
equity |
||||||||||||||||||
Balance at January 1, 2020
|
|
227,333
|
|
|
139,752
|
|
|
(174,875
|
)
|
|
7,035
|
|
|
199,245
|
|
|||||||||
Loss for the period
|
— | — | (49,450 | ) | — | (49,450 | ) | |||||||||||||||||
Other comprehensive loss
|
— | — | — | (11,617 | ) | (11,617 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Transactions with shareholders
|
|
227,333
|
|
|
139,752
|
|
|
(224,325
|
)
|
|
(4,582
|
)
|
|
138,178
|
|
|||||||||
Business combination under common control
|
— | — | (666 | ) | — | (666 | ) | |||||||||||||||||
Capital increase
|
734 | 9,324 | — | — | 10,058 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at September 30, 2020
|
|
228,067
|
|
|
149,076
|
|
|
(224,991
|
)
|
|
(4,582
|
)
|
|
147,570
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
* |
Other reserves comprise of translation reserves and equity reserves which are not distributable (see note 8)
|
in thousands of euro
|
September 30,
2021 |
September 30,
2020 |
||||||||||
Note | ||||||||||||
Cash flows used in operating activities
|
||||||||||||
(Loss) for the period
|
(1,050,496 | ) | (49,450 | ) | ||||||||
Adjustments for:
|
||||||||||||
• Depreciation/Amortisation
|
13,968 | 6,415 | ||||||||||
• Impairment losses and write-offs
|
2,043 | 650 | ||||||||||
• Net unrealised foreign exchange differences
|
(4,083 | ) | (846 | ) | ||||||||
• Net finance interest
|
(3,680 | ) | 3,317 | |||||||||
• Employee share scheme
|
17 | 3,023 | — | |||||||||
• Change in fair value of warrants including intrinsic value of warrants redeemed
|
10 | (105,838 | ) | — | ||||||||
• Listing expense
|
15 | 1,002,609 | — | |||||||||
• Fair value movement on employee loans including fair value charge for the new employee loans issued as of September 30, 2021
|
16 | 5,050 | — | |||||||||
• Reversal of difference between fair value and nominal value of loans repaid
|
16 | (1,485 | ) | — | ||||||||
• Loss on disposal of fixed assets
|
252 | |||||||||||
• Profit from the cancellation of leases
|
(1,146 | ) | — | |||||||||
• Tax income/(expense)
|
7,118 | (3,199 | ) | |||||||||
|
|
|
|
|||||||||
Cash flows used in operations before working capital changes
|
|
(132,665
|
)
|
|
(43,113
|
)
|
||||||
(Increase) in trade and other receivables
|
6 | (45,860 | ) | (4,616 | ) | |||||||
Increase in trade and other payables
|
13 | 29,294 | 6,178 | |||||||||
(Increase) of inventory
|
7 | (4,867 | ) | (3,711 | ) | |||||||
|
|
|
|
|||||||||
Cash flows used in operations
|
|
(154,098
|
)
|
|
(45,262
|
)
|
||||||
Income tax and other taxes received
|
6,466 | 4,555 | ||||||||||
Interest received
|
69 | 3 | ||||||||||
|
|
|
|
|||||||||
Net cash used in operating activities
|
|
(147,563
|
)
|
|
(40,704
|
)
|
||||||
|
|
|
|
In thousands of euro
|
September 30,
2021 |
September 30,
2020 |
||||||||||
Note | ||||||||||||
Cash flows from investing activities
|
||||||||||||
Acquisition of intangible assets
|
5 | (125,111 | ) | (51,394 | ) | |||||||
Acquisition of property, plant and equipment
|
4 | (28,981 | ) | (7,832 | ) | |||||||
Grants received
|
275 | 775 | ||||||||||
Prepayments for tangible and intangible assets
|
(33,928 | ) | (1,571 | ) | ||||||||
Cash received on acquisition of entities, net of consideration paid
|
— | 117 | ||||||||||
Proceeds from the sale of fixed assets
|
— | 6 | ||||||||||
|
|
|
|
|||||||||
Net cash used in investing activities
|
|
(187,745
|
)
|
|
(59,899
|
)
|
||||||
|
|
|
|
|||||||||
Cash flows from financing activities
|
||||||||||||
Cash received from merger with CIIG
|
8 | 534,413 | — | |||||||||
Issuance of shares to warrant holders
|
10 | 118,577 | — | |||||||||
Cash paid for redemption of public warrants
|
10 | (6 | ) | — | ||||||||
Issuance of Preferred A shares
|
— | 10,000 | ||||||||||
Proceeds from borrowings
|
— | 2,406 | ||||||||||
Repayment of interest
|
(185 | ) | (51 | ) | ||||||||
Repayment of lease liabilities
|
9 | (8,791 | ) | (6,262 | ) | |||||||
|
|
|
|
|||||||||
Net cash from financing activities
|
|
644,008
|
|
|
6,093
|
|
||||||
|
|
|
|
|||||||||
Net increase/(decrease) in cash and cash equivalents
|
|
308,700
|
|
|
(94,510
|
)
|
||||||
Cash and cash equivalents at January 1
|
67,080 | 96,644 | ||||||||||
Effects of movements in exchange rates on cash held
|
4,919 | (980 | ) | |||||||||
|
|
|
|
|||||||||
Cash and cash equivalents at the end of the period
|
|
380,699
|
|
|
1,154
|
|
||||||
|
|
|
|
In thousands of euro
|
Land and
buildings |
Plant and
equipment |
Fixtures and
fittings |
Motor
vehicles |
Assets under
construction |
Total
|
||||||||||||||||||
Cost
|
156,507 | 40,685 | 6,730 | 811 | 21,614 |
|
226,347
|
|
||||||||||||||||
Depreciation and impairment
|
(17,037 | ) | (16,263 | ) | (2,397 | ) | (361 | ) | — |
|
(36,058
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net book value at September 30, 2021
|
|
139,470
|
|
|
24,422
|
|
|
4,333
|
|
|
450
|
|
|
21,614
|
|
|
190,289
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cost
|
93,716 | 25,953 | 5,691 | 602 | 5,142 |
|
131,104
|
|
||||||||||||||||
Depreciation and impairment
|
(6,447 | ) | (10,321 | ) | (1,398 | ) | (219 | ) | — |
|
(18,385
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net book value at December 31, 2020
|
|
87,269
|
|
|
15,632
|
|
|
4,293
|
|
|
383
|
|
|
5,142
|
|
|
112,719
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
In thousands of euro
|
Goodwill
|
Assets under
construction* |
Patent,
trademarks
and other
rights
|
Software
|
Other
intangible
assets
|
Total
|
||||||||||||||||||
Cost
|
28 | 356,145 | 486 | 7,597 | 17 |
|
364,273
|
|
||||||||||||||||
Amortisation and impa
i
rment
|
(2 | ) | (41,649 | ) | (133 | ) | (3,433 | ) | (1 | ) |
|
(45,218
|
)
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net book value at September 30, 2021
|
|
26
|
|
|
314,496
|
|
|
353
|
|
|
4,164
|
|
|
16
|
|
|
319,055
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Cost
|
28 | 208,787 | 467 | 4,542 | — |
|
213,824
|
|
||||||||||||||||
Amortisation and impairment
|
(2 | ) | (39,978 | ) | (83 | ) | (2,035 | ) | — |
|
(42,098
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net book value at December 31, 2020
|
|
26
|
|
|
168,809
|
|
|
384
|
|
|
2,507
|
|
|
—
|
|
|
171,726
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
* |
Assets under construction include costs of projects in the development phase. The projects under development relate to electric vehicles, electric vehicles components and software.
|
In thousands
|
Share
capital in Arrival |
Share
premium in Arrival |
Share capital
in Arrival Luxembourg S.à r.l. |
Share
premium In Arrival Luxembourg S.à r.l. |
Exchange
impact in share capital |
Exchange
impact in share premium |
||||||||||||||||||
Ordinary shares
|
49,119 | 3,920,897 | (220,000 | ) | (47,142 | ) | (170,881 | ) | 3,873,755 | |||||||||||||||
Preferred A shares exchange for ordinary shares
|
4,265 | 256,235 | (19,103 | ) | (241,397 | ) | (14,838 | ) | 14,838 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total
|
|
53,384
|
|
|
4,177,132
|
|
|
(239,103
|
)
|
|
(288,539
|
)
|
|
(185,719
|
)
|
|
3,888,593
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
I. |
Other Comprehensive Income accumulated in reserves, net of tax
|
In thousands of euro
|
||||
January 1, 2020
|
7,035 | |||
Foreign operations – foreign currency translation differences
|
(7,757 | ) | ||
|
|
|||
December 31 2020
|
|
(722
|
)
|
|
|
|
|||
January 1, 2021
|
(722 | ) | ||
Foreign operations – foreign currency translation differences
|
12,061 | |||
|
|
|||
September 30, 2021
|
|
11,339
|
|
|
|
|
II. |
Equity Reserves
|
In thousands of euro
|
||||
January 1, 2020
|
— | |||
Treasury shares acquired by the employees of the Group
|
27,400 | |||
Equity-settled Share Plan to employees
|
24,747 | |||
|
|
|||
December 31 2020
|
|
52,147
|
|
|
|
|
|||
January 1, 2021
|
52,147 | |||
Equity-settled Share Plan to employees
|
7,562 | |||
Capital reduction
|
30 | |||
Private warrants
|
29,164 | |||
Public warrants
|
40,075 | |||
Impact from share conversion
|
(3,702,874 | ) | ||
Difference between the fair value of shares issued and the consideration received
|
737,264 | |||
Own shares
|
(150 | ) | ||
|
|
|||
September 30, 2021
|
|
(2,836,782
|
)
|
|
|
|
in thousands of euro
|
September 30, 2021
|
December 31, 2020
|
||||||
Non-current
lease liabilities
|
||||||||
Lease liability
|
143,047 | 87,907 | ||||||
|
|
|
|
|||||
Total
non-current
loans and borrowings
|
|
143,047
|
|
|
87,907
|
|
||
|
|
|
|
|||||
Current lease liabilities
|
||||||||
Current portion of lease liabilities
|
5,958 | 4,255 | ||||||
|
|
|
|
|||||
Total current loans and borrowings
|
|
5,958
|
|
|
4,255
|
|
||
|
|
|
|
in thousands of euro
|
Currency
|
Weighted
average of incremental borrowing rate |
Carrying
amount |
|||||||||
January 1, 2021
|
|
92,162
|
|
|||||||||
|
|
|||||||||||
New leases
|
||||||||||||
Offices and workshops in the UK
|
GBP | 5.47 | % | 47,627 | ||||||||
Office in Russia
|
RUR | 9.70 | % | 1,146 | ||||||||
Office in Mauritius
|
MUR | 7.10 | % | 165 | ||||||||
Office in the US
|
USD | 5.50 | % | 61 | ||||||||
Office and Workshop in Spain
|
EUR | 5.10 | % | 11,418 | ||||||||
Modification of leases
|
||||||||||||
Office in Germany
|
EUR | 17.00 | % | 26 | ||||||||
Offices in Russia
|
RUR | 9.20 | % | 134 | ||||||||
Office in the US
|
USD | 6.88 | % | (191 | ) | |||||||
Repayments
|
||||||||||||
Repayments
|
Multicurrency | (8,791 | ) | |||||||||
Interest on leases
|
5,808 | |||||||||||
Cancellation of lease
|
(4,535 | ) | ||||||||||
Foreign exchange impact
|
Multicurrency | 3,975 | ||||||||||
|
|
|||||||||||
September 30, 2021
|
|
149,005
|
|
|||||||||
|
|
In thousands of euro
|
Carrying
amount |
Total
|
Within one
year |
Between 1 and
5 years |
More than
5 years |
|||||||||||||||
September 30, 2021
|
||||||||||||||||||||
Leases
|
|
149,005
|
|
|
207,977
|
|
17,089 | 73,092 | 117,797 | |||||||||||
December 31, 2020
|
||||||||||||||||||||
Leases
|
|
92,162
|
|
|
135,595
|
|
9,891 | 42,905 | 82,799 |
Warrants
|
Number of
Warrants |
Value (EUR
thousand) |
||||||
Private Warrants
|
7,175,000 | 81,025 | ||||||
Public Warrants
|
12,937,493 | 108,972 | ||||||
|
|
|
|
|||||
Total
|
|
20,112,493
|
|
|
189,997
|
|
||
|
|
|
|
• |
Additionally, Arrival had a right to early redeem the Warrants on cash or cashless basis.
|
• |
In case of a cash redemption of Warrants, the Warrants are exercisable at a price of USD 11.5 per Warrant. However, in certain instances of a business combination or further issue of capital, Arrival has the right to change the warrant price.
|
• |
Arrival has an option to early redeem the warrants with a 30 days’ notice on a cash or cashless redemption if the reported sale price of the shares is at least USD 18 for 20 consecutive dates. In case of cashless redemption, the number of shares that will be given will be determined as a difference between strike price and fair value of the shares on warrant multiplied with total number of shares under the warrant. However, once the redemption notice has been served, it is at the option of the warrant holders to exercise the Warrants or they may be entitled to USD 0.01 per warrant on the completion of the redemption notice period.
|
• |
The equity shares of Arrival are designated in Euro. However, the Warrants are exercisable in USD.
|
• |
The private warrants are settled on a cashless basis based on the terms of the arrangement.
|
Warrants
|
Number of
Warrants |
Value (EUR
thousand)
|
||||||
January 1, 2021
|
— | — | ||||||
Warrants issued by Arrival
|
20,112,493 | 189,997 | ||||||
Change in fair value
|
— | (105,838 | ) | |||||
Warrants exercised
|
(17,009,291 | ) | (69,443 | ) | ||||
Warrants redeemed
|
(711,536 | ) | (6 | ) | ||||
Foreign exchange difference
|
— | (1,722 | ) | |||||
|
|
|
|
|||||
Total
|
|
2,391,666
|
|
|
12,988
|
|
||
|
|
|
|
In thousands of euro
|
FVTPL*
|
Financial
assets at
amortised
cost
|
Total
|
Fair Value
|
Level in the
fair value
hierarchy
|
|||||||||||||||
September 30, 2021
|
||||||||||||||||||||
Loan receivables
|
— | 29,724 |
|
29,724
|
|
30,535 | 3 | |||||||||||||
Private Warrants
|
12,988 | — |
12,988
|
12,988 | 2 | |||||||||||||||
December 31, 2020
|
||||||||||||||||||||
Loan receivables
|
— | 29,998 |
29,998
|
30,231 | 3 |
* |
FVTPL stands for fair value through profit and loss
|
In thousands of euro
|
September 30, 2021
|
December 31, 2020
|
||||||
Trade payables
|
24,545 | 9,144 | ||||||
Accrued expenses
|
11,270 | 8,815 | ||||||
Other payables
|
8,760 | 16,206 | ||||||
|
|
|
|
|||||
Trade and other payables
|
|
44,575
|
|
|
34,165
|
|
||
|
|
|
|
i. |
(Loss) attributable to Ordinary shareholders:
|
Nine months ended
|
Three months ended
|
|||||||||||||||||||||||||||||||
In thousands of euro
|
September 30, 2021
|
September 30, 2020
|
September 30, 2021
|
September 30, 2020
|
||||||||||||||||||||||||||||
Continuing
operations
|
Total
|
Continuing
operations
|
Total
|
Continuing
operations
|
Total
|
Continuing
operations
|
Total
|
|||||||||||||||||||||||||
(Loss) for the period, attributable to the owners of the Company (basic)
|
(1,050,496 | ) | (1,050,496 | ) | (47,701 | ) | (47,701 | ) | (26,391 | ) | (26,391 | ) | (21,535 | ) | (21,535 | ) | ||||||||||||||||
Nine months ended
|
Three months ended
|
|||||||||||||||
In thousands of shares |
September 30, 2021
|
September 30, 2020
|
September 30, 2021
|
September 30, 2020
|
||||||||||||
Ordinary shares
|
560,653 | 491,184 | 591,310 | 491,184 | ||||||||||||
RSP shares (1 year condition-fully vested)
|
3,486 | — | 3,486 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average number of shares
|
|
564,139
|
|
|
491,184
|
|
|
594,796
|
|
|
491,184
|
|
||||
|
|
|
|
|
|
|
|
In thousands of euro
|
Nine months ended
September 30, 2021
|
|||
Listing expenses
|
||||
Reverse merger impact in the unaudited condensed consolidated statement of profit or (loss) due to IFRS 2 accounting treatment
|
||||
Fair value of shares issued
|
1,346,909 | |||
Fair Value of Warrants transferred
|
189,997 | |||
|
|
|||
Total value of consideration
|
|
1,536,906
|
|
|
Less
|
||||
Fair Value of net asset received
|
(534,297 | ) | ||
|
|
|||
Total reverse merger impact in the unaudited condensed consolidated statement of profit or (loss) due to IFRS 2 accounting treatment
|
1,002,609 | |||
Other expenses directly linked to the listing expense**
|
15,415 | |||
|
|
|||
Total listing expense
|
|
1,018,024
|
|
|
|
|
** |
Additionally, the company had incurred additional costs of EUR 15,415,000 in relation to the SPAC transaction and reverse merger which has been presented as a part of the Listing expense for the nine months ended September 30, 2021.
|
9 months ended
|
3 months ended
|
|||||||||||||||||||
In thousands of euro
|
Note
|
September 30,
2021 |
September 30,
2020 |
September 30,
2021 |
September 30,
2020 |
|||||||||||||||
Finance income
|
||||||||||||||||||||
Change in fair value of warrants including intrinsic value of warrants redeemed
|
10 | 105,838 | — | 17,198 | — | |||||||||||||||
Interest receivable
|
6 | 9,679 | 59 | 3,503 | 26 | |||||||||||||||
Foreign exchange differences
|
2,571 | 1,738 | 7,221 | (24 | ) | |||||||||||||||
Reversal of difference between fair value and nominal value of loans
|
1,485 | — | 31 | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total finance income
|
|
119,573
|
|
|
1,797
|
|
|
27,953
|
|
|
2
|
|
||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Finance cost
|
||||||||||||||||||||
Bank charges
|
(225 | ) | (182 | ) | (61 | ) | (36 | ) | ||||||||||||
Interest payable
|
(191 | ) | (51 | ) | (40 | ) | (12 | ) | ||||||||||||
Interest on leases
|
9 | (5,808 | ) | (3,324 | ) | (2,157 | ) | (1,172 | ) | |||||||||||
Fair value movement on employee loans including fair value charge for the new employee loans provided as of September 30, 2021
|
(5,050 | ) | — | (5,050 | ) | — | ||||||||||||||
Other
|
(253 | ) | (10 | ) | (253 | ) | (4 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total finance cost
|
|
(11,527
|
)
|
|
(3,567
|
)
|
|
(7,561
|
)
|
|
(1,224
|
)
|
||||||||
|
|
|
|
|
|
|
|
I. |
Loans to key management
|
II. |
Key management personnel compensation
|
In thousands of euro
Related party
|
September 30,
2021
|
December 31,
2020
|
||||||
Hyundai Motors Company
|
(270 | ) | — |
In thousands of euro
Related party
|
Nine months ended
|
Three months ended
|
||||||||||||||
September 30,
2021 |
September 30,
2020 |
September 30,
2021 |
September 30,
2020 |
|||||||||||||
K Robolife S.à r.l.
|
— | 9 | — | 9 | ||||||||||||
Kinetik S.à r.l.
|
— | 57 | 57 | |||||||||||||
Charge Cars Ltd
|
7 | 7 | ||||||||||||||
Hyundai Motors Company
|
(467 | ) | — | (23 | ) | — | ||||||||||
Hyundai Mobis
|
740 | — | 293 | — |
* |
Filed herewith
|
# |
Certain schedules, annexes and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation
S-K,
but will be furnished supplementally to the SEC upon request.
|
## |
Certain confidential portions of this exhibit were omitted by means of marking such portions with brackets and asterisks because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed, or constituted personally identifiable information that is not material
|
+ |
Management contract or compensatory plan or arrangement.
|
(b)
|
Financial Statement Schedules
|
(1) |
to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
(i) |
to include any prospectus required by Section 10(a)(3) of the Securities Act;
|
(ii) |
to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) that, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
|
(iii) |
to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
|
(2) |
that for the purpose of determining any liability under the Securities Act, each post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof;
|
(3) |
to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering;
|
(4) |
to file a post-effective amendment to the registration statement to include any financial statements required by “Item 8.A. of Form
20-F”
at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act need not be furnished; provided, that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements; and
|
(5) |
that, for the purpose of determining liability under the Securities Act to any purchaser:
|
(i) |
if the registrant is relying on Rule 430B:
|
(A) |
each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
|
(B) |
each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; and
|
(ii) |
if the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement
|
that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
(6) |
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
|
(i) |
any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
|
(ii) |
any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
|
(iii) |
the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
|
(iv) |
any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
(1) |
that for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective; and
|
(2) |
for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
ARRIVAL
|
||
By:
|
/s/ Denis Sverdlov
|
|
Name:
|
Denis Sverdlov
|
|
Title:
|
Chief Executive Officer
|
Signature
|
Capacity
|
Date
|
||
/s/ Denis Sverdlov
Denis Sverdlov
|
Chief Executive Officer
(principal executive officer)
|
November 16, 2021 | ||
/s/ John Wozniak
John Wozniak
|
Chief Financial Officer
|
November 16, 2021 | ||
/s/ F. Peter Cuneo
F. Peter Cuneo
|
Chairman of the Board
|
November 16, 2021 | ||
/s/ Tawni Nazario-Cranz
Tawni Nazario-Cranz
|
Director
|
November 16, 2021 | ||
/s/ Alain Kinsch
Alain Kinsch
|
Director
|
November 16, 2021 | ||
/s/ Kristen O’Hara
Kristen O’Hara
|
Director
|
November 16, 2021 |
Signature
|
Capacity
|
Date
|
||
/s/ Yungseong Hwang
Yunseong Hwang
|
Director
|
November 16, 2021 | ||
/s/ Avinash Rugoobur
Avinash Rugoobur
|
Director
|
November 16, 2021 | ||
/s/ Rexford J. Tibbens
Rexford J. Tibbens
|
Director
|
November 16, 2021 |
By: | /s/ Michael Ableson | |
Name: | Michael Ableson |
Exhibit 1.1
Arrival
25,000,000 Ordinary Shares
Underwriting Agreement
November [], 2021
Goldman Sachs International,
J.P. Morgan Securities LLC,
Barclays Capital Inc.,
Cowen and Company, LLC
As representatives (the Representatives) of the several Underwriters named in Schedule I hereto,
Goldman Sachs International,
Plumtree Court
25 Shoe Lane
London EC4A 4AU
United Kingdom,
J.P. Morgan Securities LLC,
383 Madison Avenue
New York, New York 10179,
Barclays Capital Inc.,
745 Seventh Avenue
New York, New York 10019,
Cowen and Company, LLC,
599 Lexington Avenue
New York, New York 10022,
Ladies and Gentlemen:
Arrival (formerly Arrival Group), a joint stock company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg having its registered office at 1, rue Peternelchen L-2370 Howald, Grand Duchy of Luxembourg, registered with the Luxembourg register of commerce and companies (Registre de Commerce et des Sociétés de Luxembourg) under number B 248209 (the Company) proposes, subject to the terms and conditions stated in this agreement (this Agreement), to issue and sell to the Underwriters named in Schedule I hereto (the Underwriters) an aggregate of 25,000,000 ordinary shares of the Company (each, an Ordinary Share) and, at the election of the
Underwriters, up to 3,750,000 additional Ordinary Shares. The aggregate of 25,000,000 Ordinary Shares to be sold by the Company is herein called the Firm Shares and the aggregate of 3,750,000 additional Ordinary Shares to be sold by the Company is herein called the Optional Shares. The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the Shares.
1. The Company represents and warrants to, and agrees with, each of the Underwriters that:
(a) A registration statement on Form F-1 (File No. 333- ) (the Initial Registration Statement) in respect of the Shares has been filed with the Securities and Exchange Commission (the Commission); the Initial Registration Statement and any post-effective amendment thereto, each in the form heretofore delivered to you, have been declared effective by the Commission in such form; other than a registration statement, if any, increasing the size of the offering (a Rule 462(b) Registration Statement), filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the Act), which became effective upon filing, no other document with respect to the Initial Registration Statement or document incorporated by reference therein has been filed with the Commission; and no stop order suspending the effectiveness of the Initial Registration Statement, any post-effective amendment thereto or the Rule 462(b) Registration Statement, if any, has been issued and no proceeding for that purpose or pursuant to Section 8A of the Act has been initiated or, to the Companys knowledge, threatened by the Commission (any preliminary prospectus included in the Initial Registration Statement or filed with the Commission pursuant to Rule 424(a) of the rules and regulations of the Commission under the Act is hereinafter called a Preliminary Prospectus; the various parts of the Initial Registration Statement and the Rule 462(b) Registration Statement, if any, including all exhibits thereto and including the information contained in the form of final prospectus filed with the Commission pursuant to Rule 424(b) under the Act in accordance with Section 4(a) hereof and deemed by virtue of Rule 430A under the Act to be part of the Initial Registration Statement at the time it was declared effective, each as amended at the time such part of the Initial Registration Statement became effective or such part of the Rule 462(b) Registration Statement, if any, became or hereafter becomes effective, are hereinafter collectively called the Registration Statement; the Preliminary Prospectus relating to the Shares that was included in the Registration Statement immediately prior to the Applicable Time (as defined in Section 1(c) hereof) is hereinafter called the Pricing Prospectus; and such final prospectus, in the form first filed pursuant to Rule 424(b) under the Act, is hereinafter called the Prospectus; any reference herein to any Preliminary Prospectus, the Pricing Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 5 of Form F-1 under the Act, as of the date of such prospectus; and any reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after the date of such Preliminary Prospectus or Prospectus, as the case may be, under the Securities Exchange Act of 1934, as amended (the Exchange Act), and incorporated therein; any reference to any amendment to the Registration Statement shall be deemed to refer to and include any annual report of the Company filed pursuant to Section 13(a) or 15(d) of the Exchange Act after the effective date of the Initial Registration Statement that is incorporated by reference in the
2
Registration Statement; any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Act or Rule 163B under the Act is hereinafter called a Testing-the-Waters Communication; and any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the Act is hereinafter called a Written Testing-the-Waters Communication;
(b) The Company is an ineligible issuer as defined under Rule 405 under the Securities Act. The Company has not prepared or used, and will not prepare or use, any free writing prospectus as defined under Rule 405 under the Securities Act;
(c) (A) No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and (B) each Preliminary Prospectus, at the time of filing thereof, conformed in all material respects to the requirements of the Act and the rules and regulations of the Commission thereunder, and did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with the Underwriter Information (as defined in Section 9(b) of this Agreement);
(d) For the purposes of this Agreement, the Applicable Time is [] p.m. (Eastern time) on the date of this Agreement. The Pricing Prospectus, as supplemented by the information listed on Schedule II(c) hereto, taken together (collectively, the Pricing Disclosure Package), as of the Applicable Time, did not, and as of each Time of Delivery (as defined in Section 4(a) of this Agreement) will not, include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and each Written Testing-the-Waters Communication does not conflict with the information contained in the Registration Statement, the Pricing Prospectus or the Prospectus and each Written Testing-the-Waters Communication, as supplemented by and taken together with the Pricing Disclosure Package, as of the Applicable Time, did not, and as of each Time of Delivery will not, include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that this representation and warranty shall not apply to statements or omissions made in reliance upon and in conformity with the Underwriter Information;
(e) The Companys Annual Report on Form 20-F for the year ended December 31, 2020 and Form 6-Ks filed or furnished since January 1, 2021, when they were filed with or furnished to the Commission (Exchange Act Documents), conformed in all material respects to the requirements of the Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder, and none of such documents contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and no such or any other documents were filed with or furnished to the Commission, as the case may be, since the Commissions close of business on the business day immediately prior to the date of this Agreement and prior to the execution of this Agreement, except as set forth on Schedule II(b) hereto;
3
(f) The Registration Statement conforms, and the Prospectus and any further amendments or supplements to the Registration Statement and the Prospectus will conform, in all material respects to the requirements of the Act and the rules and regulations of the Commission thereunder and do not and will not, as of the applicable effective date as to each part of the Registration Statement, as of the applicable filing date as to the Prospectus and any amendment or supplement thereto, and as of each Time of Delivery, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with the Underwriter Information;
(g) Neither the Company nor any of its subsidiaries has, since the date of the latest audited financial statements included or incorporated by reference in the Pricing Prospectus, (i) sustained any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree or (ii) entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole, in each case otherwise than as set forth or contemplated in the Pricing Prospectus; and, since the respective dates as of which information is given in the Registration Statement and the Pricing Prospectus, there has not been (x) any change in the capital stock (other than as a result of (i) the exercise, if any, of stock options or the award, if any, of stock options or restricted stock in the ordinary course of business pursuant to the Companys equity plans that are described in the Pricing Prospectus and the Prospectus or (ii) the issuance, if any, of stock upon conversion of Company securities as described in the Pricing Prospectus and the Prospectus) or long-term debt of the Company or any of its subsidiaries or (y) any Material Adverse Effect (as defined below); as used in this Agreement, Material Adverse Effect shall mean any material adverse change or effect, or any development involving a prospective material adverse change or effect, in or affecting (i) the business, properties, management, financial position or results of operations of the Company and its subsidiaries, taken as a whole, except as set forth or contemplated in the Pricing Prospectus, or (ii) the ability of the Company to perform its obligations under this Agreement, including the issuance and sale of the Shares, or to consummate the transactions contemplated in the Pricing Prospectus and the Prospectus;
(h) The Company and its subsidiaries do not own any real property. The Company and its subsidiaries have good and marketable title to all personal property owned by them, in each case free and clear of all liens, encumbrances and defects except such as are described in the Pricing Prospectus or such as do not materially affect the value of such property and would not be reasonably expected to materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not materially interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries;
4
(i) The Company and its subsidiaries own or have a valid and enforceable right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, domain names, copyrights and copyrightable works, licenses, inventions, software, source code, databases, technology, know-how, and other intellectual property (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems, procedures) and all other worldwide intellectual property, industrial property and proprietary rights (including all goodwill associated with, and all registrations of and applications for, the foregoing) (collectively, Intellectual Property) used or held for use in, or otherwise necessary to the conduct of their respective businesses as currently conducted and as proposed to be conducted in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The Company and its subsidiaries (i) collectively and exclusively own all right, title and interest in and to the Intellectual Property owned by the Company and its subsidiaries or described as owned by them in the Registration Statement, the Pricing Disclosure Package or the Prospectus, and any such Intellectual Property that is registered with a government agency has not been adjudged invalid or unenforceable by a court of competent jurisdiction or applicable government agency, in whole or in part, and is owned free and clear of all liens, encumbrances, claims, defects and other restrictions (other than (A) licenses and other rights with respect to any Intellectual Property granted in the ordinary course of business and (B) defects or irregularities in title that do not materially impair the use or operation of such Intellectual Property), in each case, except as would not, individually or in the aggregate, have a Material Adverse Effect and (ii) have not received any written opinion from their legal counsel concluding that any activities of their respective businesses infringe, misappropriate, or otherwise violate, the Intellectual Property of any other person. The Intellectual Property owned by the Company and each of its subsidiaries is subsisting and, to the knowledge of the Company, the registered Intellectual Property owned by the Company and each of its subsidiaries is valid and enforceable. There is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the ownership, validity, scope or enforceability of, or any rights of the Company or any of its subsidiaries in, any Intellectual Property owned by the Company. To the knowledge of the Company and its subsidiaries and the conduct of their businesses have not infringed, misappropriated or otherwise violated any Intellectual Property of any other person. To the knowledge of the Company, no person or entity has infringed, misappropriated or otherwise violated, any Intellectual Property owned by or licensed to the Company or any of its subsidiaries. No material written claim, or to the knowledge of the Company, any other claim, has been made against the Company alleging the infringement, misappropriation or other violation of any Intellectual Property of any other person by the Company or any of its subsidiaries. The Company and its subsidiaries use, and have used, commercially reasonable efforts in accordance with customary industry practice to appropriately protect, maintain and safeguard the confidentiality of all material Intellectual Property owned or purported to be owned by the Company or any of its subsidiaries, the value of which to the Company or any of its subsidiaries is contingent upon maintaining the confidentiality thereof, including the execution of appropriate nondisclosure and confidentiality agreements. No such material Intellectual Property has been disclosed other than to employees, representatives, contractors and agents of the Company or any of its subsidiaries, all of whom are bound by written confidentiality agreements. Each such employee or contractor has executed a valid and enforceable invention assignment agreement whereby such employee or contractor presently assigns all of his or her right, title and interest in and to such Intellectual Property, giving the Company or its applicable subsidiary sole and exclusive rights to the Intellectual Property developed by such person in connection with his or her employment or engagement, as applicable, with the Company or its subsidiaries. The Company is not in breach or violation
5
nor has received any asserted or threatened written claim, or to the knowledge of the Company, any other claim, of any breach or anticipated breach or violation by any other person to any such agreement. No government funding, facilities or resources of a university, college, other educational institution or research center or funding from third parties was used in the development of any material Intellectual Property that is owned or purported to be owned by the Company or any of its subsidiaries and no governmental agency or body, university, college, other educational institution or research center has any claim or right in or to any such Intellectual Property;
(j) Except as would not, individually or in the aggregate, have a Material Adverse Effect: (i) the Company and its subsidiaries use and have used any and all software and other materials distributed under a free, open source or similar licensing model (including, but not limited to, the MIT License, Apache License, GNU General Public License, GNU Lesser General Public License and GNU Affero General Public License) (collectively, Open Source Software) in compliance with all license terms applicable to such Open Source Software; and (ii) neither the Company nor any of its subsidiaries uses or distributes or has used or distributed any Open Source Software in any manner that requires or has required (A) the Company or any of its subsidiaries to permit reverse engineering of any software code or other technology owned by the Company or any of its subsidiaries or (B) any software code or other technology owned by the Company or any of its subsidiaries to be (1) disclosed or distributed in source code form, (2) licensed for the purpose of making derivative works or (3) redistributed at no charge;
(k) Except as would not, individually or in the aggregate, have a Material Adverse Effect, the Company and its subsidiaries respective information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, IT Systems) are adequate for, and operate and perform as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted and as proposed to be conducted in the Registration Statement, the Pricing Disclosure Package and the Prospectus, free and clear of all bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. Except as would not, individually or in the aggregate, have a Material Adverse Effect, the Company and its subsidiaries have complied, and are presently in compliance with, all applicable laws, statutes or any judgment, order, rule or regulation of any court or arbitrator or other governmental or regulatory authority, internal and external policies, and contractual obligations, in each case, relating to the privacy and security of IT Systems and information that could be used to identify an individual person (Personal Data) (collectively, the Data Security Obligations) and to the protection of such Data Security Obligations from unauthorized use, access, misappropriation or modification and the collection, use, transfer, processing, import, export, storage, protection, disposal and disclosure of Personal Data. Except as would not, individually or in the aggregate, have a Material Adverse Effect, the Company and its subsidiaries have used reasonable efforts to establish and maintain reasonable physical, technical and administrative safeguards consistent with industry standards and practices that are designed to protect against and prevent breach, destruction, loss, unauthorized distribution, use, access, disablement, misappropriation or modification relating to any IT Systems and Personal Data (Breach). Except as would not, individually or in the aggregate, have a Material Adverse Effect, there has been no such Breach to any IT Systems and Personal Data used in connection with the operation of the Companys and its subsidiaries businesses, and neither the Company nor any of its
6
subsidiaries has received any written notification of or complaint regarding any Data Security Obligation by the Company or any of its subsidiaries, and have no knowledge of any event or condition that would reasonably be expected to result in, a Breach to such Data Security Obligations. To the knowledge of the Company, there is no action, suit or proceeding by or before any court or governmental agency, authority or body, pending or threatened alleging non-compliance with any Data Security Obligation by the Company or any of its subsidiaries;
(l) Each of the Company and each of its subsidiaries has been (i) duly organized and is validly existing and in good standing (to the extent that the concept of good standing is applicable under the law of the relevant jurisdiction) under the laws of its jurisdiction of organization, with power and authority (corporate and other) to own its properties and conduct its business as described in the Pricing Prospectus, and (ii) duly qualified as a foreign corporation for the transaction of business and is in good standing (to the extent that the concept of good standing is applicable under the law of the relevant jurisdiction) under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to require such qualification, except, in the case of this clause (ii), where the failure to be so qualified or in good standing (to the extent that the concept of good standing is applicable under the law of the relevant jurisdiction) would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;
(m) The Company has an authorized capitalization as set forth in the Pricing Prospectus and all of the issued Ordinary Shares of the Company have been duly and validly authorized and issued and are fully paid and non-assessable and conform to the description of the Ordinary Shares contained in the Pricing Disclosure Package and Prospectus; and all of the issued shares of capital stock of each subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable and (except, in the case of any foreign subsidiary, for directors qualifying shares) are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims, except for such liens or encumbrances described in the Pricing Prospectus and the Prospectus;
(n) The Shares to be issued and sold by the Company to the Underwriters hereunder have been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued and fully paid and non-assessable and will conform to the description of the Ordinary Shares contained in the Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject to any preemptive or similar rights that have not been validly waived;
(o) The issue and sale of the Shares to be sold by the Company and the compliance by the Company with this Agreement and the consummation of the transactions contemplated in this Agreement and the Pricing Prospectus will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, (A) any indenture, mortgage, deed of trust, loan agreement, lease, or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (B) the certificate of incorporation or by-laws (or other applicable organizational document) of the Company or any of its subsidiaries, or (C) any statute or any judgment, order, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its
7
subsidiaries or any of their properties, except, in the case of clauses (A) and (C) for such defaults, breaches, or violations that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company and its subsidiaries, taken as a whole, or on the power and ability of the Company to perform its obligations under this Agreement. No consent, approval, authorization, order, registration or qualification of or with any such court or governmental agency or body is required for the issue of the Shares to be sold by the Company and the sale of the Shares or the consummation by the Company of the transactions contemplated by this Agreement, except such as have been obtained under the Act, the approval by the Financial Industry Regulatory Authority (FINRA) of the underwriting terms and arrangements, and such consents, approvals, authorizations, orders, registrations or qualifications as may be validly obtained or waived or as may be required under state securities or Blue Sky laws in connection with the purchase and distribution of the Shares by the Underwriters;
(p) Neither the Company nor any of its subsidiaries is (i) in violation of its certificate of incorporation or by-laws (or other applicable organizational document), (ii) in violation of any statute or any judgment, order, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any of their properties, or (iii) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or by which it or any of its properties may be bound, except, in the case of the foregoing clauses (ii) and (iii), for such defaults as would not, individually or in the aggregate, have a Material Adverse Effect;
(q) The statements set forth in the Pricing Prospectus and Prospectus under the caption Description of Securities, insofar as they purport to constitute a summary of the terms of the Ordinary Shares, under the captions Material Luxembourg Income Tax Considerations and Material U.S. Federal Income Tax Considerations, and under the caption Underwriting, insofar as they purport to describe the provisions of the laws and documents referred to therein, are accurate, complete and fair in all material respects;
(r) Other than as set forth in the Pricing Prospectus, there are no legal or governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (Actions) pending to which the Company or any of its subsidiaries or, to the Companys knowledge, any officer or director of the Company, is a party or of which any property of the Company or any of its subsidiaries or, to the Companys knowledge, any officer or director of the Company, is the subject which, if determined adversely to the Company or any of its subsidiaries (or such officer or director), would individually or in the aggregate reasonably be expected to have a Material Adverse Effect; and, to the Companys knowledge, no such proceedings are threatened or contemplated by governmental authorities or others; to the Companys knowledge, there are no current or pending Actions that are required under the Act to be described in the Registration Statement or the Pricing Prospectus that are not so described therein; and there are no statutes, regulations or contracts or other documents that are required under the Act to be filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement and the Pricing Prospectus;
8
(s) The Company is not and, after giving effect to the offering and sale of the Shares and the application of the proceeds thereof, will not be an investment company, as such term is defined in the Investment Company Act of 1940, as amended (the Investment Company Act);
(t) KPMG LLP, who have certified certain financial statements of the Company and its subsidiaries, and have audited the Companys internal control over financial reporting and managements assessment thereof, are independent public accountants as required by the Act and the rules and regulations of the Commission thereunder;
(u) The Company maintains a system of internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) that (i) complies in all material respects with the requirements of the Exchange Act, (ii) has been designed by the Companys principal executive officer and principal financial officer, or under their supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and (iii) is sufficient to provide reasonable assurance that (A) transactions are executed in accordance with managements general or specific authorization, (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain accountability for assets, (C) access to assets is permitted only in accordance with managements general or specific authorization and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and except as disclosed in the Pricing Prospectus, the Companys internal control over financial reporting is effective and the Company is not aware of any material weaknesses in its internal control over financial reporting;
(v) Except as disclosed in the Pricing Prospectus, since the date of the latest audited financial statements included or incorporated by reference in the Pricing Prospectus, there has been no change in the Companys internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting;
(w) The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that material information relating to the Company and its subsidiaries is made known to the Companys principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective;
(x) This Agreement has been duly authorized, executed and delivered by the Company;
(y) None of the Company or any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i) made, offered, promised or authorized any unlawful contribution, gift, entertainment or other unlawful expense or taken any act in furtherance thereof; (ii) made, offered, promised or authorized any direct
9
or indirect unlawful payment; or (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, or any applicable anti-corruption laws, rules, or regulations of the Grand Duchy of Luxembourg or the United Kingdom, including, without limitation, the UK Bribery Act 2010, as amended, and any applicable European Union national law regulating payments to governments officials or employees or any other applicable anti-corruption or anti-bribery or related law, statute or regulation (collectively, Anti-Corruption Laws); the Company and its subsidiaries have conducted their businesses in compliance with Anti-Corruption Laws and have instituted and maintained and will continue to maintain policies and procedures reasonably designed to promoted and achieve compliance with such laws and with the representations and warranties contained herein; neither the Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of the Anti-Corruption Laws;
(z) The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with the requirements of applicable anti-money laundering laws, including, but not limited to, the Bank Secrecy Act of 1970, as amended by the USA PATRIOT ACT of 2001, and the rules and regulations promulgated thereunder, and the anti-money laundering laws of the various jurisdictions in which the Company and its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulation or guidelines issued, administered or enforced by any governmental agency (collectively, the Money Laundering Laws) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened;
(aa) None of the Company or any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. Government, including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury, the Bureau of Industry and Security (BIS), or the U.S. Department of State and including, without limitation, the designation as a specially designated national or blocked person, the European Union, the Grand Duchy of Luxembourg, Her Majestys Treasury, the United Nations Security Council, or other relevant sanctions authority (collectively, Sanctions), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions (a Sanctioned Jurisdiction), and the Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person, or in any country or territory, that, at the time of such funding, is the subject or the target of Sanctions or (ii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions; neither the Company nor any of its subsidiaries is engaged in, or has, at any time in the past five years, engaged in, any dealings or transactions with or involving any individual or entity that was or is, as applicable, at the time of such dealing or transaction, the subject or target of Sanctions or with any Sanctioned Jurisdiction; the Company and its subsidiaries have instituted, and
10
maintain, policies and procedures designed to promote and achieve continued compliance with Sanctions; or applicable export control laws and regulations administered by BIS or other relevant authorities, including the Export Administration Regulations (collectively, Export Controls); provided, however, that no provision of this sub-section shall apply to any person if and to the extent that it is or would be unenforceable by or in respect of that person by reason of breach of (i) any provision of Council Regulation (EC) No 2271/96, as amended from time to time (the EU Blocking Regulation) (or any law or regulation implementing the EU Blocking Regulation in any member state of the European Union or the United Kingdom) or (ii) any similar blocking or anti-boycott law in the United Kingdom;
(bb) The Company and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not knowingly engage in, any dealings or transactions with any person or entity, or in any country or territory, that at the time of the dealing or transaction is or was the subject of applicable Sanctions or Export Controls, except as would not constitute a violation of Sanctions or Export Controls, or would otherwise violate Sanctions or Export Controls; provided, however, that no provision of this sub-section shall apply to any person if and to the extent that it is or would be unenforceable by or in respect of that person by reason of breach of (i) any provision of Council Regulation (EC) No 2271/96, as amended from time to time (the EU Blocking Regulation) (or any law or regulation implementing the EU Blocking Regulation in any member state of the European Union or the United Kingdom) or (ii) any similar blocking or anti-boycott law in the United Kingdom;
(cc) The financial statements included in the Registration Statement, the Pricing Prospectus and the Prospectus, together with the related schedules and notes, present fairly the financial position of the Company and its subsidiaries at the dates indicated and the statement of operations, stockholders equity and cash flows of the Company and its subsidiaries for the periods specified; said financial statements have been prepared in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board (IFRS) applied on a consistent basis throughout the periods involved. The supporting schedules, if any, present fairly in accordance with IFRS the information required to be stated therein. The selected financial data and the summary financial information included in the Registration Statement, the Pricing Prospectus and the Prospectus present fairly the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included therein. Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included in the Registration Statement, the Pricing Prospectus or the Prospectus under the Act or the rules and regulations promulgated thereunder. All disclosures contained in the Registration Statement, the Pricing Prospectus and the Prospectus regarding non-IFRS financial measures (as such term is defined by the rules and regulations of the Commission) comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Act, to the extent applicable;
(dd) From the time of initial confidential submission of a registration statement relating to the Shares with the Commission through the date hereof, the Company has been and is an emerging growth company as defined in Section 2(a)(19) of the Act (an Emerging Growth Company);
11
(ee) Except for any net income, capital gains or franchise taxes imposed on the Underwriters by the government of the Grand Duchy of Luxembourg or any political subdivision or taxing authority thereof or therein as a result of any present or former connection (other than any connection resulting from the transactions contemplated by this Agreement) between the Underwriters and the jurisdiction imposing such tax, no stamp duties or other issuance or transfer taxes are payable by or on behalf of the Underwriters in the Grand Duchy of Luxembourg, the United States or any political subdivision or taxing authority thereof solely in connection with (i) the execution, delivery and performance of this Agreement, (ii) the issuance and delivery of the Shares in the manner contemplated by this Agreement and the Pricing Prospectus or (iii) the sale and delivery by the Underwriters of the Shares as contemplated herein and in the Pricing Disclosure Package;
(ff) Neither the Company nor any of its subsidiaries or their properties or assets has immunity under the laws of the Grand Duchy of Luxembourg, or U.S. federal or New York state law from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from set-off or counterclaim, from the jurisdiction of any the Grand Duchy of Luxembourg, U.S. federal or New York state court, from service of process, attachment upon or prior to judgment, or attachment in aid of execution of judgment, or from execution of a judgment, or other legal process or proceeding for the giving of any relief or for the enforcement of a judgment, in any such court with respect to their respective obligations, liabilities or any other matter under or arising out of or in connection herewith; and, to the extent that the Company or any of its subsidiaries or any of its properties, assets or revenues may have or may hereafter become entitled to any such right of immunity in any such court in which proceedings arising out of, or relating to the transactions contemplated by this Agreement, may at any time be commenced, the Company has, pursuant to Section 23 of this Agreement, waived, and it will waive, or will cause its subsidiaries to waive, such right to the extent permitted by law;
(gg) Any final judgment for a fixed or determined sum of money rendered by any U.S. Federal or New York state court located in the State of New York having jurisdiction under its own laws in respect of any suit, action or proceeding against the Company based upon this Agreement would be declared, as Luxembourg case-law currently stands, enforceable against the Company by the courts of the Grand Duchy of Luxembourg, pursuant to an exequatur procedure, without reconsideration or reexamination of the merits;
(hh) The choice of laws of the State of New York as the governing law of this Agreement is a valid choice of law under the laws of the Grand Duchy of Luxembourg and will be honored by the courts of Luxembourg (Grand Duchy of Luxembourg), subject to the restrictions described under the caption Service Of Process And Enforcement Of Civil Liabilities Under U.S. Securities Laws in the Registration Statement, the Pricing Prospectus and the Prospectus and any overriding Luxembourg law provisions that may apply. The Company has the power to submit, and pursuant to Section 25 of this Agreement, has legally, validly, effectively and irrevocably submitted, to the personal jurisdiction of each New York state and United States federal court sitting in the City of New York and has validly and irrevocably waived any objection to the laying of venue of any suit, action or proceeding brought in such court;
(ii) The indemnification and contribution provisions set forth in Section 9 hereof do not contravene The Grand Duchy of Luxembourg law or public policy;
12
(jj) Based on the projected composition of the Companys income and assets, including goodwill, and the fact that the Company is not yet producing revenue from its active operations, the Company may be classified as a passive foreign investment company, as defined in section 1297 of the Internal Revenue Code of 1986, as amended, for the current taxable year or in the foreseeable future;
(kk) Except as otherwise disclosed in the Registration Statement, the Pricing Prospectus and the Prospectus, no approvals are currently required in the Grand Duchy of Luxembourg in order for the Company to pay dividends or other distributions declared by the Company to the holders of Shares. Under current laws and regulations of the Grand Duchy of Luxembourg and any political subdivision thereof, any amount payable with respect to the Shares upon liquidation of the Company or upon redemption thereof and dividends and other distributions declared and payable on the share capital of the Company may be paid by the Company in United States dollars and freely transferred out of the Grand Duchy of Luxembourg, and no such payments made to the holders thereof or therein who are non-residents of the Grand Duchy of Luxembourg will be subject to income, withholding or other taxes under laws and regulations of the Grand Duchy of Luxembourg or any political subdivision or taxing authority thereof or therein and without the necessity of obtaining any governmental authorization in the Grand Duchy of Luxembourg or any political subdivision or taxing authority thereof or therein. However, dividends distributed by the Company will in principle be subject to a 15% withholding tax unless a domestic exemption or a treaty reduction applies.
(ll) The legality, validity, enforceability or admissibility into evidence of any of the Registration Statement, the Pricing Disclosure Package, the Prospectus, this Agreement or the Shares in any jurisdiction in which the Company is organized or does business is not dependent upon such document being submitted into, filed or recorded with any court or other authority in any such jurisdiction on or before the date hereof or that any tax, imposition or charge be paid in any such jurisdiction on or in respect of any such document;
(mm) Any holder of the Shares and each Underwriter are each entitled to sue as plaintiff in the court of the jurisdiction of formation and domicile of the Company for the enforcement of their respective rights under this Agreement and the Shares and such access to such courts will not be subject to any conditions which are not applicable to residents of such jurisdiction or a company incorporated in such jurisdiction except that plaintiffs not residing in the Grand Duchy of Luxembourg may be required to guarantee payment of a possible order for payment of costs or damages at the request of the defendant;
(nn) No forward looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package, the Prospectus or any road show (as defined in Rule 433 under the Securities Act) has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.
2. Subject to the terms and conditions herein set forth (a) the Company agrees to sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at a purchase price per share of $[], the number of Firm Shares (to be adjusted by you so as to eliminate fractional shares) determined by multiplying the aggregate number of Firm Shares to be sold by the Company by a fraction, the numerator of which is the aggregate number of Firm Shares to be purchased by such Underwriter as set forth opposite the name of such Underwriter in Schedule I hereto and the denominator of which is the aggregate number of Firm Shares to be purchased by all
13
of the Underwriters from the hereunder and (b) in the event and to the extent that the Underwriters shall exercise the election to purchase Optional Shares as provided below, the Company agrees to sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company at the purchase price per share set forth in clause (a) of this Section 2 (provided that the purchase price per Optional Share shall be reduced by an amount per share equal to any dividends or distributions declared by the Company and payable on the Firm Shares but not payable on the Optional Shares), that portion of the number of Optional Shares as to which such election shall have been exercised (to be adjusted by you so as to eliminate fractional shares) determined by multiplying such number of Optional Shares by a fraction, the numerator of which is the maximum number of Optional Shares which such Underwriter is entitled to purchase as set forth opposite the name of such Underwriter in Schedule I hereto and the denominator of which is the maximum number of Optional Shares that all of the Underwriters are entitled to purchase hereunder.
The Company hereby grants to the Underwriters the right to purchase at their election up to 3,750,000 Optional Shares, at the purchase price per share set forth in the paragraph above, provided that the purchase price per Optional Share shall be reduced by an amount per share equal to any dividends or distributions declared by the Company and payable on the Firm Shares but not payable on the Optional Shares. Any such election to purchase Optional Shares may be exercised only by written notice from you to the Company, given within a period of 30 calendar days after the date of this Agreement and setting forth the aggregate number of Optional Shares to be purchased and the date on which such Optional Shares are to be delivered, as determined by you but in no event earlier than the First Time of Delivery (as defined in Section 4 hereof) or, unless you and the Company otherwise agree in writing, earlier than two or later than ten business days after the date of such notice.
3. Upon the authorization by you of the release of the Shares, the several Underwriters propose to offer the Shares for sale upon the terms and conditions set forth in the Pricing Prospectus and the Prospectus.
4. (a) The Shares to be purchased by each Underwriter hereunder, in definitive or book-entry form, and in such authorized denominations and registered in such names as the Representatives may request upon at least forty-eight hours prior notice to the Company shall be delivered by or on behalf of the Company to the Representatives, through the facilities of the Depository Trust Company (DTC), for the account of such Underwriter, against payment by or on behalf of such Underwriter of the purchase price therefor by wire transfer of Federal (same-day) funds to the accounts specified by the Company and the Custodian to the Representatives at least forty-eight hours in advance. The Company will cause the certificates, if any, representing the Shares to be made available for checking and packaging at least twenty-four hours prior to the Time of Delivery (as defined below) with respect thereto at the office of DTC or its designated custodian (the Designated Office). The time and date of such delivery and payment shall be, with respect to the Firm Shares, 9:30 a.m., New York time, on November 22, 2021 or such other time and date as the Representatives and the Company may agree upon in writing, and, with respect to the Optional Shares, 9:30 a.m., New York time, on the date specified by the Representatives in each written notice given by the Representatives of the Underwriters election to purchase such Optional Shares, or such other time and date as the Representatives and the Company may agree upon in writing. Such time and date for delivery of the Firm Shares is herein called the First Time of Delivery, each such time and date for delivery of the Optional Shares, if not the First Time of Delivery, is herein called the Second Time of Delivery, and each such time and date for delivery is herein called a Time of Delivery.
14
(b) The documents to be delivered at each Time of Delivery by or on behalf of the parties hereto pursuant to Section 8 hereof, including the cross receipt for the Shares, will be delivered at the offices of Davis Polk & Wardwell LLP: 450 Lexington Ave, New York, New York 10017 (the Closing Location), and the Shares will be delivered at the Designated Office, all at such Time of Delivery. A meeting will be held at the Closing Location at [] p.m., New York City time, on the New York Business Day next preceding such Time of Delivery, at which meeting the final drafts of the documents to be delivered pursuant to the preceding sentence will be available for review by the parties hereto. For the purposes of this Section 4, New York Business Day shall mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in New York City are generally authorized or obligated by law or executive order to close.
5. The Company agrees with each of the Underwriters:
(a) To prepare the Prospectus in a form approved by you and to file such Prospectus pursuant to Rule 424(b) under the Act not later than the Commissions close of business on the second business day following the execution and delivery of this Agreement, or, if applicable, such earlier time as may be required by Rule 430A(a)(3) under the Act; to make no further amendment or any supplement to the Registration Statement or the Prospectus prior to the last Time of Delivery which shall be disapproved by you promptly after reasonable notice thereof; to advise you, promptly after it receives notice thereof, of the time when any amendment to the Registration Statement has been filed or becomes effective or any amendment or supplement to the Prospectus has been filed and to furnish you with copies thereof; to file promptly all material required to be filed by the Company with the Commission pursuant to Rule 433(d) under the Act; to file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is required in connection with the offering or sale of the Shares; to advise you, promptly after it receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus or other prospectus in respect of the Shares, of the suspension of the qualification of the Shares for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement or the Prospectus or for additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus or other prospectus or suspending any such qualification, to promptly use its best efforts to obtain the withdrawal of such order;
(b) If required by applicable law, to endeavor to qualify the Shares for offering and sale under the securities laws of such jurisdictions as you may reasonably request; provided, however, nothing contained herein shall require the Company to do business in any jurisdiction, qualify as a foreign corporation (where not otherwise required), to file a general consent to service of process in any jurisdiction (where not otherwise required) or to subject itself to taxation in any jurisdiction (where not otherwise required);
15
(c) Prior to 10:00 a.m., New York City time, on the New York Business Day next succeeding the date of this Agreement and from time to time, to furnish the Underwriters with written and electronic copies of the Prospectus in New York City in such quantities as you may reasonably request, and, if the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is required at any time prior to the expiration of nine months after the time of issue of the Prospectus in connection with the offering or sale of the Shares and if at such time any event shall have occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is delivered, not misleading, or, if for any other reason it shall be necessary during such same period to amend or supplement the Prospectus or to file under the Exchange Act any document incorporated by reference in the Prospectus in order to comply with the Act or the Exchange Act, to notify you and upon your request to file such document and to prepare and furnish without charge to each Underwriter and to any dealer in securities as many written and electronic copies as you may from time to time reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct such statement or omission or effect such compliance; and in case any Underwriter is required to deliver a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) in connection with sales of any of the Shares at any time nine months or more after the time of issue of the Prospectus, upon your request but at the expense of such Underwriter, to prepare and deliver to such Underwriter as many written and electronic copies as you may request of an amended or supplemented Prospectus complying with Section 10(a)(3) of the Act;
(d) To make generally available to its securityholders as soon as practicable (which may be satisfied by filing with the Commissions Electronic Data Gathering, Analysis and Retrieval System (EDGAR)), but in any event not later than sixteen months after the effective date of the Registration Statement (as defined in Rule 158(c) under the Act), an earnings statement of the Company and its subsidiaries (which need not be audited) complying with Section 11(a) of the Act and the rules and regulations of the Commission thereunder (including, at the option of the Company, Rule 158);
(e) During the period beginning from the date hereof and continuing to and including the date 90 days after the date of the Prospectus (the Lock-Up Period), not to (i) offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise transfer or dispose of, directly or indirectly, or file with or confidentially submit to the Commission a registration statement under the Act relating to, any securities of the Company that are substantially similar to the Shares, including but not limited to any options or warrants to purchase Ordinary Shares or any securities that are convertible into or exchangeable for, or that represent the right to receive, Ordinary Shares or any such substantially similar securities, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Ordinary Shares or any such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Ordinary Shares or such other securities, in cash or otherwise without the prior written consent of the Representatives, provided, however, that the foregoing restrictions shall not apply to:
16
(A) |
the shares of Ordinary Shares to be sold hereunder and the Companys Convertible Senior Notes due 2026 (the Notes) to be sold in the concurrent private placement (including any Notes subject to the initial purchasers option to purchase additional Notes thereunder), as well as any Ordinary Shares issuable upon conversion of the Notes; |
(B) |
any privately negotiated capped call transactions expected to made with one or more of the initial purchasers and/or their respective affiliates in connection with the offering of the Notes; |
(C) |
offers of Ordinary Shares or securities convertible into, exchangeable for or repayable with Ordinary Shares in connection with a private placement in which Goldman Sachs International or one of its affiliates is engaged as placement agent; or |
(D) |
Ordinary Shares to be sold pursuant to employee stock option plans existing on, or upon the conversion or exchange of convertible or exchangeable securities outstanding as of, the date of this Agreement. |
(f) To furnish to its stockholders as soon as reasonably practicable after the end of each fiscal year an annual report (including a balance sheet and statements of income, stockholders equity and cash flows of the Company and its consolidated subsidiaries certified by independent public accountants) and, as soon as practicable after the end of each of the first three quarters of each fiscal year (beginning with the fiscal quarter ending after the effective date of the Registration Statement), to make available to its stockholders consolidated summary financial information of the Company and its subsidiaries for such quarter in reasonable detail; provided, however, that the Company will be deemed to have furnished such statement to its stockholders to the extent it is filed on EDGAR;
(g) To use the net proceeds received by it from the sale of the Shares pursuant to this Agreement in the manner specified in the Pricing Prospectus under the caption Use of Proceeds;
(h) To file with the Commission such information on Form 6-K or Form 20-F as may be required by Rule 463 under the Act;
(i) If the Company elects to rely upon Rule 462(b), the Company shall file a Rule 462(b) Registration Statement with the Commission in compliance with Rule 462(b) by 10:00 P.M., Washington, D.C. time, on the date of this Agreement, and the Company shall at the time of filing either pay to the Commission the filing fee for the Rule 462(b) Registration Statement or give irrevocable instructions for the payment of such fee pursuant to Rule 111(b) under the Act; and
(j) To promptly notify you if the Company ceases to be an Emerging Growth Company at any time prior to the later of (i) completion of the distribution of the Shares within the meaning of the Act and (ii) the last Time of Delivery.
17
6. (a) The Company represents and agrees that it will not take any action that would result in an Underwriter or the Company being required to file with the Commission pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of the Underwriter that the Underwriter otherwise would not have been required to file thereunder;
(b) [Reserved.]
(c) The Company agrees that if at any time following issuance of a Written Testing-the-Waters Communication any event occurred or occurs as a result of which such Written Testing-the-Waters Communication would conflict with the information in the Registration Statement, the Pricing Prospectus or the Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances then prevailing, not misleading, the Company will give prompt notice thereof to the Representatives and, if reasonably requested by the Representatives, will prepare and furnish without charge to each Underwriter a Written Testing-the-Waters Communication or other document which will correct such conflict, statement or omission;
(d) The Company represents and agrees that (i) it has not engaged in, or authorized any other person to engage in, any Testing-the-Waters Communications, other than Testing-the-Waters Communications with the prior consent of the Representatives with entities that the Company reasonably believes are qualified institutional buyers as defined in Rule 144A under the Act or institutions that are accredited investors as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Act; and (ii) it has not distributed, or authorized any other person to distribute, any Written Testing-the-Waters Communications, other than those distributed with the prior consent of the Representatives that are listed on Schedule II(d) hereto; and the Company reconfirms that the Underwriters have been authorized to act on its behalf in engaging in Testing-the-Waters Communications.
7. The Company covenants and agrees with the several Underwriters that the Company will pay or cause to be paid the following: (i) the fees, disbursements and expenses of the Companys counsel and accountants in connection with the registration of the Shares under the Act and all other expenses in connection with the preparation, printing, reproduction and filing of the Registration Statement, any Preliminary Prospectus, any Written Testing-the-Waters Communication and the Prospectus and amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers; (ii) the cost of printing or producing any Agreement among Underwriters, this Agreement, the Blue Sky Memorandum, closing documents (including any compilations thereof) and any other documents in connection with the offering, purchase, sale and delivery of the Shares; (iii) all expenses in connection with the qualification of the Shares for offering and sale under state securities laws as provided in Section 5(b) hereof, including the reasonable and documented fees and disbursements of counsel for the Underwriters in connection with such qualification and in connection with the Blue Sky survey (iv) all fees and expenses in connection with listing the Shares on NASDAQ; (v) the filing fees incident to, and the reasonable and documented fees and disbursements of counsel for the Underwriters in connection with, any required review by FINRA of the terms of the sale of the Shares (provided that the amount payable by the Company with respect
18
to the fees and disbursements of counsel to the Underwriters pursuant to this clause (v) shall not exceed $[] in the aggregate); (vi) the cost of preparing stock certificates; (vii) the cost and charges of any transfer agent or registrar; and (viii) all other costs and expenses incident to the performance of its obligations hereunder which are not otherwise specifically provided for in this Section. It is understood, however, that, except as provided in this Section, and Sections 9 and 11 hereof, the Underwriters will pay all of their own costs and expenses, including the fees of their counsel, stock transfer taxes on resale of any of the Shares by them, and any advertising expenses connected with any offers they may make.
8. The obligations of the Underwriters hereunder, as to the Shares to be delivered at each Time of Delivery, shall be subject, in their discretion, to the condition that all representations and warranties and other statements of the Company herein are, at and as of the Applicable Time and the Time of Delivery, true and correct, the condition that the Company shall have performed all of its obligations hereunder theretofore to be performed, and the following additional conditions:
(a) The Prospectus shall have been filed with the Commission pursuant to Rule 424(b) under the Act within the applicable time period prescribed for such filing by the rules and regulations under the Act and in accordance with Section 5(a) hereof; all material required to be filed by the Company pursuant to Rule 433(d) under the Act shall have been filed with the Commission within the applicable time period prescribed for such filing by Rule 433; if the Company has elected to rely upon Rule 462(b) under the Act, the Rule 462(b) Registration Statement shall have become effective by 10:00 P.M., Washington, D.C. time, on the date of this Agreement; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no stop order suspending or preventing the use of the Pricing Prospectus, or Prospectus shall have been initiated or threatened by the Commission; and all requests for additional information on the part of the Commission shall have been complied with to your reasonable satisfaction;
(b) Davis Polk & Wardwell LLP, counsel for the Underwriters, shall have furnished to the Representatives their written opinion and negative assurance letter, dated such Time of Delivery, in form and substance satisfactory to the Representatives, and such counsel shall have received such papers and information as they may reasonably request to enable them to pass upon such matters;
(c) Weil, Gotshal & Manges LLP, counsel for the Company, shall have furnished to you their written opinion and negative assurance letter, dated such Time of Delivery, in form and substance satisfactory to you;
(d) Linklaters LLP, Luxembourg counsel for the Company, shall have furnished to you their written opinion, dated such Time of Delivery, in form and substance satisfactory to you;
(e) On the date of the Prospectus at a time prior to the execution of this Agreement, at 9:30 a.m., New York City time, on the effective date of any post-effective amendment to the Registration Statement filed subsequent to the date of this Agreement and also at each Time of Delivery, KPMG shall have furnished to you a letter or letters, dated the respective dates of delivery thereof, in form and substance satisfactory to you;
19
(f) (i) Neither the Company nor any of its subsidiaries shall have sustained since the date of the latest audited financial statements included or incorporated by reference in the Pricing Prospectus any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth or contemplated in the Pricing Prospectus, and (ii) since the respective dates as of which information is given in the Pricing Prospectus there shall not have been any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any change or effect, or any development involving a prospective change or effect, in or affecting (x) the business, properties, general affairs, management, financial position, stockholders equity or results of operations of the Company and its subsidiaries, taken as a whole, except as set forth or contemplated in the Pricing Prospectus and the Prospectus, or (y) the ability of the Company to perform its obligations under this Agreement, including the issuance and sale of the Shares, or to consummate the transactions contemplated in the Pricing Prospectus and the Prospectus, the effect of which, in any such case described in clause (i) or (ii), is in your judgment, acting reasonably, so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares being delivered at such Time of Delivery on the terms and in the manner contemplated in the Pricing Prospectus and the Prospectus;1
(g) The Shares to be sold at such Time of Delivery shall have been duly listed;
(h) There are (and prior to each Time of Delivery, will be) no debt securities, convertible securities or preferred stock issued or guaranteed by the Company or any of its subsidiaries that are rated by a nationally recognized statistical rating organization, as such term is defined in Section 3(a)(62) under the Exchange Act;
(i) On or after the Applicable Time there shall not have occurred any of the following: (i) a suspension or material limitation in trading in securities generally on the New York Stock Exchange or on NASDAQ; (ii) a suspension or material limitation in trading in the Companys securities on NASDAQ; (iii) a general moratorium on commercial banking activities declared by either Federal or New York State authorities or a material disruption in commercial banking or securities settlement or clearance services in the United States; (iv) the outbreak or escalation of hostilities involving the United States or the declaration by the United States of a national emergency or war or (v) the occurrence of any other calamity or crisis or any change in financial, political or economic conditions in the United States or elsewhere, if the effect of any such event specified in clause (iv) or (v) in your judgment makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares being delivered at such Time of Delivery on the terms and in the manner contemplated in the Pricing Prospectus and the Prospectus;
1 |
Note to Weil: this covenant is already covered by the materiality qualifier at the end of the paragraph. |
20
(j) The Company shall have obtained and delivered to the Underwriters executed copies of an agreement from each of the parties listed on Schedule III hereto, substantially to the effect set forth in Annex I hereto;
(k) The Company shall have complied with the provisions of Section 5(c) hereof with respect to the furnishing of prospectuses on the New York Business Day next succeeding the date of this Agreement; and
(l) The Company shall have furnished or caused to be furnished to you at such Time of Delivery certificates of officers of the Company satisfactory to you as to the accuracy of the representations and warranties of the Company herein at and as of such Time of Delivery, as to the performance by the Company of all of their respective obligations hereunder to be performed at or prior to such Time of Delivery, as to such other matters as you may reasonably request, and the Company shall have furnished or caused to be furnished certificates as to the matters set forth in subsections (a) and (e) of this Section.
9. (a) The Company will indemnify and hold harmless each Underwriter against any losses, claims, damages or liabilities, joint or several, to which such Underwriter may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, any roadshow as defined in Rule 433(h) under the Act (a roadshow), any issuer information filed or required to be filed pursuant to Rule 433(d) under the Act, any Exchange Act Documents or any Testing-the-Waters Communication, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse each Underwriter for any legal or other expenses reasonably incurred by such Underwriter in connection with investigating or defending any such action or claim as such expenses are incurred; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, or any Testing-the-Waters Communication, in reliance upon and in conformity with the Underwriter Information.
(b) Each Underwriter, severally and not jointly, will indemnify and hold harmless the Company against any losses, claims, damages or liabilities to which the Company may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, or any roadshow or any Testing-the-Waters Communication, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment
21
or supplement thereto, or any roadshow or any Testing-the-Waters Communication, in reliance upon and in conformity with the Underwriter Information; and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection with investigating or defending any such action or claim as such expenses are incurred. As used in this Agreement with respect to an Underwriter and an applicable document, Underwriter Information shall mean the written information furnished to the Company by such Underwriter through the Representatives expressly for use therein; it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus furnished on behalf of each Underwriter: the concession and reallowance figures appearing in the [] paragraph under the caption Underwriting, and the information contained in the [] paragraph under the caption Underwriting.
(c) Promptly after receipt by an indemnified party under subsection (a), (b) or (c) above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying party in writing of the commencement thereof; provided that the failure to notify the indemnifying party shall not relieve it from any liability that it may have under the preceding paragraphs of this Section 9 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided further that the failure to notify the indemnifying party shall not relieve it from any liability that it may have to an indemnified party otherwise than under the preceding paragraphs of this Section 9. In case any such action shall be brought against any indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying party), and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation. No indemnifying party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (i) includes an unconditional release of the indemnified party from all liability arising out of such action or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party.
(d) If the indemnification provided for in this Section 9 is unavailable to or insufficient to hold harmless an indemnified party under subsection (a), (b) or (c) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the
22
offering of the Shares. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law, then each indemnifying party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one hand and the Underwriters on the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the total gross proceeds from the offering (after deducting underwriting discounts and commissions but before deducting expenses) received by the Company bear to the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or the Underwriters on the other and the parties relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this subsection (e) were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this subsection (e). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this subsection (e) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this subsection (e), no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Shares underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters obligations in this subsection (e) to contribute are several in proportion to their respective underwriting obligations and not joint.
(e) The obligations of the Company under this Section 9 shall be in addition to any liability which the Company may otherwise have and shall extend, upon the same terms and conditions, to each employee, officer and director of each Underwriter and each person, if any, who controls any Underwriter within the meaning of the Act and each broker-dealer or other affiliate of any Underwriter; and the obligations of the Underwriters under this Section 9 shall be in addition to any liability which the respective Underwriters may otherwise have and shall extend, upon the same terms and conditions, to each officer and director of the Company and to each person, if any, who controls the Company within the meaning of the Act.
23
10. (a) If any Underwriter shall default in its obligation to purchase the Shares which it has agreed to purchase hereunder at a Time of Delivery, you may in your discretion arrange for you or another party or other parties to purchase such Shares on the terms contained herein. If within thirty-six hours after such default by any Underwriter you do not arrange for the purchase of such Shares, then the Company shall be entitled to a further period of thirty-six hours within which to procure another party or other parties satisfactory to you to purchase such Shares on such terms. In the event that, within the respective prescribed periods, you notify the Company that you have so arranged for the purchase of such Shares, or the Company notifies you that it has so arranged for the purchase of such Shares, you or the Company shall have the right to postpone such Time of Delivery for a period of not more than seven days, in order to effect whatever changes may thereby be made necessary in the Registration Statement or the Prospectus, or in any other documents or arrangements, and the Company agrees to file promptly any amendments or supplements to the Registration Statement or the Prospectus which in your opinion may thereby be made necessary. The term Underwriter as used in this Agreement shall include any person substituted under this Section with like effect as if such person had originally been a party to this Agreement with respect to such Shares.
(b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by you, the Company as provided in subsection (a) above, the aggregate number of such Shares which remains unpurchased does not exceed one-eleventh of the aggregate number of all the Shares to be purchased at such Time of Delivery, then the Company shall have the right to require each non-defaulting Underwriter to purchase the number of shares which such Underwriter agreed to purchase hereunder at such Time of Delivery and, in addition, to require each non-defaulting Underwriter to purchase its pro rata share (based on the number of Shares which such Underwriter agreed to purchase hereunder) of the Shares of such defaulting Underwriter or Underwriters for which such arrangements have not been made; but nothing herein shall relieve a defaulting Underwriter from liability for its default.
(c) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by you, the Company as provided in subsection (a) above, the aggregate number of such Shares which remains unpurchased exceeds one-eleventh of the aggregate number of all the Shares to be purchased at such Time of Delivery, or if the Company shall not exercise the right described in subsection (b) above to require non-defaulting Underwriters to purchase Shares of a defaulting Underwriter or Underwriters, then this Agreement (or, with respect to a Second Time of Delivery, the obligations of the Underwriters to purchase and of the Company to sell the Optional Shares) shall thereupon terminate, without liability on the part of any non-defaulting Underwriter, or the Company, except for the expenses to be borne by the Company and the Underwriters as provided in Section 6 hereof and the indemnity and contribution agreements in Section 9 hereof; but nothing herein shall relieve a defaulting Underwriter from liability for its default.
11. The respective indemnities, rights of contribution, agreements, representations, warranties and other statements of the Company and the several Underwriters, as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall remain in full force and effect, regardless of any investigation (or any statement as to the results thereof) made by or on behalf of any Underwriter or any director, officer, employee, affiliate or controlling person of any Underwriter, or the Company, or any officer or director or controlling person of the Company and shall survive delivery of and payment for the Shares.
24
12. If this Agreement shall be terminated pursuant to Section 10 hereof, the Company shall not be under any liability to any Underwriter except as provided in Sections 7 and 9 hereof; but, if for any other reason, any Shares are not delivered by or on behalf of the Company as provided herein or the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the Company will reimburse the Underwriters through you for all out-of-pocket expenses approved in writing by you, including documented fees and disbursements of counsel, reasonably incurred by the Underwriters in making preparations for the purchase, sale and delivery of the Shares not so delivered, but the Company shall then be under no further liability to any Underwriter except as provided in Sections 7 and 9 hereof.
13. In all dealings hereunder, the Representatives shall act on behalf of each of the Underwriters, and the parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement on behalf of any Underwriter made or given by you jointly or by Goldman Sachs International on behalf of you as the Representatives.
14. All statements, requests, notices and agreements hereunder shall be in writing, and if to the Underwriters shall be delivered or sent by mail, telex or facsimile transmission to you as the representatives at Goldman Sachs International, Plumtree Court, 25 Shoe Lane, London EC4A 4AU, United Kingdom, Attention: Registration Department; J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Equity Syndicate Desk (facsimile: (212) 622-8358); Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019 (facsimile: 646-834-8133); and Cowen and Company, LLC, 599 Lexington Avenue, New York, New York 10022; and if to the Company shall be delivered or sent by mail, telex or facsimile transmission to the address of the Company set forth in the Registration Statement, Attention: Secretary; and if to any stockholder that has delivered a lock-up letter described in Section 8(j) hereof shall be delivered or sent by mail to his or her respective address or such other address as such stockholder provides in writing to the Company; provided, however, that any notice to an Underwriter pursuant to Section 9(b) hereof shall be delivered or sent by mail, telex, facsimile transmission or email to such Underwriter at its address set forth in its Underwriters Questionnaire, or telex constituting such Questionnaire, which address will be supplied to the Company by you upon request; provided, however, that notices under subsection 5(e) shall be in writing, and if to the Underwriters shall be delivered or sent by mail, telex or facsimile transmission to you as the representatives at Goldman Sachs International, Plumtree Court, 25 Shoe Lane, London EC4A 4AU, United Kingdom, Attention: Control Room; J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Equity Syndicate Desk (facsimile: (212) 622-8358); Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019; and Cowen and Company, LLC, 599 Lexington Avenue, New York, New York 10022. Any such statements, requests, notices or agreements shall take effect upon receipt thereof.
15. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include the name and address of their respective clients, as well as other information that will allow the underwriters to properly identify their respective clients.
25
16. This Agreement shall be binding upon, and inure solely to the benefit of, the Underwriters, the Company and, to the extent provided in Sections 9 and 11 hereof, the officers and directors of the Company and each person who controls the Company or any Underwriter, and their respective heirs, executors, administrators, successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement. No purchaser of any of the Shares from any Underwriter shall be deemed a successor or assign by reason merely of such purchase.
17. Time shall be of the essence of this Agreement. As used herein, the term business day shall mean any day when the Commissions office in Washington, D.C. is open for business.
18. The Company acknowledges and agrees that (i) the purchase and sale of the Shares pursuant to this Agreement is an arms-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other, (ii) in connection therewith and with the process leading to such transaction each Underwriter is acting solely as a principal and not the agent or fiduciary of the Company, (iii) no Underwriter has assumed an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement, (iv) the Company and each has consulted its own legal and financial advisors to the extent it deemed appropriate, and (v) none of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment advice, or solicitation of any action by the Underwriters with respect to any entity or natural person. The Company agrees that it will not claim that the Underwriters, or any of them, has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto.
19. This Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company and the Underwriters, or any of them, with respect to the subject matter hereof.
20. The Company and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
21. This Agreement may be executed by any one or more of the parties hereto in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
26
22. Notwithstanding anything herein to the contrary, the Company is authorized to disclose to any persons the U.S. federal and state income tax treatment and tax structure of the potential transaction and all materials of any kind (including tax opinions and other tax analyses) provided to the Company relating to that treatment and structure, without the Underwriters imposing any limitation of any kind. However, any information relating to the tax treatment and tax structure shall remain confidential (and the foregoing sentence shall not apply) to the extent necessary to enable any person to comply with securities laws. For this purpose, tax structure is limited to any facts that may be relevant to that treatment.
23. The Company will indemnify and hold harmless the Underwriters against any documentary, stamp, registration or similar issuance tax, including any interest and penalties, on the sale of the Shares by the Company to the Underwriters and on the execution and delivery of this Agreement. All payments to be made by the Company hereunder shall be made without withholding or deduction for or on account of any present or future Luxembourg taxes, duties or governmental shares whatsoever unless the Company is compelled by law to deduct or withhold such taxes, duties or charges. The Company will not cover any registration duties (droits denregistrement) in Luxembourg triggered upon the voluntary registration by the Underwriters of the Agreement or any ancillary documents if such registration is not required to maintain, enforce or protect their rights under this Agreement.
24. The Company agrees to indemnify each Underwriter, each employee, officer and director of each Underwriter, and each person, if any, who controls any Underwriter within the meaning of the Act and each broker-dealer or other affiliate of any Underwriter, against any loss incurred as a result of any judgment or order being given or made for any amount due hereunder and such judgment or order being expressed and paid in a currency (the judgment currency) other than U.S. dollars and as a result of any variation as between (i) the rate of exchange at which the U.S. dollar amount is converted into the judgment currency for the purpose of such judgment or order, and (ii) the rate of exchange at which such indemnified person is able to purchase U.S. dollars with the amount of the judgment currency actually received by the indemnified person. The foregoing indemnity shall constitute a separate and independent obligation of the Company and shall continue in full force and effect notwithstanding any such judgment or order as aforesaid. The term rate of exchange shall include any premiums and costs of exchange payable in connection with the purchase of, or conversion into, the relevant currency.
25. To the extent that the Company has or hereafter may acquire any immunity (sovereign or otherwise) from jurisdiction of any court of (i) the Grand Duchy of Luxembourg, or any political subdivision thereof, (ii) the United States or the State of New York, (iii) any jurisdiction in which it owns or leases property or assets or from any legal process (whether through service of notice, attachment prior to judgment, attachment in aid of execution, execution, set-off or otherwise) with respect to themselves or their respective property and assets or this Agreement, the Company hereby irrevocably waives such immunity in respect of its obligations under this Agreement to the fullest extent permitted by applicable law.
26. This Agreement and any transaction contemplated by this Agreement and any claim, controversy or dispute arising under or related thereto shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflict of laws that would results in the application of any other law than the laws of the State of New York.
27
27. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and may be enforced in any court to the jurisdiction of which the Company is subject by a suit upon such judgment. The Company appoints CT Corporation System, located at 28 Liberty Street, New York, New York 10005 as its authorized agent in the Borough of Manhattan in The City of New York upon which process may be served in any such suit or proceeding, and agrees that service of process upon such authorized agent, and written notice of such service to the Company by the person serving the same to the address provided in this Section, shall be deemed in every respect effective service of process upon the Company in any such suit or proceeding. The Company hereby represents and warrants that such authorized agent has accepted such appointment and has agreed to act as such authorized agent for service of process. The Company and further agrees to take any and all action as may be necessary to maintain such designation and appointment of such authorized agent in full force and effect;
28. Solely for the purposes of the requirements of Article 9(8) of the MIFID Product Governance rules under EU Delegated Directive 2017/593 (the Product Governance Rules) regarding the mutual responsibilities of manufacturers under the Product Governance Rules (i) each manufacturer acknowledges to each other manufacturer that it understands the responsibilities conferred upon it under the Product Governance Rules relating to each of the product approval process, the target market and the proposed distribution channels as applying to the Ordinary Shares and the related information set out in the Prospectus in connection with the Ordinary Shares; and (ii) the Underwriters and the Company note the application of the Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Ordinary Shares by the manufacturers and the related information set out in the Prospectus in connection with the Ordinary Shares.
29. (a) Notwithstanding any other term of this Agreement or any other agreements, arrangements, or understanding among the Bank, any Manager organized in a member state of the European Economic Area which has implemented the Bail-in Legislation or the United Kingdom (together with the Bank, each a BRRD Party) and the Managers, each BRRD Party and each Manager acknowledges and accepts that a BRRD Liability arising under this Agreement may be subject to the exercise of Bail-in Powers by the Relevant Resolution Authority, and acknowledges, accepts, and agrees to be bound by:
(i) the effect of the exercise of Bail-in Powers by the Relevant Resolution Authority in relation to any BRRD Liability of a BRRD Party (Relevant BRRD Party) to the other BRRD Party or to such Manager under this Agreement, that (without limitation) may include and result in any of the following, or some combination thereof:
(A) the reduction of all, or a portion, of the BRRD Liability or outstanding amounts due thereon on a permanent basis;
(B) the conversion of all, or a portion, of the BRRD Liability into shares, other securities or other obligations of the Relevant BRRD Party or another person, and the issue to or conferral on the other BRRD Party or such Manager of such shares, securities or obligations;
28
(C) the cancellation of the BRRD Liability; and/or
(D) the amendment or alteration of any interest, if applicable, thereon, the maturity or the dates on which any payments are due, including by suspending payment for a temporary period; and
(ii) the variation of the terms of this Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of Bail-in Powers by the Relevant Resolution Authority.
(b) Neither a reduction, in part or in full, of any BRRD Liability, the conversion thereof into another security or obligation of the Relevant BRRD Party or another person, as a result of the exercise of the Bail-in Power by the Relevant Resolution Authority with respect to the Relevant BRRD Party, nor the exercise of any Bail-in Power by the Relevant Resolution Authority with respect to the Agreement will be an event of default or otherwise constitute non-performance of a contractual obligation, or entitle the Manager to any remedies (including equitable remedies), which are hereby expressly waived.
(c) For purposes of this Article 29:
Bail-in Legislation means in relation to the United Kingdom or a member state of the European Economic Area which has implemented, or which at any time implements, the BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU Bail-in Legislation Schedule from time to time.
Bail-in Powers means any Write-down and Conversion Powers as defined in the EU Bail-in Legislation Schedule, in relation to the relevant Bail-in Legislation.
BRRD means Directive 2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms.
EU Bail-in Legislation Schedule means the document described as such, then in effect, and published by the Loan Market Association (or any successor person) from time to time at https://www.lma.eu.com/documents-guidelines/eu-bail-legislation-schedule (or any such successor web page).
BRRD Liability means a liability in respect of which the relevant Bail-in Powers in the applicable Bail-in Legislation may be exercised.
Relevant Resolution Authority means the resolution authority with the ability to exercise any Bail-in Powers in relation to the Relevant BRRD Party.
30. Recognition of the U.S. Special Resolution Regimes.
29
(a) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.
(b) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.
(c) As used in this section:
BHC Act Affiliate has the meaning assigned to the term affiliate in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).
Covered Entity means any of the following:
(i) a covered entity as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);
(ii) a covered bank as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or
(iii) a covered FSI as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
Default Right has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.
U.S. Special Resolution Regime means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
If the foregoing is in accordance with your understanding, please sign and return to us one for the Company and each of the Representatives plus one for each counsel counterparts hereof, and upon the acceptance hereof by you, on behalf of each of the Underwriters, this letter and such acceptance hereof shall constitute a binding agreement among each of the Underwriters, the Company. It is understood that your acceptance of this letter on behalf of each of the Underwriters is pursuant to the authority set forth in a form of Agreement among Underwriters, the form of which shall be submitted to the
30
Company for examination upon request, but without warranty on your part as to the authority of the signers thereof.
Very truly yours, | ||
Arrival | ||
By: | ||
Name: | ||
Title: |
31
Accepted as of the date hereof: | ||
Goldman Sachs International, | ||
By: |
|
|
Name: | ||
Title: | ||
J.P. Morgan Securities LLC, | ||
By: |
|
|
Name: | ||
Title: | ||
Barclays Capital Inc., | ||
By: |
|
|
Name: | ||
Title: | ||
Cowen and Company, LLC. | ||
By: |
|
|
Name: | ||
Title: | ||
On behalf of each of the Underwriters |
32
SCHEDULE II
(a) |
Additional Documents Incorporated by Reference: |
None
(b) |
Information other than the Pricing Prospectus that comprise the Pricing Disclosure Package: |
The initial public offering price per share for the Shares is $
The number of Shares purchased by the Underwriters is [ ].
(c) |
Written Testing-the-Waters Communications: |
[ ]
SCHEDULE III
1. |
Denis Sverdlov |
2. |
John Wozniak |
3. |
Avinash Rugoobur |
4. |
Michael Ableson |
5. |
Daniel Chin |
6. |
Tawni Nazario-Cranz |
7. |
F. Peter Cuneo |
8. |
Alain Kinsch |
9. |
Kristen OHara |
10. |
Yunseong Hwang |
11. |
Rexford J. Tibbens |
12. |
Kinetik S.à r.l. |
ANNEX I
Lock-up Agreement
Exhibit 5.1
Avocats |
Linklaters LLP 35 Avenue John F. Kennedy P.O. Box 1107 L-1011 Luxembourg Telephone (352) 26 08 1 Facsimile (352) 26 08 88 88 manfred.muller@linklaters.com |
|||
Arrival 1, rue Peternelchen L-2370 Howald Grand Duchy of Luxembourg
(the Addressee) |
||||
16 November 2021 |
1 |
Introduction |
We have acted as Luxembourg legal advisers to Arrival (formerly named Arrival Group), a company incorporated under the laws of the Grand Duchy of Luxembourg as a société anonyme with its registered office at 1, rue Peternelchen, L-2370 Howald, Grand Duchy of Luxembourg, and registered with the Luxembourg Register of Commerce and Companies under number B 248209 in connection with the Registration Statement on Form-F-1 (the Registration Statement) filed with the U.S. Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended, relating to the offering (the Offering) by the Company of new ordinary shares with a nominal value of EUR 0.10 per ordinary share (which number may be increased if the underwriters exercise their option to purchase additional Shares (as defined thereafter) from the Company (the Shares).
2 |
Scope of Inquiry |
For the purpose of this opinion, we have reviewed the following documents:
2.1 |
a copy of the draft Registration Statement; |
2.2 |
a copy of the articles of association of the Company as of 29 July 2021 (the Articles); |
2.3 |
a copy of the written resolutions of all the directors of Company (the Directors or Board of Directors) dated 12 November 2021 approving, inter alia, the Offering (the Board Resolutions); |
This communication is confidential and may be privileged or otherwise protected by work product immunity.
Linklaters LLP is a limited liability partnership registered in England and Wales with registered number OC326345. It is a law firm authorised and regulated by the Solicitors Regulation Authority, Linklaters LLP is registered on the list V of the Luxembourg Bar. The term partner in relation to Linklaters LLP is used to refer to a member of Linklaters LLP or an employee or consultant of Linklaters LLP or any of its affiliated firms or entities with equivalent standing and qualifications. A list of the names of the members of Linklaters LLP together with a list of those non-members who are designated as partners and their professional qualifications is open to inspection at its registered office, One Silk Street, London EC2Y 8HQ, England or on www.linklaters.com and such persons are either solicitors, registered foreign lawyers or European lawyers.
Please refer to www.linklaters.com/regulation for important information on our regulatory position.
2.4 |
an excerpt of the Luxembourg Register of Commerce and Companies dated 15 November 2021 obtained from the online services of the Luxembourg Business Registers official website pertaining to the Company (the Excerpt); and |
2.5 |
a certificate of non-inscription of judicial decisions dated 15 November 2021 obtained from the online services of the Luxembourg Business Registers official website pertaining to the Company (the Certificate). |
The documents under paragraph 2.1 to 2.5 being hereafter referred to as the Documents.
3 |
Assumptions |
For the purpose of this opinion, we have assumed, and we have not verified independently, the following:
3.1 |
that each signature (whether manuscript or electronic) is the genuine signature of the individual concerned and was affixed or inserted by such individual concerned or authorised to be inserted in the relevant document by the individual concerned; |
3.2 |
that copy documents, drafts or the forms of documents provided to us are true copies of, or in the final form of, the originals; |
3.3 |
the legal capacity and legal right under all relevant laws and regulations of all individuals signing the Documents or who give information on which we rely; |
3.4 |
that all authorisations and consents of any country (other than Luxembourg) which may be required in connection with (i) the Offering and other documents in respect thereof and (ii) the publication of the Registration Statement, have been or will be obtained; |
3.5 |
that the Articles have not been amended since 29 July 2021 and remain in full force and effect without modification; |
3.6 |
that the Excerpt is correct, complete and up-to-date; |
3.7 |
that the Certificate is correct, complete and up-to-date; |
3.8 |
that the Board Resolutions are true records of the proceedings described therein in a duly convened, constituted and quorate meeting, and the resolutions set out therein were validly passed and remain in full force and effect without modification; |
3.9 |
that there have been no amendments to or termination or replacement of any of the Documents; |
3.10 |
that the Company derives an economic and commercial benefit (intérêt social) from the Offering; |
3.11 |
that there are no provisions of the laws of any jurisdiction outside Luxembourg which would have a negative impact on the opinions we express in this legal opinion; |
3.12 |
that the Shares will be offered to the public in circumstances where the obligation to publish a prospectus in accordance with Regulation (EU) 2017/1129 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, as amended does not apply as set out in the Registration Statement; |
3.13 |
that the Company has its central administration, within the meaning of the Luxembourg law of 10 August 1915 on commercial companies, as amended and the centre of its main interests, within the meaning of Regulation (EU) 2015/848 of 20 May 2015 on insolvency proceedings (recast), in Luxembourg; |
Page 2 of 5 |
3.14 |
that the Company complies with the provisions of the Luxembourg act dated 31 May 1999 concerning the domiciliation of companies, as amended; and |
3.15 |
that the Board of Directors has not passed and shall not pass any resolutions that impose transfer or selling restrictions on the Shares. |
4 |
Opinion |
Based on the documents referred to in paragraph 2 above, subject to the assumptions made in paragraph 3 and to the qualifications made in paragraph 5 and to any matters or documents not disclosed to us, we are of the following opinion:
4.1 |
The Company is a public limited liability company (société anonyme) and has been incorporated for an unlimited duration and is validly existing under the laws of Luxembourg. |
4.2 |
The Shares, if and when issued and paid for in accordance with the Articles, the Board Resolutions and Luxembourg law, will be validly issued, fully paid as to their nominal value and non-assessable (as this term is defined under the laws of the State of New-York, meaning that the holder of such shares shall not be liable, solely because of his or her shareholder status, for additional payments to the Company or the Companys creditors). |
5 |
Qualifications |
The above opinions are subject to the following qualifications:
5.1 |
This opinion is subject to any limitations arising from bankruptcy, insolvency, liquidation, moratorium, controlled management, general settlement with creditors, recovery, resolution, reorganisation and other laws of general application relating to or affecting the rights of creditors. |
5.2 |
Our opinion that the Company exists is based on the Articles, the Excerpt and the Certificate. It should be noted that the analysis of the Excerpt is not capable of revealing conclusively whether or not a winding up petition has been presented because notice of a winding up order or winding up resolution passed may not be filed immediately with the Luxembourg Register of Commerce and Companies (Registre de Commerce et des Sociétés à Luxembourg). It should be also noted that the Certificate is not capable of revealing conclusively whether or not a winding up or administration petition or order has been presented or made, a receiver appointed, an arrangement with creditors proposed or approved or any other insolvency proceeding commenced in relation to the Company, as the case may be. Under Luxembourg law, the clerks office of the Luxembourg District Court (Tribunal darrondissement de et à Luxembourg), sitting in collective proceedings has a statutory (one-month) period to officially inform the Luxembourg Register of Commerce and Companies (Registre de Commerce et des Sociétés à Luxembourg) of the opening of such proceedings. |
5.3 |
We do not express any opinion as to whether the Registration Statement is accurate, true, correct, complete or not misleading. In particular, and without limitation to the foregoing, we express no opinion on whether the Registration Statement provides sufficient information for investors to reach an informed assessment of the Company, any companies within the Companys consolidation perimeter (if applicable) and the Shares. |
5.4 |
We do not express any opinion as to (i) the Luxembourg law of 13 January 2019 creating a Register of economic beneficiaries, as amended, and related regulations and circulars or (ii) Regulation (EU) |
Page 3 of 5 |
2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, as amended (GDPR) and its delegated and/or national implementing legislation. |
5.5 |
We do not express any opinion as to tax, accounting and regulatory matters, including but without limitation, (i) Regulation (EU) 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC derivatives, central counterparties and trade repositories, as amended (EMIR), (ii) Regulation (EU) 600/2014 of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments, as amended (MiFIR) and/or (iii) Regulation (EU) 2015/2365 of the European Parliament and of the Council of 25 November 2015 on transparency of securities financing transactions and of reuse, as amended (SFTR) and, in each case, their respective EU and/or national delegated and/or implementing legislation or regulation. |
5.6 |
The issuance of the Shares shall require (i) a confirmation from the delegate of the Board of Directors pursuant to the Board Resolutions resolving on the issuance of the Shares under the Companys authorized share capital (ii) an acknowledgment deed passed in front of a notary in Luxembourg recording the increase of the share capital increase of the Company by the issue of the Shares and (iii) depending on the number of Shares to be issued by the Company, resolutions taken by the shareholders of the Company at an extraordinary general meeting of shareholders of the Company, to increase the Companys authorized share capital. |
5.7 |
Any corporate documents relating to the Company and the publication of which is required by law are not effective (opposable) vis-à-vis third parties prior to their publication in the Luxembourg electronic platform for companies and associations (Recueil Electronique des Sociétés et Associations (RESA)), unless the relevant company proves that the relevant third party had knowledge of such documents. Third parties may however rely on such documents which have not yet been published. In relation to any transactions which have occurred before the sixteenth day following the date of publication, such documents are not effective (opposable) vis-à-vis third parties who prove that it was impossible for them to have knowledge of the relevant document. |
6 |
Luxembourg law |
6.1 |
This opinion is given on the basis that there will be no amendments to or termination or replacement of any of the documents, authorisations and consents referred to above. |
6.2 |
This opinion is governed by and based upon Luxembourg laws in existence as at the date hereof and as applied by the Luxembourg courts, published and presently in effect. We undertake no responsibility to notify the Addressee of this opinion of any change in the laws of Luxembourg or their construction or application after the date of this opinion. |
6.3 |
In this opinion, Luxembourg legal concepts are expressed in English terms and not in their original French terms. The concepts concerned may not be identical to the concepts described by the same English terms as they exist under the laws of other jurisdictions. This opinion may, therefore, only be relied upon under the express condition that any issues of interpretation arising above will be governed by Luxembourg law. |
6.4 |
We express no opinion as to any laws other than the laws of Luxembourg. |
7 |
Reliance |
7.1 |
This opinion is issued solely for the purposes of the filing of the Registration Statement and the issuance of the Shares. It may not be relied upon for any other purpose without our written consent. |
Page 4 of 5 |
We hereby consent to filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the U.S. Securities Act of 1933, as amended. This Opinion is strictly limited to the matters stated in it. |
Yours faithfully,
Linklaters LLP
by
/s/ Manfred Müller
Manfred Müller
Page 5 of 5 |
Exhibit 10.14
7th August 2021
John Wozniak
[*]1
RE: Offer of employment
Dear John
We are pleased to extend to you an offer of employment with Arrival USA Inc., (the Company). This offer is for the exempt position of Chief Financial Officer (Global CFO, covering all Arrival entities), commencing on 23rd August 2021. The offer is contingent upon proof of eligibility to work in the United States.
We are offering to you, employment under the following conditions:
1. |
Your annual base salary shall be $500,000, paid according to the Companys regular payroll practices and subject to applicable taxes and withholdings. This position is classified as exempt, meaning that overtime is not paid for hours worked in excess of a normal 40 hour work week. |
2. |
You will be eligible to participate in the Companys standard employee benefits in effect from time to time. Participation is subject to the terms and conditions of the particular plans and policies then in effect. The Company may amend or discontinue such benefits at its discretion. |
3. |
In addition, the Company currently provides a maximum of 15 paid vacation days per year. The accrual and use of such vacation days are governed by the Companys policies and procedures. The Company also provides 10 paid holidays per year. |
4. |
Your employment with the company will be at will. This means that either you or the company may terminate the employment relationship at any time, for any reason, with or without advanced notice. Importantly, no person other than the Chief Executive or the President of the Company may change this at will employment relationship and as such a change must be in writing and signed by the Chief Executive or President. After competition of a successful probationary period of 2 months from your start date of 23rd August 2021, should your employment with the Company be terminated either with or without cause, a payment equal to 3 months of the annual salary will be made to you. Alternatively, should you decide to leave your employment with the Company for good reason, a payment equal to 3 months of your annual salary will be made to you. |
1 |
Certain portions of this exhibit have been redacted in accordance with Item 601(a)(6) of Regulation S-K. This information is not material and disclosure of such information would constitute an unwarranted invasion of personal privacy. [*] indicates that information has been redacted. |
5. |
Your employment with the Company will be full-time, and you shall not accept other employment or duties that conflict with these requirements without the advance written consent of the Company. You agree to serve the Company faithfully in the performance of your duties and to devote your full time and best efforts to your employment with the Company. In addition, you agree to observe and comply with all the rules, regulations and personnel policies of the Company in effect from time to time. |
6. |
You shall directly report to the Chief Executive of Arrival globally, Denis Sverdlov. The Company retains the right to reassign you to a different position, at any time with or without notice, and to change your job duties to meet our business needs. Our industry changes rapidly and we must be flexible to meet the needs of the business. |
7. |
You shall perform the job duties virtually and shall participate in Company business meetings via phone or video conferencing platforms. You will be required to travel as business needs dictate, including to Companys offices in the U.S and U.K. Expenses for such travel are to be paid by the Company. |
8. |
As a material condition of employment, you will be required to sign a Confidentiality and Intellectual Property Agreement prior to commencing employment with the Company. The Confidentiality and Intellectual Property Agreement is intended to protect the Company from unauthorized disclosure or use of its confidential and proprietary information. A copy of the Confidentiality and Intellectual Property Agreement is attached for your review and signature. |
9. |
You represent that you are not bound by the terms of a confidentiality agreement or non-competition agreement or any other agreement with a former employer or other third party which would preclude you from accepting employment with the Company or which would preclude you from effectively performing your duties for the Company. You further warrant that you have the right to make all disclosures that you will make to the Company during the course of your employment with the Company. You agree that you shall not disclose to the Company, or seek to induce the Company to use, any confidential information in the nature of trade secrets or other proprietary information belonging to others and that in the event that the Company directs you to perform tasks that would result in the disclosure or use of any such confidential information, that you shall notify the Company in advance of any such disclosure. |
10. |
The terms of your employment shall be governed under Illinois State law. |
This offer is the entire offer to you; there are no other express or implied promises, representations or contracts being offered to you. If you agree to accept this offer, please sign, and date this letter and the Confidentiality and Intellectual Property Agreement and return the documents to me within ten (10) days of the date of this letter.
2
We look forward to you joining the Company. We believe you will find work here to be both personally and professionally rewarding. In addition, we believe that your skills, experience, and integrity will be of great benefit to the Company and its customers and clients.
Sincerely, |
/s/ Avinash Rugoobur |
President Date 07 August 2021 |
I accept the position as described in this letter. |
/s/ John Wozniak |
John Wozniak Date 07 August 2021 |
3
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated April 30, 2021, with respect to the consolidated financial statements of Arrival Luxembourg S.à r.l., included herein and to the reference to our firm under the heading Experts in the prospectus.
/s/ KPMG LLP
London, United Kingdom
November 16, 2021
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated April 30, 2021, with respect to the financial statements of Arrival, included herein and to the reference to our firm under the heading Experts in the prospectus.
/s/ KPMG LLP
London, United Kingdom
November 16, 2021